Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42678,0.111547263921094,0.00312934341236126,0.105413750832866,0.117680777009322,4.97544900830407e-266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42610,0.106905353852577,0.00314731640974194,0.100736613689483,0.113074094015672,1.10599127396709e-242
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,42610,-0.126980700395815,0.00417191413665537,-0.135157652103659,-0.11880374868797,8.05503159732249e-197
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,40510,-0.229263685653189,0.00792417095461493,-0.244795060724234,-0.213732310582144,1.24843774479804e-177
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42769,0.331167101523553,0.0115449638398721,0.308538972397404,0.353795230649703,9.7131866603393e-176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,42345,-0.342146704120349,0.0121186516795426,-0.365899261412253,-0.318394146828446,2.6114563681321e-170
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,42567,-0.112537889878825,0.00404007730829114,-0.120456441403075,-0.104619338354574,4.85447526833506e-166
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,40526,-0.110486310829737,0.00397240046769092,-0.118272215746411,-0.102700405913062,9.41857552007905e-165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C9,Complement component C9,40531,0.132221846755782,0.00511685483910466,0.122192811271137,0.142250882240428,4.12378656698304e-143
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,40531,0.0582182915930174,0.00230194770787584,0.0537064740855808,0.0627301091004541,2.4736254512639e-137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40450,-0.131080190371801,0.00531074854115093,-0.141489257512457,-0.120671123231146,4.88720665677182e-131
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,42586,-0.215732096462554,0.00884263035909151,-0.233063651966373,-0.198400540958734,1.16414362905634e-128
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42675,0.0629412349563202,0.00276521336194612,0.0575214167669059,0.0683610531457346,1.43289509925129e-112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,42720,-0.141283785823316,0.0062598136903908,-0.153553020656482,-0.12901455099015,9.37832011677015e-111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,42415,0.113837026873595,0.00518987725837674,0.103664867447177,0.124009186300014,8.91132822700043e-105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PYY,Peptide YY,40115,-0.217969875745157,0.00995112859090925,-0.237474087783339,-0.198465663706975,4.06548526866807e-104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,42635,-0.12797609846923,0.00588627823008443,-0.139513203800196,-0.116438993138265,4.91590021531377e-103
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,40538,0.144177949090751,0.00671720159376633,0.131012233966969,0.157343664214533,3.27802607268952e-100
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42593,-0.110961125463345,0.00523765155435635,-0.121226922509883,-0.100695328416806,5.24319956992661e-98
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42710,-0.281624043579071,0.0134835424942759,-0.308051786867852,-0.25519630029029,2.26465798823375e-95
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,42653,0.039007365521699,0.00194170682132152,0.0352016201519088,0.0428131108914891,1.80715227950954e-88
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,42610,-0.0793325180298395,0.00399698754848856,-0.0871666136248771,-0.071498422434802,1.98142693400451e-86
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,42654,-0.0649959808226252,0.00329266231984175,-0.071449598969515,-0.0585423626757354,1.58883023507053e-85
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,40510,-0.17263815385787,0.00874918600171819,-0.189786558421237,-0.155489749294502,3.08353167287635e-85
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,40531,0.096981654518457,0.0049268827662582,0.0873249642965909,0.106638344740323,7.62877971932082e-85
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,42720,0.0688609695323551,0.00352128999985271,0.0619592411326438,0.0757626979320664,5.32105110764971e-84
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,42660,-0.15401063243208,0.00790532348757411,-0.169505066467725,-0.138516198396435,2.18963743940317e-83
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42770,0.117096921329833,0.00605424707911933,0.105230597054759,0.128963245604907,3.07341251089731e-82
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42356,-0.151708816039606,0.00793524696021402,-0.167261900081626,-0.136155731997587,2.17550670765003e-80
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,40526,0.111650941142563,0.00587839161570572,0.10012929357578,0.123172588709347,3.26492332014544e-79
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,42635,0.0864138496274593,0.00455764264536084,0.0774808700425521,0.0953468292123666,3.9096919906512e-79
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,42688,-0.208080940757034,0.0114545637023098,-0.230531885613561,-0.185629995900507,7.0999330491029e-73
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40482,0.0638539306653826,0.00361333458133467,0.0567717948859667,0.0709360664447986,5.85130366038778e-69
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,42369,-0.137758608769585,0.00781306857832253,-0.153072223183097,-0.122444994356072,8.63973650010386e-69
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42688,0.0641312968694399,0.00367413577834448,0.0569299907438847,0.071332602994995,1.74189129256109e-67
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40282,0.0531261207434718,0.00305129046747128,0.0471455914272281,0.0591066500597155,5.27734664731521e-67
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,42617,-0.0953686695613748,0.00554667337584622,-0.106240149378033,-0.0844971897447162,1.48466768219098e-65
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,42658,0.0906350038782821,0.0052769475302005,0.0802921867190891,0.100977821037475,2.00856544278641e-65
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,42599,-0.173971089638831,0.0101562092569765,-0.193877259782505,-0.154064919495158,4.39769430474697e-65
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFM,Afamin,40538,-0.0334093737652772,0.00195049612362029,-0.037232346167573,-0.0295864013629814,5.93202206539007e-65
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,40222,-0.0982273110831903,0.00573515374233174,-0.10946821241816,-0.0869864097482201,6.40474319746097e-65
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42356,-0.0870958199955758,0.00526348786188385,-0.0974122562048682,-0.0767793837862835,6.90685030679006e-61
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,42753,-0.0837653273396505,0.00506844165777559,-0.0936994729888906,-0.0738311816904103,9.22896097567845e-61
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,42610,0.0438415290024863,0.00266680980734887,0.0386145817800825,0.0490684762248901,3.84695333212933e-60
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FURIN,Furin,42678,-0.0519107634843297,0.00319707520471241,-0.058177030885566,-0.0456444960830933,9.9553899233406e-59
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40461,-0.135874010937149,0.00836250001239599,-0.152264510961445,-0.119483510912853,1.07005660800517e-58
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42494,-0.0484923542927188,0.00298964249080575,-0.054352053574698,-0.0426326550107395,1.32572590826468e-58
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,40448,-0.11324153726776,0.00709650204901643,-0.127150681283833,-0.0993323932516883,1.05808141429734e-56
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,40282,-0.0443486272959468,0.00278028173787863,-0.0497979795021889,-0.0388992750897047,1.19167028998336e-56
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42662,0.0464941839888929,0.00296026519568575,0.0406920642053489,0.052296303772437,4.23230133801811e-55
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42610,-0.126417313376116,0.00808574758951442,-0.142265378651564,-0.110569248100667,1.28303736712942e-54
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42657,-0.0497343629909838,0.0032384971560438,-0.0560818174168296,-0.0433869085651379,8.87055166934718e-53
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42793,0.0374057269936613,0.0024406319902262,0.0326220882928179,0.0421893656945046,1.40393359121645e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,42673,-0.0697139731405372,0.00458613189281673,-0.078702791650458,-0.0607251546306164,9.34470294800308e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42678,-0.0523255145805341,0.00345018195963668,-0.059087871221422,-0.0455631579396462,1.57926003905012e-51
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,42720,-0.0507147851989601,0.00338243308749726,-0.0573443540504547,-0.0440852163474655,2.05402465471115e-50
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,42310,-0.0767514061751495,0.00513559334047139,-0.0868171691224734,-0.0666856432278256,4.3357218613474e-50
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42688,0.0490107709746748,0.00330301405515709,0.0425368634265669,0.0554846785227827,2.03331721410268e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42753,0.0371393514826465,0.00250917711734099,0.0322213643326582,0.0420573386326349,3.4707083958701e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MME,Neprilysin,42586,-0.117540200159613,0.00797718189176165,-0.133175476667466,-0.10190492365176,9.31070687296237e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,42345,-0.109921518113409,0.00747641045160253,-0.12457528259855,-0.0952677536282684,1.50912335782211e-48
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,42635,-0.0492518898147633,0.00336575727067172,-0.0558487740652798,-0.0426550055642467,4.04100478301967e-48
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42710,0.0311404885793946,0.00214342482669966,0.0269393759190633,0.0353416012397259,1.82455099422842e-47
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,42753,-0.0413363706305318,0.0028542097005022,-0.0469306216435161,-0.0357421196175475,3.51051905226483e-47
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42793,0.0483462742201567,0.00335155423593143,0.0417772279177311,0.0549153205225823,7.97854095572634e-47
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,40266,-0.0528293876937499,0.00365994949915189,-0.0600028887120876,-0.0456558866754122,8.34725404268777e-47
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42617,0.0438613626633677,0.00304219491626318,0.0378986606274918,0.0498240646992435,8.95412693111682e-47
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,41746,-0.0596951953707283,0.00414856161597008,-0.0678263761380297,-0.051564014603427,1.41568230325761e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GH1,Somatotropin,42612,0.241445010509436,0.0168799989205704,0.208360212625118,0.274529808393754,4.52981102367463e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,42610,0.0392973291340606,0.0028261912756853,0.0337579942337174,0.0448366640344038,1.19105328313282e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42610,0.0524251390767283,0.00377883242092199,0.0450186275317212,0.0598316506217354,1.83300561589795e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40012,-0.0439719472975944,0.00316945119613852,-0.0501840716420259,-0.0377598229531629,2.15051729152961e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,42610,-0.0424645667677898,0.00306435178155645,-0.0484706962596404,-0.0364584372759392,2.27642680370466e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42678,0.0549644219111001,0.00396849290170188,0.0471861758237644,0.0627426679984358,2.51127800471608e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40350,-0.0359633217309212,0.00262019035295612,-0.0410988948227152,-0.0308277486391272,1.58244191274661e-42
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,40032,0.0574685955778885,0.00428417892518372,0.0490716048845284,0.0658655862712486,1.05452980666712e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42688,0.0584194241340149,0.00437353911505571,0.0498472874685057,0.0669915607995241,1.93513362798504e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,42356,-0.0893879062120401,0.00671708230974152,-0.102553387539133,-0.0762224248849468,3.8012278637661e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42653,0.0584836708491655,0.00441430800237462,0.0498316271645113,0.0671357145338198,8.15318681292596e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,42675,0.0551483576326815,0.00416348671300387,0.046987923675194,0.0633087915901691,8.46742461315886e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42586,-0.0517666515378294,0.00391646630376557,-0.0594429254932099,-0.0440903775824489,1.22809398608596e-39
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,42793,-0.0677303498107563,0.00513322764860099,-0.0777914760020142,-0.0576692236194983,1.65042020118506e-39
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTR,Transthyretin,40423,-0.0324144322024522,0.00248278491301644,-0.0372806906319644,-0.0275481737729399,1.1274893874543e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42586,-0.104317267762419,0.00800646899829255,-0.120009946999072,-0.0886245885257654,1.43357564333373e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42720,-0.0466381437275621,0.00358318386570122,-0.0536611841043365,-0.0396151033507877,1.69335638847024e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42586,-0.103192207541672,0.00793628732300049,-0.118747330694753,-0.0876370843885906,2.02046735378084e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42415,-0.105585065072206,0.00812907632395283,-0.121518054667154,-0.0896520754772584,2.43764528496195e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42593,-0.0349966896902689,0.0027042036332087,-0.040296928811358,-0.0296964505691799,4.43272064119694e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,42662,-0.0228387007106287,0.0017764912785454,-0.0263206236165777,-0.0193567778046797,1.32289408585782e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42610,0.034259411574078,0.00267688462041214,0.0290127177180702,0.0395061054300858,2.77047816550918e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42793,0.0415164882806136,0.00324490876867271,0.0351564670940151,0.0478765094672121,2.89168591633154e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42732,-0.0394483634880372,0.00309267543393769,-0.0455100073385551,-0.0333867196375194,4.75136307697557e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,42669,-0.0823013366719673,0.00650518555498582,-0.0950515003597395,-0.0695511729841951,1.76594713254362e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,42325,-0.0735789630030278,0.00588005393594718,-0.0851038687174843,-0.0620540572885713,1.00916221028319e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,40222,-0.0767885697456818,0.00616222628772435,-0.0888665332696215,-0.0647106062217421,2.10394386591133e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,42657,-0.081737287841202,0.00657558186552278,-0.0946254282976266,-0.0688491473847773,2.79012620635076e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42586,-0.0967540744937939,0.00781037985146477,-0.112062419002665,-0.081445729984923,4.72894740593117e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42710,0.057472127497918,0.00464898435076709,0.0483601181704146,0.0665841368254215,6.45449297787372e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42494,-0.0634327129417582,0.00513185045355704,-0.07349113983073,-0.0533742860527864,6.63757814112391e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42793,-0.0480118475830659,0.00388838014075382,-0.0556330726589434,-0.0403906225071884,7.72045148395512e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,42487,0.0338555226077875,0.00274298813010376,0.0284792658727842,0.0392317793427909,8.28532418249608e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POSTN,Periostin,40526,0.0468612117839401,0.0037954262282906,0.0394221763764905,0.0543002471913896,8.48584736184334e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40450,-0.0630084409111574,0.00511083344422977,-0.0730256744618477,-0.052991207360467,1.06618642124467e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42345,-0.0711738782326513,0.00580078662087693,-0.0825434200095701,-0.0598043364557325,2.03193520507803e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42593,0.0475380873317845,0.00388327302101373,0.0399268722105976,0.0551493024529714,2.83443065922986e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42635,0.0326591063356448,0.00267270929818397,0.0274205961112042,0.0378976165600854,3.71297954776322e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,42720,0.0566638799121975,0.00465600135043462,0.0475381172653457,0.0657896425590494,6.74688169340762e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42586,0.0285305146888469,0.00234439464010874,0.0239355011942338,0.0331255281834601,6.80730504883275e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42672,0.0388758642899934,0.0032038043407463,0.0325964077821306,0.0451553207978562,1.04190461991373e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42494,-0.0406500519303038,0.00335834861301134,-0.047232415211806,-0.0340676886488015,1.5063504995074e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40526,-0.0406580738262949,0.00336152695615847,-0.0472466666603655,-0.0340694809922243,1.80134401150082e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,42586,-0.0656624970738151,0.00549534149752584,-0.0764333664089658,-0.0548916277386645,9.66723456489748e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),40323,0.214329171296686,0.0179398540486706,0.179167057361291,0.24949128523208,1.06515549195863e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40276,-0.0546133858259215,0.00457761033081984,-0.0635855020743284,-0.0456412695775146,1.29888320159409e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELE,E-selectin,42793,-0.0595028656291586,0.00499574377889495,-0.0692945234357927,-0.0497112078225245,1.51079666818193e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40222,-0.0663286655176634,0.00562102353260217,-0.0773458716415637,-0.0553114593937632,6.06568416713255e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40538,0.0310806864582696,0.00263570462043935,0.0259147054022084,0.0362466675143307,6.57652941789067e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42369,-0.0645547412964736,0.00548486969096209,-0.0753050858907593,-0.0538043967021879,8.07948647522612e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42617,0.0398029265205076,0.00338870407344202,0.0331610665365613,0.046444786504454,1.06120199089081e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,40181,-0.0944446774534194,0.00807505428552917,-0.110271783853057,-0.0786175710537823,2.05411810623898e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40503,0.056984712504756,0.00487275479383481,0.0474341131088397,0.0665353119006722,2.06032096883382e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREH,Trehalase,40526,-0.085015237185119,0.00730844452973319,-0.099339788463396,-0.070690685906842,4.23260969167689e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,42662,0.0323276617439923,0.00278403842639237,0.0268709464282632,0.0377843770597213,5.04519974505922e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42720,-0.142998691759915,0.0123157555552743,-0.167137572648253,-0.118859810871578,5.08186083450507e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,42704,0.0317245917516229,0.00273604674595863,0.026361940129544,0.0370872433737018,6.11727234132409e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42345,-0.073272815682393,0.00633225152203542,-0.0856840286655824,-0.0608616026992036,8.11538720682257e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42476,-0.17098870718422,0.0147810616175087,-0.199959587954537,-0.142017826413903,8.39957557963671e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,40510,0.0395811972641755,0.00345130364718064,0.0328166421157014,0.0463457524126495,2.7918763963485e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,40508,0.0842476842902418,0.00736516994529896,0.0698119511974559,0.0986834173830278,3.9231748820936e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40501,0.0171305613688968,0.00150018900862525,0.0141901909119913,0.0200709318258023,4.9120179122279e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,40341,-0.0270078184357561,0.00237432308874953,-0.0316614916897052,-0.0223541451818071,8.13605111238349e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,42710,-0.0675260833686652,0.00596600341467995,-0.0792194500614379,-0.0558327166758925,1.44405253825243e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42667,0.0340365783708786,0.00301141389061615,0.028134207145271,0.0399389495964863,1.73075676307317e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40198,-0.139566713305327,0.0123923213145434,-0.163855663081832,-0.115277763528821,2.90985799788525e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42214,-0.112574454272502,0.0100177215341917,-0.132209188479518,-0.0929397200654865,3.6333237675125e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,40283,0.0343530121892887,0.003056612709322,0.0283620512790176,0.0403439730995598,3.77369256092782e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,40345,-0.0308284588857042,0.00274854243534247,-0.0362156020589754,-0.025441315712433,4.85090780817407e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,42494,0.0382986857962566,0.00341861015959613,0.0315982098834482,0.044999161709065,5.31486757707542e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40531,-0.0245025217056586,0.0021867517370905,-0.028788555110356,-0.0202164883009613,5.47231097975048e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42720,0.0645895560080317,0.00578002933791642,0.0532606985057155,0.0759184135103479,7.26289034612095e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,42635,-0.0700570363585068,0.00626925932524243,-0.082344784635982,-0.0577692880810316,7.26935812944281e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,42620,0.0494898886611903,0.00442909602314111,0.0408088604558337,0.0581709168665468,7.343361225854e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,42568,-0.0804957307384413,0.00725013936960564,-0.0947060039028683,-0.0662854575740142,1.62248623646869e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42249,-0.0604467027127618,0.00544658670427688,-0.0711220126531445,-0.0497713927723791,1.71847984656404e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,42710,0.0414691561608149,0.00375420280942694,0.0341109186543381,0.0488273936672917,3.02510532722456e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,40510,-0.0302889061089565,0.00278408534531846,-0.0357457133857807,-0.0248320988321323,1.97741651147264e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,42586,-0.0377096270214151,0.00348516979477668,-0.0445405598191774,-0.0308786942236529,3.58399563046361e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42610,0.0314383606312104,0.00291005494046797,0.0257346529478931,0.0371420683145276,4.28958013561777e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,42670,-0.03292846341856,0.00305673457158792,-0.0389196631788723,-0.0269372636582476,5.98111271954557e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,42720,-0.0491789549431182,0.00456910581192409,-0.0581344023344894,-0.0402235075517469,6.58827576338156e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40115,-0.0593809345686463,0.00551485009937663,-0.0701900407634245,-0.0485718283738681,6.69071421411156e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASN,Vasorin,42448,0.0292586596097418,0.00272059979714141,0.0239262840073446,0.0345910352121389,7.28554154129831e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,40481,-0.0466982573185726,0.00434565341073781,-0.0552157380036187,-0.0381807766335265,8.34359121833222e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42589,-0.0532179488337928,0.00495539320810391,-0.0629305195216765,-0.0435053781459091,8.54513582727307e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,42753,-0.0324737252127521,0.00303079251401073,-0.0384140785402131,-0.026533371885291,1.11161573582448e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,40510,-0.0279737697398634,0.00261390208498009,-0.0330970178264244,-0.0228505216533024,1.33613301697304e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,40222,-0.0621109873148481,0.00580572560225747,-0.0734902094952727,-0.0507317651344234,1.40043743943811e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,40282,-0.0408263735134688,0.00382359386163969,-0.0483206174822826,-0.033332129544655,1.74455191140784e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42586,0.0433006346649008,0.00405956794711431,0.0353438814885568,0.0512573878412449,1.8683588734786e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,40448,-0.117010618520078,0.0109868178526314,-0.138544781511235,-0.0954764555289201,2.32535364655438e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42599,-0.0208822792922943,0.00196364446145119,-0.0247310224367386,-0.0170335361478499,2.62288868653791e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40282,-0.0518889613183375,0.00489937950159527,-0.0614917451414643,-0.0422861774952108,4.37383564773428e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42720,0.0360005024625302,0.0034087671711565,0.0293193188070634,0.0426816861179969,5.69330608349667e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEP,Leptin,42635,-0.0687741997254016,0.00654909021811599,-0.0816104165529089,-0.0559379828978942,1.07086250697884e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSN,Gelsolin,40487,0.020132652638765,0.00192040187252974,0.0163686649686067,0.0238966403089233,1.34728349532846e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELL,L-selectin,40538,0.0246938270042569,0.00235870283369958,0.0200707694502057,0.0293168845583081,1.56332677224544e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,42678,-0.0408918052068633,0.00391354271005137,-0.048562348918564,-0.0332212614951626,1.85625128087362e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,42610,-0.0568107605807125,0.0054628649199098,-0.0675179758237357,-0.0461035453376893,3.10993475106396e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,42763,0.0561879467164321,0.00544991263516288,0.0455061179515129,0.0668697754813514,7.85138235364309e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42675,0.0210963478891279,0.00204826420848543,0.0170817500404964,0.0251109457377593,8.73998201584148e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNC,Tenascin,42688,0.0483210581432526,0.00477608669976046,0.0389599282117221,0.0576821880747831,5.63825954984193e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42610,-0.0534124642741225,0.00528045618084473,-0.0637621583885781,-0.0430627701596668,5.77008186222609e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,42667,0.0388103511804133,0.00383987093554917,0.0312842041467369,0.0463364982140896,6.24702019855456e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,40381,0.0422575164446008,0.00418548028037409,0.0340539750950676,0.050461057794134,7.26468805017666e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40222,0.0603530121299783,0.00597953251834259,0.0486331283940268,0.0720728958659298,7.5097105818617e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,40515,-0.0279524095271786,0.00277191613691777,-0.0333853651555374,-0.0225194538988197,8.18351685195443e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42637,0.0339380775506803,0.0033780034622869,0.0273171907645979,0.0405589643367626,1.15032182002218e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40282,-0.0737232492441238,0.00734029293212147,-0.0881102233910819,-0.0593362750971657,1.23647590616256e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,42586,-0.0695918335269305,0.00694967389634436,-0.0832131943637655,-0.0559704726900956,1.60565916140682e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,42753,-0.0438432201424389,0.00438302162258607,-0.0524339425227076,-0.0352524977621702,1.78373452265752e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42759,-0.0497640382191982,0.00497641703198842,-0.0595178156018955,-0.0400102608365009,1.83792586684364e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,40510,-0.0826424633004498,0.00827275490809238,-0.0988570629203109,-0.0664278636805887,2.11325520288645e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40481,-0.0561667537150083,0.00567086780647518,-0.0672816546156997,-0.045051852814317,4.94326560497288e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42704,-0.0458560790269332,0.00463593532749644,-0.0549425122688262,-0.0367696457850402,5.42820296490502e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42584,-0.0530723715443471,0.00536561323993582,-0.0635889734946213,-0.0425557695940729,5.44972928361415e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,40222,-0.0546551445377945,0.0055288869441358,-0.0654917629483007,-0.0438185261272883,6.00061745157055e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FST,Follistatin,42653,0.0477795978593934,0.00485219381491113,0.0382692979821676,0.0572898977366192,8.43188007528549e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,42593,0.0428448036355548,0.00436884511994913,0.0342818672004545,0.051407740070655,1.25305240702276e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42635,-0.0419483385890659,0.00428993611665952,-0.0503566133777186,-0.0335400638004133,1.65828152773269e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42635,-0.0295245818031686,0.00302787853863119,-0.0354592237388857,-0.0235899398674514,2.16879977851806e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42601,0.0548266442774493,0.00563766576933616,0.0437768193695504,0.0658764691853481,2.79315066939226e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42643,-0.0488915026159488,0.00504594019311569,-0.0587815453944555,-0.039001459837442,3.95584434533188e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,40378,0.103995106146122,0.0107659868289866,0.082893771961308,0.125096440330936,5.45449829899392e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,42753,-0.0329064945295715,0.00343540874679709,-0.0396398956732938,-0.0261730933858492,1.15163141322784e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,42635,-0.0657066139900053,0.00688345176450543,-0.079198179448436,-0.0522150485315747,1.58354782041939e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42586,-0.0813480565073583,0.00852664412291609,-0.0980602789882738,-0.0646358340264428,1.66437984643793e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42345,-0.0761574452891713,0.00799520270634522,-0.0918280425936079,-0.0604868479847347,1.92794049606499e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,42710,-0.0345001360070411,0.00363106412143448,-0.0416170216850527,-0.0273832503290296,2.41453519371059e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD248,Endosialin,40526,0.0378147876837012,0.00402693319431744,0.029921998622839,0.0457075767445633,7.1123797970636e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,42678,-0.0486113996447552,0.00518447463447069,-0.0587729699283177,-0.0384498293611926,7.90323907213045e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,42140,0.0295759089421184,0.00318804588912828,0.0233273389994269,0.0358244788848098,2.01418446499789e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42586,-0.063721852748298,0.00687515040823884,-0.0771971475484462,-0.0502465579481499,2.1736942942661e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42356,-0.0843804384535718,0.00910981429678297,-0.102235674475266,-0.0665252024318772,2.30085986261732e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,42593,-0.0350169622414913,0.00379468848188456,-0.0424545516659851,-0.0275793728169976,3.16823128018909e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42678,-0.0203686388429637,0.00220917328540222,-0.0246986184823521,-0.0160386592035754,3.40481028424745e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,42570,-0.0279842868490964,0.00304635748149721,-0.0339551475128309,-0.0220134261853619,4.66324016615463e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REN,Renin,42635,-0.0777369332349637,0.00847030610391846,-0.0943387331986439,-0.0611351332712835,5.04354169687114e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,42639,0.034537538378525,0.00376861865211961,0.0271510458203706,0.0419240309366795,5.68942199210994e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42651,0.0322510401766757,0.00353052451057162,0.0253312121359553,0.0391708682173961,7.46879634976406e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42237,-0.0177813222862763,0.00195673985692881,-0.0216165324058568,-0.0139461121666959,1.16092492126408e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,42793,-0.0544046288201005,0.00598957861502104,-0.0661442029055417,-0.0426650547346592,1.19766160601383e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42586,-0.0932140743019784,0.0103036814415287,-0.113409289927375,-0.0730188586765822,1.67438411844531e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42688,-0.0367966467076,0.00406835570771894,-0.0447706238947291,-0.0288226695204709,1.70469594713619e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,40481,-0.0490405234913171,0.00542658346659998,-0.0596766270858531,-0.0384044198967812,1.87050335179086e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40386,-0.0280179055522232,0.00311044215579124,-0.034114372177574,-0.0219214389268724,2.44479867641088e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,42587,0.0343859351397095,0.00381936202535143,0.0268999855700207,0.0418718847093983,2.48782123686451e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,40448,-0.0877343024780466,0.0097426270110251,-0.106829851419656,-0.0686387535364374,2.4985144240433e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42593,-0.0460354121339337,0.00512337618618828,-0.0560772294588627,-0.0359935948090046,2.9195272428187e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40538,0.0227401219268539,0.00253056759263825,0.017780209445283,0.0277000344084249,2.96389429149555e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,40531,-0.025181902069281,0.00280509362028548,-0.0306798855650406,-0.0196839185735215,3.21410559712357e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42678,-0.0326921726094452,0.00364463302566701,-0.0398356533397525,-0.0255486918791379,3.35314329475612e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,42793,-0.055067532675081,0.00616629898021025,-0.0671534786762931,-0.0429815866738689,4.78281672880064e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,40526,0.0465600104828023,0.00522065982961085,0.036327517216765,0.0567925037488395,5.45394879741271e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40198,-0.0602584489848261,0.00676734341105496,-0.0735224420704938,-0.0469944558991583,6.21515145645895e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42586,0.0364502148892007,0.00410290434681307,0.0284085223694471,0.0444919074089543,7.26289580861273e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40198,-0.0389959642786297,0.00439866186052939,-0.0476173415252673,-0.0303745870319921,8.7955489668745e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42593,-0.0841586891689886,0.00949751788217168,-0.102773824218045,-0.0655435541199321,8.9086614113669e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40282,-0.033098006311355,0.00373752268916462,-0.0404235507821177,-0.0257724618405924,9.58879968000474e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,40282,-0.0551566974230226,0.00625196187211795,-0.0674105426923737,-0.0429028521536714,1.28906776017341e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40450,-0.0332504231928982,0.00377054437148072,-0.0406406901610004,-0.025860156224796,1.33090678591174e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42637,0.0208531741489093,0.00237058590937211,0.01620682576654,0.0254995225312786,1.57972070415039e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42586,-0.0314129761063947,0.00357579063192713,-0.0384215257449719,-0.0244044264678175,1.75328665344414e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40115,-0.0549704306356903,0.00626308650722999,-0.0672460801898611,-0.0426947810815195,1.93058586631336e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,42635,0.0269890878108819,0.0030834038004703,0.0209456163619601,0.0330325592598037,2.32245013839812e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40282,-0.0331178981391935,0.00378788072440377,-0.0405421443590249,-0.0256936519193621,2.59419865891359e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,42705,-0.0180425164163672,0.00206937445682484,-0.0220984903517439,-0.0139865424809905,3.13571548851385e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,42586,0.0254820883843673,0.00292262001093005,0.0197537531629444,0.0312104236057902,3.13618563077088e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40526,0.0182951720415597,0.00209896760437674,0.0141811955369813,0.0224091485461381,3.27457872761534e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40282,0.024024112201938,0.00276371013213989,0.0186072403429438,0.0294409840609322,4.03666994367122e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,40382,-0.023052585561616,0.00265242654904175,-0.0282513415977378,-0.0178538295254942,4.0877838304437e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,42691,-0.0535610885494371,0.00616532388168408,-0.0656451233575379,-0.0414770537413363,4.1280599906585e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,42793,0.013969975434365,0.00161124634352773,0.0108119326010507,0.0171280182676794,4.79330988824331e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,42710,0.0253659153316025,0.00293021989492666,0.0196226843375462,0.0311091463256588,5.40241672405615e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42793,0.0247678037931296,0.00286394903006837,0.0191544636941956,0.0303811438920636,5.81563562846341e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,42187,-0.0339973616577406,0.00394747602933454,-0.0417344146752363,-0.0262603086402449,7.97084187975419e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42753,-0.028049507038237,0.00325761584706408,-0.0344344340984826,-0.0216645799779914,8.07321507763047e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42369,-0.0588360074914859,0.00683468992475911,-0.0722319997440137,-0.045440015238958,8.23939755089556e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,42316,-0.0420118133502926,0.00489682487142181,-0.0516095900982793,-0.0324140366023058,1.05994085731206e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42593,-0.0767017811129753,0.00895571671593017,-0.0942549858761984,-0.0591485763497521,1.20226995226423e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,42586,-0.0360575040213365,0.00421580533667191,-0.0443204824812135,-0.0277945255614596,1.32916783305166e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,42793,0.0235187044232288,0.00275194170554819,0.0181248986803543,0.0289125101661032,1.40612879607544e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,40282,0.046201420439392,0.00540481325247317,0.0356079864645445,0.0567948544142394,1.41405294339216e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,42494,0.029013164598728,0.00340541483215989,0.0223385515276947,0.0356877776697614,1.77012000658957e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,42635,0.0434574127181703,0.00510640625937662,0.0334488564497921,0.0534659689865485,1.9159023058597e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42369,-0.0500345065286791,0.00588587885796179,-0.0615708290902842,-0.038498183967074,2.08444608845257e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42475,-0.0615998729078832,0.00725530307342212,-0.0758202669317906,-0.0473794788839759,2.27768431017351e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,42310,-0.0531704126858088,0.00629020645650326,-0.0654992173405552,-0.0408416080310624,3.13963826858748e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40510,-0.0555485917870685,0.00661187116990344,-0.0685078592800793,-0.0425893242940578,4.94060520192746e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42356,0.0177385489834253,0.00211789891331394,0.01358746711333,0.0218896308535206,6.04962631698708e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42593,-0.0602069761037891,0.00719259829153737,-0.0743044687552023,-0.0461094834523759,6.29222880934732e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42593,-0.0871630073604395,0.0104138373825661,-0.107574128630269,-0.0667518860906099,6.33289857581776e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,42494,-0.0341434628024318,0.0040827539928798,-0.0421456606284762,-0.0261412649763874,6.72695754935884e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42610,0.0340339068137213,0.00407738948125233,0.0260422234304667,0.0420255901969758,7.68311818357446e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40282,0.0356923332395148,0.00428938991448189,0.0272851290071302,0.0440995374718993,9.73772443327127e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,42720,-0.0220506885352897,0.00265458272176017,-0.0272536706699396,-0.0168477064006398,1.07737334816855e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASPN,Asporin,40510,0.0230625876390521,0.0027822499289318,0.0176093777783458,0.0285157974997584,1.26889325762433e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,42770,0.0386778640431191,0.00467614901175784,0.0295126119800737,0.0478431161061645,1.44744541598903e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42793,-0.0537769110294933,0.0065095152439923,-0.0665355609077182,-0.0410182611512684,1.57352535749037e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,42637,0.0173480096155486,0.0021165710070587,0.0131995304417136,0.0214964887893837,2.70240047484497e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42606,0.0179728167567937,0.0022064867002778,0.0136481028242492,0.0222975306893382,4.11099670000211e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,42593,-0.0592758120835107,0.00730977730577727,-0.0736029756028341,-0.0449486485641872,5.53948523179466e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,40282,-0.041011608541483,0.00507295116031012,-0.0509545928156908,-0.0310686242672751,6.89794776003771e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,42678,0.0224182955287478,0.00278031926766394,0.0169688697641264,0.0278677212933691,8.05478460911842e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42586,-0.0346670798580705,0.00430476286342584,-0.0431044150703851,-0.0262297446457558,8.74386968631725e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,42793,0.0239644479200448,0.00298007280800961,0.018123505216346,0.0298053906237437,9.59889911861774e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42345,-0.0506064897222265,0.00629652640930665,-0.0629476814844676,-0.0382652979599855,9.97129613133892e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,42653,0.025681796760954,0.00319904749041198,0.0194116636797466,0.0319519298421615,1.07291445853871e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42704,0.0160117774501564,0.00200026021121918,0.0120912674361668,0.019932287464146,1.29330137262774e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPTC,Opticin,42586,0.03670431570576,0.00458982851458383,0.0277082518171757,0.0457003795943444,1.38026289718514e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,42593,-0.0395995290912716,0.00495232693890763,-0.0493060898915305,-0.0298929682910126,1.38843531916427e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40526,0.0262030672406101,0.0032770692931068,0.0197800114261208,0.0326261230550994,1.41133463085386e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,42710,0.0241872237165556,0.00302748196440183,0.018253359066328,0.0301210883667832,1.46729925603308e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,42415,0.032937541242442,0.0041372134796054,0.0248286028224154,0.0410464796624686,1.84089576177317e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAST,Gastrin,40482,-0.113822340396406,0.0143877612808088,-0.142022352506791,-0.0856223282860204,2.79025684957254e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,40538,-0.0281959698076269,0.00357364233324071,-0.0352003087807787,-0.0211916308344751,3.2997171378788e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42793,0.020941381290026,0.00266225186371,0.0157233676371544,0.0261593949428976,3.93534811757366e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42753,-0.0591625710180432,0.00755368702437837,-0.0739677975858248,-0.0443573444502616,5.14579703023654e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,42593,0.0262580618995406,0.00335665439921852,0.0196790192770723,0.0328371045220089,5.55626809370801e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42310,-0.0395502903700629,0.00505929622247466,-0.0494665109661133,-0.0296340697740126,5.80479688603479e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40448,0.0234922740965664,0.00300577901159598,0.0176009472338383,0.0293836009592945,5.95230296601134e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42586,-0.0747047590010746,0.00956274138440382,-0.093447732114506,-0.0559617858876431,6.04327006319578e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,42710,-0.0419779229562048,0.00538703178366606,-0.0525365052521903,-0.0314193406602193,7.05293094234768e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,42610,-0.0177737117733346,0.00228257895502072,-0.0222475665251752,-0.013299857021494,7.38206797720641e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,42688,-0.042974923271295,0.00552256628502906,-0.0537991531899519,-0.0321506933526381,7.67447627676924e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,42751,0.0274087598471163,0.00353454740999954,0.0204810469235172,0.0343364727707154,9.49740030860822e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40482,-0.065360022274137,0.00845077590978101,-0.0819235430573077,-0.0487965014909662,1.12898091085698e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42568,-0.0194855679299044,0.00252015394542557,-0.0244250696629385,-0.0145460661968703,1.13505543302866e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40481,-0.0473326455460672,0.00614445523575727,-0.0593757778081515,-0.035289513283983,1.43675323581076e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,40222,-0.0454150423098811,0.0059077264985421,-0.0569941862470236,-0.0338358983727385,1.62914980981201e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42586,0.020209458988913,0.00263181947147299,0.0150510928248259,0.025367825153,1.71571879922986e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PXN,Paxillin,42310,-0.0387672748723848,0.00505688501511282,-0.0486787695020059,-0.0288557802427637,1.89553122127561e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42610,0.0269275122667925,0.0035182473454141,0.0200317474697809,0.0338232770638041,2.08628954388089e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40115,-0.0273687166598487,0.00357584556533332,-0.034377373967902,-0.0203600593517954,2.11615512971854e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42652,0.0372632202294376,0.00487173776943849,0.0277146142013382,0.0468118262575371,2.16513087172573e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,42753,-0.0277348255727721,0.00362680778416061,-0.0348433688297269,-0.0206262823158173,2.19245911811537e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,42586,0.0210651352395404,0.00275617690310189,0.0156630285094607,0.0264672419696201,2.26830368503578e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,40282,0.0393315065206129,0.00515003619189281,0.029237435584503,0.0494255774567228,2.40381418082099e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42635,-0.026395083338399,0.00345916074652956,-0.033175038401597,-0.0196151282752011,2.49578204807283e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42793,0.0120364085187523,0.00157825274010407,0.00894303314814833,0.0151297838893563,2.57360632933417e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,42369,-0.0341349046491702,0.00447845746634532,-0.042912681283207,-0.0253571280151333,2.66779597280329e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42682,-0.0232347959041814,0.00305082298876002,-0.029214408962151,-0.0172551828462117,2.79229684532625e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,42494,-0.0655924656709997,0.0086437051435955,-0.0825341277524469,-0.0486508035895525,3.45210984752074e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,42479,-0.0277932216513209,0.00366366165308714,-0.0349739984913716,-0.0206124448112701,3.5133452702752e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40450,-0.042590564375785,0.00562295827875028,-0.0536115626021356,-0.0315695661494344,3.89023565107033e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42678,0.0212264755479719,0.00280329357084301,0.0157320201491196,0.0267209309468242,3.91441740273122e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,42369,0.0301093188014591,0.00398129665058333,0.0223059773663158,0.0379126602366024,4.20924710852478e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,40115,-0.0581672862768722,0.00769238138881418,-0.0732443537989479,-0.0430902187547964,4.29836574511634e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42710,0.0348539741136293,0.0046114740389677,0.0258154849972526,0.043892463230006,4.35288550655223e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40198,0.0245471893120264,0.00325300857330472,0.0181712925083491,0.0309230861157037,4.84272394866739e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42345,-0.06061035286744,0.0080382339017837,-0.0763652913149361,-0.0448554144199439,4.99752143878791e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,42586,-0.0525384056174279,0.00697314366480617,-0.066205767200448,-0.0388710440344078,5.22036895056938e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42678,-0.0174868410596544,0.00233084461127979,-0.0220552964977628,-0.012918385621546,6.65962187091248e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42442,-0.0356128504289644,0.00477450498900495,-0.0449708802074141,-0.0262548206505147,9.26298224800481e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42720,-0.0212878822467414,0.00285863713049821,-0.0268908110225179,-0.0156849534709649,1.01365402605414e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42678,0.0176872971114455,0.00237727817748235,0.0130278318835801,0.0223467623393109,1.06653314119044e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,40526,-0.0837763624447635,0.0112882450134608,-0.105901322671147,-0.0616514022183803,1.24034171266828e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42733,0.026500476031793,0.00357238168192971,0.0194986079352108,0.0335023441283753,1.25828275158525e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42720,-0.0240006897654825,0.00323906284661687,-0.0303492529448515,-0.0176521265861134,1.34023414548713e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,42647,-0.0235653214999419,0.00318623133396137,-0.0298103349145062,-0.0173203080853777,1.48665492311098e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42634,0.0275421715655406,0.00373076714075477,0.0202298679696613,0.0348544751614199,1.64546231680391e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42593,-0.0620476787381448,0.00840539891868684,-0.078522260618771,-0.0455730968575186,1.65263497137458e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,42325,0.0356184415652755,0.00483693341182993,0.0261380520780889,0.0450988310524622,1.89329606445811e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,42593,-0.0241797764571774,0.00328383848397013,-0.0306160998857589,-0.017743453028596,1.89934169679744e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42678,0.0204504781056549,0.0027827346853539,0.0149963181223612,0.0259046380889485,2.11088944901911e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,42742,-0.0175441491151826,0.00238837472805546,-0.0222253635821713,-0.0128629346481939,2.16469657968184e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,42345,-0.0461216420541732,0.00628250179151606,-0.0584353455655447,-0.0338079385428017,2.2398118918534e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,42753,-0.0193071112934997,0.0026302280433779,-0.0244623582585203,-0.014151864328479,2.24958947932064e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,40198,-0.03247838190145,0.00442737902371216,-0.0411560447879258,-0.0238007190149741,2.35903336870054e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,40514,-0.0404042773448206,0.00551690664252712,-0.0512174143641738,-0.0295911403254675,2.57563675971274e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EZR,Ezrin,42710,-0.0172624942233853,0.00235855359520548,-0.0218852592699881,-0.0126397291767826,2.63724320474793e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,42793,0.0174551534977613,0.00238586419103746,0.0127788596833279,0.0221314473121947,2.69631316006585e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42615,-0.0714652153862392,0.00978289420573851,-0.0906396880294867,-0.0522907427429918,2.92645894872771e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,42793,-0.0322692339424098,0.00442478767434674,-0.0409418177841294,-0.0235966501006902,3.20282633148524e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42617,-0.0679668453319669,0.00933366186938201,-0.0862608225959556,-0.0496728680679782,3.47463917762246e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40482,-0.0540705146776879,0.00743204908271127,-0.068637330879802,-0.0395036984755738,3.68513834771824e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42586,-0.0314417513002455,0.00434755165123143,-0.0399629525366591,-0.0229205500638319,5.01551438879462e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,40510,-0.0398698870349538,0.00552636094618074,-0.0507015544894681,-0.0290382195804396,5.75950546539585e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TF,Serotransferrin,40538,-0.0152226202103545,0.00211061375017363,-0.0193594231606948,-0.0110858172600142,5.8468146577454e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42593,0.0194448996118617,0.00271645950251275,0.0141206389869367,0.0247691602367867,8.60131964205813e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,42720,0.0116008833259502,0.00162330044359687,0.00841921445650034,0.0147825521954001,9.35924704539423e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,42440,0.0199106169351063,0.00279258188741748,0.014437156435768,0.0253840774344445,1.05707822628284e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,42612,-0.0218013286313931,0.00308252270015958,-0.0278430731237059,-0.0157595841390803,1.59634853256316e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40115,-0.0473590433418424,0.00670020498145876,-0.0604914451055015,-0.0342266415781832,1.66416145490372e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42688,0.0210930735018009,0.00299510787128984,0.0152226620740729,0.026963484929529,1.97950246438832e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42635,-0.0601847923302078,0.00855426437935522,-0.076951150513744,-0.0434184341466716,2.07940875327383e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,42494,-0.0370667635828018,0.00528976683213183,-0.0474347065737802,-0.0266988205918234,2.54736957283905e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42586,-0.0780911565051543,0.0111813263259165,-0.100006556103951,-0.056175756906358,3.00282157888605e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40482,0.0216614789063601,0.00310576827242728,0.0155741730924027,0.0277487847203176,3.23897064699119e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42678,0.0301632513032569,0.00433448520630965,0.02166766029889,0.0386588423076238,3.58777908301397e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,40538,0.0209432741913603,0.00300962394230598,0.0150444112644406,0.0268421371182801,3.62177788902736e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,40515,0.0254032756367154,0.00365296984108499,0.0182434547481888,0.0325630965252419,3.74246355315471e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42494,-0.0499380716563047,0.0071877283318878,-0.0640260191868048,-0.0358501241258046,3.88609913655617e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,40526,0.034245256347586,0.0049313321621567,0.0245798453097588,0.0439106673854131,4.00800969842849e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,42589,-0.0627439878563108,0.00905360021436616,-0.0804890442764685,-0.0449989314361531,4.39218020396805e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40510,-0.0505177047000962,0.00729632479145136,-0.0648185012913409,-0.0362169081088515,4.63753749127678e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,42586,-0.0951978037718849,0.0137675393839646,-0.122182180964455,-0.0682134265793142,4.90262184860286e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42635,-0.0515702925596659,0.00745909823096535,-0.066190125092358,-0.0369504600269738,4.93337888757756e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,42635,0.0179538221545519,0.00259897966069523,0.0128598220195893,0.0230478222895146,5.13552657478521e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,42593,-0.064294871743019,0.00932809808423909,-0.0825779439881276,-0.0460117994979104,5.72315825296648e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,40234,0.0237428782201087,0.00345083833966023,0.0169792350743747,0.0305065213658428,6.29504045292272e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42591,0.0333653521310077,0.00485176012797023,0.0238559022801861,0.0428748019818294,6.38550938500905e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42586,0.0133913622420575,0.00194923683439383,0.00957085804664556,0.0172118664374694,6.70128970889795e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42437,0.0258552856390097,0.00377112648433835,0.0184638777297065,0.0332466935483129,7.38935015431709e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42310,-0.0368879510068054,0.00541967860376937,-0.0475105210701933,-0.0262653809434174,1.04495368833205e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42612,-0.0764586992254163,0.0112366331071546,-0.0984825001154394,-0.0544348983353933,1.05766767981612e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42745,-0.0255628201048338,0.00375986054951085,-0.032932146781875,-0.0181934934277925,1.0985439655354e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANG,Angiogenin,42617,-0.022511655108037,0.00331940351699417,-0.0290176860013456,-0.0160056242147285,1.23623370911676e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42586,0.0167331624922116,0.00247209028828139,0.0118878655271801,0.0215784594572432,1.35231841175422e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,42793,0.0201848062857755,0.0029875664576002,0.0143291760288791,0.0260404365426719,1.47349908630663e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40510,-0.0402195497595975,0.00595268667898384,-0.0518868156504058,-0.0285522838687892,1.48264706428626e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42753,-0.0277284684071342,0.00411109715885751,-0.0357862188384949,-0.0196707179757734,1.59464911576173e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,40455,-0.0722011762320429,0.010715766620829,-0.0932040788088676,-0.0511982736552181,1.68594015165467e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42586,-0.0184956940605552,0.00274600802643124,-0.0238778697923604,-0.01311351832875,1.70054259133879e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,40538,-0.0204066175459423,0.00303232790227123,-0.0263499802343939,-0.0144632548574907,1.78220411086789e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,42593,-0.053481528342509,0.00794859838052464,-0.0690607811683373,-0.0379022755166807,1.78480595989046e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42593,-0.0263805171365802,0.00392531109939279,-0.0340741268913901,-0.0186869073817703,1.88273194071458e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,40478,0.0318008249721095,0.00473139439376064,0.0225272919603386,0.0410743579838803,1.88872462803695e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42345,-0.0476118531285465,0.00709390323350507,-0.0615159034662164,-0.0337078027908765,2.00314267189088e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42753,-0.0266045614601059,0.00396421125952264,-0.0343744155287702,-0.0188347073914415,2.00718271406894e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42345,-0.044820298994977,0.00669012816040365,-0.0579329501893681,-0.0317076478005858,2.17693829045971e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42586,-0.0392021914260794,0.00585310709239551,-0.0506742813271746,-0.0277301015249842,2.20218372904176e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40510,-0.0490595040224458,0.0073315402916895,-0.0634293229941573,-0.0346896850507344,2.31215885097873e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42678,-0.0543295763230454,0.00812519247397951,-0.0702549535720452,-0.0384041990740455,2.37476023980985e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42753,0.018541716873394,0.0027877530665166,0.0130777208630215,0.0240057128837666,3.01994115042557e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42673,0.0159735862012414,0.00240336772572395,0.0112629854588225,0.0206841869436604,3.12036425556925e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42494,0.0342178275871817,0.0051514879009061,0.0241209113014057,0.0443147438729576,3.20792737713713e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40482,-0.0311712415052716,0.00469548364568864,-0.0403743894508214,-0.0219680935597219,3.3129091128831e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,42720,-0.042334203941322,0.00638136304307045,-0.0548416755057401,-0.029826732376904,3.39049782882034e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42356,-0.0362987771446594,0.00547733334808164,-0.0470343505068994,-0.0255632037824194,3.55703687790285e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,40282,0.018878450508896,0.00285231196095179,0.0132879190654305,0.0244689819523615,3.79222840107914e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFI,Complement factor I,40538,-0.0127945175006523,0.00193497715037849,-0.0165870727153941,-0.00900196228591047,3.95567497834599e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,40282,-0.0176405407659994,0.0026695342710383,-0.0228728279372344,-0.0124082535947643,4.07139721836415e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42568,-0.0498765335364882,0.0075578709116701,-0.0646899605233616,-0.0350631065496148,4.28716614210529e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,42753,0.00569293898372457,0.000865488998845645,0.00399658054598711,0.00738929742146203,4.95257940618836e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42610,0.0187741435077822,0.00285716419506928,0.0131741016854464,0.024374185330118,5.18581178483847e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,42643,0.0180109667574788,0.00274264393263556,0.0126353846495131,0.0233865488654445,5.32222082847859e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42635,0.0214950513335255,0.00328021613823735,0.0150658277025803,0.0279242749644707,5.84725958733906e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,40448,-0.0664050749189187,0.0101482999064873,-0.0862957427356338,-0.0465144071022037,6.27181985571148e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42593,-0.0666646384113953,0.0102112235852185,-0.0866786366384235,-0.0466506401843671,6.87951987404613e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40222,0.022796434381304,0.00349790189744893,0.0159405466623041,0.0296523221003039,7.47694675794064e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42561,-0.045482942121093,0.00698266218082131,-0.0591689599955028,-0.0317969242466832,7.59479265950542e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,40526,0.0210166316623028,0.00323377669671151,0.0146784293367483,0.0273548339878574,8.41934875282995e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTD,Biotinidase,40538,-0.0132230739079884,0.00203717074575047,-0.0172159285696593,-0.0092302192463175,8.88828471051098e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,42678,-0.0364980303199698,0.0056243905415654,-0.047521835781438,-0.0254742248585016,8.92844706410286e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42593,-0.0411904862732397,0.00634916053219583,-0.0536348409163436,-0.0287461316301359,9.03099128196249e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40450,-0.0443545088470372,0.00684514134565806,-0.057770985884527,-0.0309380318095474,9.57377103433593e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,42610,0.0157874839306979,0.00244026624793778,0.0110045620847399,0.020570405776656,1.01690451443198e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42593,0.0224909531168175,0.00347855964216114,0.0156729762181817,0.0293089300154533,1.04399950014118e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40526,-0.0149303915403115,0.00231201207564751,-0.0194619352085806,-0.0103988478720424,1.1061961367484e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,42678,0.0201423156034401,0.00311980217944238,0.0140275033317331,0.0262571278751472,1.10983413928027e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,40482,-0.0244779377462756,0.00379555524904851,-0.0319172260344107,-0.0170386494581405,1.17107990752585e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,40508,0.0230583171803857,0.00358554874540592,0.0160306416393901,0.0300859927213813,1.31959552909528e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42715,-0.0371285111704147,0.00578542631179,-0.0484679467415231,-0.0257890755993063,1.43062834496266e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42688,0.0175977700123544,0.00274506816322414,0.0122174364124351,0.0229781036122737,1.4968658970142e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,40198,-0.0520694715242577,0.00812305493558962,-0.0679906591980133,-0.036148283850502,1.51390210698293e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,42135,-0.0578216128065429,0.00905635462353723,-0.0755720678686759,-0.04007115774441,1.77663734913279e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42688,0.0371431661959371,0.00581821039612331,0.0257394738195354,0.0485468585723388,1.78224974864827e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42637,-0.0332065881244087,0.00521449210778805,-0.0434269926556733,-0.0229861835931442,1.97565359893046e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,42494,0.0162252430433325,0.00255008856114581,0.0112270694634867,0.0212234166231783,2.04841931151565e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,42586,-0.0343992330380412,0.0054263226804634,-0.0450348254917495,-0.0237636405843329,2.38173124646947e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42586,-0.0770597246906902,0.0121753635640073,-0.100923437276145,-0.0531960121052359,2.5436905823917e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,40198,-0.0215386607951725,0.00340997461359357,-0.0282222110378159,-0.0148551105525291,2.78112934226449e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42345,-0.0361589227736467,0.00572970841088361,-0.0473891512589786,-0.0249286942883148,2.86544305347496e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORT1,Sortilin,42612,-0.0230288558183251,0.00365382060217876,-0.0301903441985955,-0.0158673674380547,3.01697818583901e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42345,-0.0389762590478097,0.00619081533260705,-0.0511102570997195,-0.0268422609958998,3.15499999015684e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42345,-0.0316437763053088,0.00503831020104941,-0.0415188642993656,-0.0217686883112519,3.47815408415858e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,40115,-0.0269044331103956,0.00428461570823671,-0.0353022798985396,-0.0185065863222517,3.52997415673278e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42593,-0.0347918849154812,0.00554183958942872,-0.0456538905107615,-0.0239298793202009,3.53446485656413e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,42665,0.0172483523705688,0.00275034877091322,0.0118576687795789,0.0226390359615587,3.68906760045231e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,42593,-0.0563137954871148,0.00898109631328042,-0.0739167442611444,-0.0387108467130852,3.71513488507318e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,42586,-0.0580281199932451,0.00926379064340937,-0.0761851496543275,-0.0398710903321628,3.86774617882796e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40510,-0.0182729648362497,0.00291867128885588,-0.0239935605624073,-0.0125523691100922,3.970983019774e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42310,-0.0354859049186727,0.00566950055947555,-0.0465981260152448,-0.0243736838221006,3.99295387339888e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40481,0.0166161992751106,0.00265611386000785,0.0114102161094952,0.0218221824407259,4.09717509715894e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNST,Consortin,42635,-0.067015337298424,0.0107166882992578,-0.0880200463649693,-0.0460106282318787,4.13869210162222e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,40301,-0.0336757198023005,0.00540904091766939,-0.0442774400009325,-0.0230739996036685,4.96333391817543e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40115,-0.0452794848667299,0.00727743048461404,-0.0595432486165734,-0.0310157211168864,5.09143963708536e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42710,-0.0408218465145802,0.00657224706699261,-0.0537034507658857,-0.0279402422632747,5.41065928807135e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,40282,-0.0436429427600675,0.00703457377545439,-0.0574307073599581,-0.0298551781601769,5.69857745773976e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42656,-0.0630032942267749,0.0101591194273778,-0.0829151683044353,-0.0430914201491144,5.75087823838574e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,40222,-0.0315289051799776,0.00508352615131295,-0.041492616436551,-0.0215651939234042,5.76835673542591e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42586,0.0241161092117147,0.00388939709008874,0.0164928909151407,0.0317393275082886,5.79469829756013e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,42345,-0.035926105377697,0.00580421473620944,-0.0473023662606675,-0.0245498444947265,6.20868095531778e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40448,-0.0316265522584249,0.0051186130250831,-0.0416590337875878,-0.021594070729262,6.68506749891282e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,42593,0.0264593559102362,0.00428736552771787,0.0180561194759091,0.0348625923445632,6.96074552912929e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,40448,-0.0652507314584316,0.0105727054292524,-0.0859732340997663,-0.044528228817097,6.99188894257129e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,42440,-0.0220358269688528,0.00357423436116492,-0.029041326316736,-0.0150303276209695,7.24442573718102e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40482,-0.0499807967012164,0.00811769455187,-0.0658914780228816,-0.0340701153795512,7.66459077388495e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40450,-0.0291901708665892,0.00474332913663941,-0.0384870959744025,-0.019893245758776,7.81509653336663e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42345,-0.0300517757526285,0.00488491859330004,-0.0396262161954966,-0.0204773353097604,7.87563095180885e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MLN,Promotilin,42593,-0.0538657744307446,0.00876888808136782,-0.0710527950702255,-0.0366787537912637,8.33590785915554e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,42593,-0.0495910664962662,0.00808202205131323,-0.0654318297168401,-0.0337503032756923,8.70245415611321e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42759,-0.0116855709998645,0.00190776611983722,-0.0154247925947455,-0.00794634940498359,9.30353949426597e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,42537,-0.043390121640688,0.00710546291215334,-0.0573168289485086,-0.0294634143328675,1.04610675786186e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,40115,-0.0410023921752413,0.00672278321654396,-0.0541790472796675,-0.0278257370708152,1.10332367094698e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42612,-0.0488678074704202,0.00802710240074152,-0.0646009281758736,-0.0331346867649668,1.17557099562631e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42345,-0.0360777987470767,0.00593421438529556,-0.0477088589422559,-0.0244467385518974,1.23799083640565e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42442,0.0184382147864263,0.0030358060940871,0.0124880348420156,0.024388394730837,1.28512845824093e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42635,-0.0378065276523448,0.00624623647128292,-0.0500491511360593,-0.0255639041686302,1.46238360933292e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42494,-0.0350858228407445,0.00579873221129511,-0.0464513379748829,-0.0237203077066061,1.48181336430238e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42474,-0.0530345609376678,0.00877655657336985,-0.0702366118214727,-0.0358325100538629,1.55561700836851e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,42310,-0.0369966672697152,0.00612471486927286,-0.04900110841349,-0.0249922261259404,1.57743128714224e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40510,0.0192467838355473,0.00318737156670935,0.0129995355647969,0.0254940321062976,1.60484859434089e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42345,-0.0223581583410779,0.00371033279626383,-0.029630410621755,-0.0150859060604008,1.72648550187259e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42593,-0.041387258976808,0.0068692811497192,-0.0548510500302576,-0.0279234679233584,1.73568161399491e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40282,-0.0128750237029846,0.00214162254234111,-0.0170726038859732,-0.00867744351999604,1.89241256682264e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,42369,-0.0279291382539726,0.0046549463172262,-0.0370528330357359,-0.0188054434722092,2.02638263905674e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42310,-0.0170722190731152,0.00285075095066229,-0.0226596909364133,-0.0114847472098171,2.17092245978944e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,40531,-0.0431090227671754,0.00721134247700381,-0.0572432540221029,-0.028974791512248,2.3276932686712e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42494,-0.0423172472244642,0.00709775284393467,-0.0562288427985761,-0.0284056516503522,2.55385960310661e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42635,0.0200923814334165,0.00337122782468874,0.0134847748970266,0.0266999879698064,2.58617963321777e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,42610,-0.0229077003944013,0.00384425205809164,-0.0304424344282609,-0.0153729663605417,2.60230420861432e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,42356,-0.0341426993831057,0.00573354058305077,-0.0453804389258852,-0.0229049598403262,2.66853491488139e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,42781,0.026876528120947,0.00451877590267536,0.0180197273517033,0.0357333288901907,2.78540431179965e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42793,0.0171625158011085,0.00289279886228244,0.0114926300310349,0.0228324015711821,3.04973684991693e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42494,-0.0312238473319885,0.00527147759286067,-0.0415559434139954,-0.0208917512499816,3.2359760918197e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42610,-0.0136277779284279,0.0023030823880496,-0.0181418194090051,-0.00911373644785068,3.35472584352929e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42610,0.0262003689641333,0.00444138497050715,0.0174952544219393,0.0349054835063274,3.74196214286873e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42710,-0.0552474274581604,0.00940555317780345,-0.0736823116866551,-0.0368125432296656,4.35627536725047e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42650,-0.0338306269287211,0.00576214433065618,-0.0451244298168072,-0.022536824040635,4.42887097459813e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42356,-0.0336569475653251,0.00573421023709742,-0.0448959996300361,-0.0224178955006142,4.47637299821746e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42589,-0.0482952438049739,0.0082320063333201,-0.0644299762182813,-0.0321605113916665,4.54874714005465e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40482,-0.0399653151502537,0.0068228683244736,-0.053338137066222,-0.0265924932342855,4.82842463129647e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,40282,-0.0193316177262958,0.00330135219382091,-0.0258022680261848,-0.0128609674264069,4.88581545758137e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42310,-0.0333592645419279,0.00570161307689102,-0.0445344261726343,-0.0221841029112215,5.0074881694167e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42662,0.0161766818968386,0.00277104511940117,0.0107454334628124,0.0216079303308649,5.41275552117682e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42586,-0.0198092841789945,0.0034037037577556,-0.0264805435441955,-0.0131380248137935,6.02232316075582e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,40450,-0.0567068431520057,0.00974691846063275,-0.0758108033348459,-0.0376028829691656,6.12057657894777e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,42461,0.0353328893992381,0.00608147011256756,0.0234132079786056,0.0472525708198705,6.39349201391197e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42586,-0.0382822274479999,0.00659881344559528,-0.0512159018013667,-0.0253485530946332,6.7257721213592e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42191,-0.0489604318254387,0.00845989252016986,-0.0655418211649716,-0.0323790424859058,7.31517246428811e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40222,-0.0334165866968925,0.00578027527893438,-0.0447459262436039,-0.0220872471501812,7.62083615494649e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,40222,-0.0356563295791843,0.0061701600487681,-0.0477498432747698,-0.0235628158835988,7.72574761055289e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42544,-0.0256622088201517,0.00446061854730948,-0.0344050211728783,-0.0169193964674251,8.95649704359702e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,42793,0.0232786949249338,0.00404947969379814,0.0153417147250894,0.0312156751247781,9.19366722916397e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42610,0.0135108208355719,0.00235080672422323,0.00890323965609434,0.0181184020150494,9.26448562225577e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,40282,-0.0258164309419836,0.00449725683258938,-0.0346310543338588,-0.0170018075501084,9.68835128248793e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,40450,0.0656526022527573,0.0114404642278398,0.0432292923661913,0.0880759121393232,9.79084561089249e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40222,-0.0388464367364778,0.0067724392429358,-0.0521204176526319,-0.0255724558203236,9.95121774157763e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42720,-0.0195205796394838,0.00340731818160605,-0.0261989232754316,-0.0128422360035359,1.03166553984495e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLC,Galectin-10,42610,0.0374209613065684,0.00653488605049045,0.0246125846476071,0.0502293379655297,1.04821956499716e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,42793,-0.031120745066521,0.00544107993768166,-0.0417852617443771,-0.020456228388665,1.09029046980705e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,40482,-0.0400969300737347,0.00701062534779514,-0.0538377557554132,-0.0263561043920563,1.09583102698223e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40481,-0.0243075442784332,0.00425404473203476,-0.0326454719532213,-0.015969616603645,1.13154196477928e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,42662,-0.0181692650243592,0.0031802890177413,-0.0244026314991322,-0.0119358985495863,1.13293041922831e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42793,-0.0289302116768421,0.00506780150497487,-0.0388631026265929,-0.0189973207270914,1.16267213495652e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,42593,-0.0312485129810481,0.00547462035101267,-0.0419787688690329,-0.0205182570930633,1.16811752858863e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42635,0.0265701901245168,0.00466096555481152,0.0174346976370862,0.0357056826119473,1.21912955915737e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40222,-0.0208772968052689,0.00366580781379507,-0.0280622801203072,-0.0136923134902305,1.26421575077275e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42635,0.0445422033975257,0.00784342442413704,0.0291690915262171,0.0599153152688343,1.3835250714151e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42345,-0.0369172100248155,0.00650258648176996,-0.0496622795290846,-0.0241721405205464,1.39721462365659e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42678,-0.0510965166008878,0.00900658049535881,-0.0687494143717911,-0.0334436188299845,1.4300062989725e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42635,0.022429881712417,0.00395571502166875,0.0146766802699463,0.0301830831548878,1.45526995400937e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42793,0.0140587168360877,0.00248416190676735,0.00918975949882369,0.0189276741733517,1.55024415202013e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,42610,-0.0249012324736166,0.00440134359362466,-0.0335278659171209,-0.0162745990301122,1.56603174435478e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40531,0.015128410133653,0.0026742104721514,0.0098869576082363,0.0203698626590698,1.57635347964771e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42653,-0.047356715679567,0.00839335549327584,-0.0638076924463876,-0.0309057389127463,1.71308376728419e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,40198,-0.0261268588546798,0.0046307778957217,-0.0352031835302943,-0.0170505341790653,1.72236173271441e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42345,-0.0335256740689707,0.00595435951077009,-0.0451962187100801,-0.0218551294278613,1.83428139756851e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OCLN,Occludin,40481,-0.025076827819026,0.00445618870992626,-0.0338109576904815,-0.0163426979475705,1.87289063216919e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40510,0.0206106385497772,0.00366778443361212,0.0134217810598974,0.0277994960396569,1.9618533696659e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40450,-0.063048015926595,0.0112296735846516,-0.0850581761525121,-0.0410378557006779,2.01902841115527e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40979,0.0177009554007573,0.00315559087747062,0.0115159972809149,0.0238859135205997,2.07609987250121e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,40222,-0.0289982204503617,0.00517269954674431,-0.0391367115619805,-0.0188597293387428,2.12017159286158e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42793,0.0152223782097775,0.00271595251291908,0.00989911128445613,0.0205456451350989,2.12545150214551e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42736,0.0192629908537689,0.00343914221929129,0.0125222721039579,0.0260037096035798,2.17138974094137e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42561,-0.0373748606090858,0.00668306097759658,-0.0504736601251751,-0.0242760610929965,2.28243295564596e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,42474,-0.0293722213687239,0.00526109699590698,-0.0396839714807016,-0.0190604712567462,2.41167325827311e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,42610,-0.0319843542228139,0.00573891228513069,-0.04323262230167,-0.0207360861439577,2.54859689549862e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40282,-0.0458746940400595,0.00823563601677386,-0.0620165406329362,-0.0297328474471827,2.60278459457352e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,40515,-0.0196793578408062,0.00353501206727584,-0.0266079814926669,-0.0127507341889456,2.65088447413338e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,42474,0.0180341981098237,0.00324451425719195,0.0116749501657274,0.0243934460539199,2.77559646612439e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42678,0.0138612462730754,0.00249689222364596,0.00896733751472934,0.0187551550314215,2.8874343811509e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40531,-0.035933390468683,0.00647422421159452,-0.0486228699234083,-0.0232439110139577,2.91717415171108e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40464,-0.0441011802655766,0.00794807087938327,-0.0596793991891678,-0.0285229613419854,2.9436130259961e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,42753,-0.0262461584639577,0.00474679429747142,-0.0355498752870017,-0.0169424416409138,3.27569754144348e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,40510,-0.016392253756366,0.0029664363275744,-0.0222064689584118,-0.0105780385543202,3.35041426519185e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40222,-0.0406048527057628,0.00734907871747112,-0.0550090469920062,-0.0262006584195194,3.36655407145236e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42586,-0.0183199097114484,0.0033188678008931,-0.0248248906011989,-0.0118149288216979,3.45446601355359e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42753,0.0139649225396571,0.00253159439556597,0.00900299752434779,0.0189268475549664,3.52641648915792e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42586,-0.0290591870510369,0.0052702462859485,-0.039388869771496,-0.0187295043305779,3.57630425048935e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,40526,-0.0226364136730326,0.00410742668579315,-0.0306869699771872,-0.014585857368878,3.6441017584289e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,40198,-0.0243509246704588,0.0044320974422795,-0.0330378356573266,-0.015664013683591,4.01173655225177e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MENT,Protein MENT,40282,0.0126154238777737,0.00229756446231901,0.00811219753162846,0.017118650223919,4.08977610619055e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42678,0.015931444789431,0.00290296992783202,0.0102416237308802,0.0216212658479817,4.13893276700931e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42610,-0.052734903648593,0.00962512843559767,-0.0716001553823645,-0.0338696519148216,4.35748823727752e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42494,-0.0198129444687431,0.00361915405190266,-0.0269064864104723,-0.0127194025270139,4.46783304813397e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,42720,-0.0233879176926581,0.00427905226954259,-0.0317748601409615,-0.0150009752443546,4.69312062904474e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,42345,-0.0255476501154811,0.00468536269659817,-0.0347309610008135,-0.0163643392301486,5.05201634382289e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42710,0.0153949596226317,0.00282356821792159,0.00986076591550542,0.0209291533297581,5.05936531140576e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,42593,-0.0454978317127919,0.00836678895230434,-0.0618967380593084,-0.0290989253662754,5.48547656439455e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,40510,-0.0364849560713156,0.00671216611980417,-0.0496408016661318,-0.0233291104764995,5.57314001800122e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40301,-0.0600970559601661,0.0110607636910585,-0.0817761527946408,-0.0384179591256913,5.64717362409005e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,40222,-0.0215138644465786,0.00396422185558327,-0.0292837392835218,-0.0137439896096354,5.85194712948164e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42648,0.0115209838973087,0.00212503804704984,0.00735590932509105,0.0156860584695264,6.01064786745739e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,39869,-0.0663707973193033,0.0122477814495015,-0.0903764489603262,-0.0423651456782805,6.12347179457296e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,42688,0.0241995612099985,0.00446999444106585,0.0154383721055095,0.0329607503144876,6.27640171801662e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42593,-0.0308454566615291,0.00570228891536088,-0.0420219429356365,-0.0196689703874218,6.43540474866237e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40198,-0.0425596417686312,0.00786797133351676,-0.057980865582324,-0.0271384179549383,6.46230050314127e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,-0.0148914056207857,0.0027556031693761,-0.0202923878327628,-0.00949042340880851,6.6515308314943e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42310,-0.0274980489326276,0.00509241854819505,-0.0374791892870899,-0.0175169085781653,6.78773080594268e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,40266,0.0161954106948729,0.00300051047709779,0.0103144101597612,0.0220764112299845,6.89505664491209e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,40531,0.0156521692519312,0.00290054313925817,0.00996710469898522,0.0213372338048773,6.94029919055078e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42494,-0.0206815009331071,0.00384842940096639,-0.0282244225590012,-0.013138579307213,7.83029872907544e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42610,-0.0323717487770197,0.00602448568340245,-0.0441797407164885,-0.0205637568375509,7.85729453952798e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,40198,0.0139442961900263,0.00259775475573201,0.00885269686879153,0.019035895511261,8.13107884438685e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42710,-0.0274735495786491,0.00512417591926737,-0.0375169343804131,-0.017430164776885,8.38655437033228e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,42610,0.0136979995578177,0.00255734606823957,0.00868560126406809,0.0187103978515672,8.63292188844994e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40198,-0.0238478724649122,0.00446190174262191,-0.0325931998804512,-0.0151025450493733,9.23372159612696e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,40526,0.0135206871308195,0.00253328295609143,0.00855545253688034,0.0184859217247588,9.62037523769805e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42678,0.0145479954631523,0.00273147629430014,0.00919430192632397,0.0199016889999805,1.01980386906074e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42710,0.0159874402044241,0.00300402930284076,0.0100995427708562,0.021875337637992,1.04272988137771e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,40526,-0.0205047482879933,0.0038526994975129,-0.0280560393031186,-0.012953457272868,1.04489332222073e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,40198,0.0162343194306021,0.00305098340843178,0.0102543919500758,0.0222142469111284,1.05218126230736e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40135,-0.0427718045766516,0.00804740703045336,-0.0585447223563402,-0.026998886796963,1.08766943073659e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,40482,-0.0331402264899776,0.00624037843625254,-0.0453713682250326,-0.0209090847549226,1.11333282598965e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42345,-0.0298095208095629,0.00562273235811259,-0.0408300762314636,-0.0187889653876623,1.16644462698889e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42516,0.0218911987413579,0.00413358638362732,0.0137893694294484,0.0299930280532675,1.20293012060248e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40115,-0.0323664211427404,0.00612384539929409,-0.0443691581253568,-0.020363684160124,1.27911042035765e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40448,-0.0310191261094572,0.00587405126889967,-0.0425322665965005,-0.0195059856224139,1.31086878412151e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42617,-0.0143073481787037,0.00271100039093914,-0.0196209089449444,-0.00899378741246298,1.32985554936895e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,40482,-0.032400098192966,0.00614783556604383,-0.0444498559024119,-0.0203503404835201,1.38815307474925e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,40481,0.0252257107155083,0.00478656160350357,0.0158440499726413,0.0346073714583753,1.38855133051759e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,42474,-0.0265277251565671,0.00504194044652126,-0.0364099284317488,-0.0166455218813854,1.45176709292242e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40450,-0.0345365866361584,0.00656763865193154,-0.0474091583939442,-0.0216640148783726,1.47816969456374e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,40198,0.0229572132177714,0.00437581572192868,0.0143806144027912,0.0315338120327516,1.57995577068372e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,42475,0.02593660678674,0.00494465572711207,0.0162450815616004,0.0356281320118797,1.58355794007302e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,40493,-0.0243361811589326,0.00464392837285039,-0.0334382807697193,-0.0152340815481458,1.6308924971427e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,40115,-0.0400782584366055,0.00765252779060812,-0.0550772129061974,-0.0250793039670136,1.66011846882222e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42593,-0.0357890314480923,0.00685266421287198,-0.0492202533053214,-0.0223578095908632,1.79027021761258e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40282,-0.0403369525924417,0.0077256112318782,-0.055479150606923,-0.0251947545779604,1.80986263007433e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,40448,-0.0443626026212883,0.00850060834158416,-0.0610237949707932,-0.0277014102717833,1.83334840448205e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40222,-0.0433056206339094,0.00830430572409543,-0.0595820598531364,-0.0270291814146823,1.87309065327336e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,42553,-0.0431691758431526,0.00828683104562389,-0.0594113646925754,-0.0269269869937298,1.92300242174196e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42569,-0.0159237904263738,0.0030646270160299,-0.0219304593777924,-0.00991712147495522,2.06621161637741e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40208,-0.0409405482690075,0.0078798247557643,-0.0563850047903055,-0.0254960917477094,2.07690222884356e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42610,0.0270529631849761,0.00521179519191089,0.0168378446088308,0.0372680817611215,2.12543149502232e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,42793,-0.0237869073681091,0.0045838878575256,-0.0327713275688592,-0.0148024871673589,2.14189429968239e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42586,-0.0518509221897933,0.00999489363377524,-0.0714409137119927,-0.0322609306675938,2.15967355932941e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42675,0.0112615052757046,0.0021712636323939,0.0070058285562126,0.0155171819951967,2.17255306915379e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42688,-0.0219427254763463,0.00423191657731849,-0.0302372819678906,-0.0136481689848021,2.19071823471254e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42710,-0.0182121953008974,0.00351875964343748,-0.0251089642020348,-0.0113154263997599,2.30259639715939e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,42345,-0.0496046677997711,0.0095922164963723,-0.0684054121326608,-0.0308039234668814,2.35827115362681e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,42635,0.020828218397803,0.00403471014402544,0.0129201865155132,0.0287362502800929,2.47468819889416e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42720,0.0311624450551926,0.00604122541909128,0.0193216432337736,0.0430032468766115,2.52726619205615e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42793,0.0210029359547029,0.00407703313272407,0.0130119510145637,0.0289939208948421,2.61991694212332e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,42610,0.0122567780676516,0.00238241550722098,0.00758724367349851,0.0169263124618048,2.71749836736234e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42586,0.0337228398603975,0.00656513622957767,0.0208551728504253,0.0465905068703697,2.83600169743822e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42577,-0.0420851493334945,0.00819868082392849,-0.0581545637483943,-0.0260157349185947,2.88910128985774e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42710,-0.0329898734964595,0.00643353552807169,-0.04559960313148,-0.020380143861439,2.97202580390011e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42720,-0.0271301242377839,0.00529699214185355,-0.0375122288358169,-0.016748019639751,3.06797440813887e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40198,-0.0269716823285097,0.00527003591744462,-0.0373009527267012,-0.0166424119303183,3.14117573970665e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42345,-0.0553564031379624,0.0108277152372275,-0.0765787250029282,-0.0341340812729966,3.22434322104352e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42585,-0.00959185716383819,0.00187634925919427,-0.013269501711859,-0.00591421261581743,3.2319747712694e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,42364,-0.0201361970080352,0.00393904932448442,-0.0278567336840246,-0.0124156603320457,3.23331785553185e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,42310,-0.0176725906818634,0.00345769660402944,-0.0244496760257611,-0.0108955053379657,3.24815478169131e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42310,-0.0393033762932375,0.00771829051841252,-0.054431225709326,-0.0241755268771489,3.58767903787184e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42463,-0.0180410028353854,0.00354543077180971,-0.0249900471481324,-0.0110919585226383,3.65797199721134e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,40222,-0.0238661708645687,0.00469104635644909,-0.0330606217232089,-0.0146717200059285,3.68587971552388e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40029,-0.0168119973903476,0.00330791858005969,-0.0232955178072645,-0.0103284769734306,3.79013752221157e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,42545,-0.028184765365551,0.00554896516150738,-0.0390607370821055,-0.0173087936489966,3.83971934767586e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KAZN,Kazrin,40448,-0.0522117585940936,0.0102878933632355,-0.0723760295860353,-0.032047487602152,3.93542158051529e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42720,0.0170868784511671,0.00336751751696417,0.0104865441179173,0.0236872127844169,3.94645935960238e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42673,-0.0363535547160437,0.00718328404156014,-0.0504327914375016,-0.0222743179945858,4.22879827020553e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42688,0.0180187153801108,0.00356938768021589,0.0110227155268876,0.0250147152333339,4.51980563424413e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40168,-0.0245628306232186,0.00486584762189153,-0.034099891962126,-0.0150257692843112,4.53604727574615e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,40269,0.0204529201410715,0.00405689937216293,0.0125013973716321,0.0284044429105108,4.6916352670462e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42593,-0.0254622848570045,0.00505856032989398,-0.0353770631035967,-0.0155475066104123,4.87843262359573e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42510,0.0167556964912688,0.00333959037894966,0.0102100993485275,0.0233012936340102,5.30809345717526e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42572,0.0310001268980346,0.00618763364528182,0.0188723649532822,0.0431278888427869,5.51208950381442e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42593,0.0261663779135867,0.00522446722643693,0.0159264221497703,0.0364063336774031,5.55742532028477e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40222,0.0104294323274801,0.00208219215006154,0.00634833571335952,0.0145105289416008,5.55980237356306e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,40531,0.0325723672608717,0.00651995134042303,0.0197932626336426,0.0453514718881008,5.94661720658889e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,42571,0.0219927479293024,0.00440318231588501,0.0133625105901678,0.030622985268437,5.96584067671775e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40448,-0.0149709627251761,0.00300104271628779,-0.0208530064491002,-0.00908891900125203,6.17309291904645e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,42753,-0.0243275402509553,0.00488023019585801,-0.033892791434837,-0.0147622890670736,6.27540365592544e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40450,-0.0351776889194614,0.00706559739610162,-0.0490262598158206,-0.0213291180231022,6.49518973573319e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42407,-0.0236024530812123,0.00474662632889206,-0.0329058406858408,-0.0142990654765839,6.69352035340452e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,40198,-0.0268098931994735,0.00540844418098676,-0.0374104437942075,-0.0162093426047394,7.26407918067033e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42581,-0.0333519160156733,0.00674020100208296,-0.0465627099797559,-0.0201411220515907,7.58102775355551e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40482,-0.0432793122708322,0.00875573591740398,-0.060440554668944,-0.0261180698727204,7.80481615737064e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,42494,0.0207309509817797,0.00420057363409006,0.0124978266589632,0.0289640753045962,8.10107345997511e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42356,-0.0185864547816464,0.00376759872914779,-0.0259709482907761,-0.0112019612725167,8.18665012596415e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42558,0.0105819184131847,0.0021459032786564,0.0063759479870182,0.0147878888393513,8.27000035096807e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,42369,0.0145114858750154,0.00294403682477869,0.00874117369844917,0.0202817980515816,8.36095267790454e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,42637,0.0166991512258166,0.00338796559284379,0.0100587386638428,0.0233395637877904,8.36535814442683e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,42543,-0.011310377747452,0.00229635204066232,-0.0158112277471501,-0.00680952774775386,8.52101124598803e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,42572,-0.033755630754783,0.00686961135025516,-0.0472200690012831,-0.0202911925082829,9.04032124719549e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,42635,0.0197553093031023,0.00402886067533609,0.0118587423794435,0.027651876226761,9.5269403608835e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,40482,-0.0271281062896382,0.00553505083594249,-0.0379768059280854,-0.0162794066511909,9.66026835121513e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,42254,-0.0334511822917412,0.00682845220803946,-0.0468349486194985,-0.0200674159639838,9.75823068723349e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,42688,0.0146783581108858,0.00299642570206284,0.00880536373484261,0.0205513524869289,9.7630133150475e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42678,-0.0129042961129089,0.00263434328471487,-0.01806760895095,-0.00774098327486775,9.76981848273081e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,40115,-0.0191278162903142,0.00391165940577009,-0.0267946687256236,-0.0114609638550049,1.02298876161747e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,40341,-0.0523521947009919,0.0107582089910307,-0.0734382843234121,-0.0312661050785717,1.15290103848241e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLU,Clusterin,40538,0.015222004982077,0.00312896401610073,0.00908923551051959,0.0213547744536344,1.16071280175296e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40448,-0.0381338595453716,0.00784342478613771,-0.0535069721262016,-0.0227607469645417,1.17842668407327e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,40510,-0.043709802454771,0.00903002440474953,-0.0614086502880801,-0.0260109546214619,1.31226762576385e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42753,-0.0359888657516125,0.00743712164734692,-0.0505656241804125,-0.0214121073228125,1.31873938878185e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42720,0.0284339528209981,0.00589114328910714,0.0168873119743482,0.0399805936676481,1.40429601666858e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,42494,0.0162194482565228,0.00336192494009364,0.00963007537393922,0.0228088211391063,1.41945419597681e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40526,0.0129596998993296,0.0026899598752391,0.00768737854386092,0.0182320212547982,1.47027775678861e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40448,0.0485745467168612,0.0100888767982087,0.0288003481923721,0.0683487452413503,1.49367494507011e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42793,0.0131213752602185,0.00272800537619946,0.00777448472286755,0.0184682657975694,1.52641031892064e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42310,-0.0288744381328495,0.00600763859789254,-0.0406494097847189,-0.0170994664809802,1.55463361515545e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,42635,-0.0280398510585455,0.00583497195563061,-0.0394763960915815,-0.0166033060255095,1.56048178204121e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,42476,-0.0220581731404603,0.00459334199157663,-0.0310611234439505,-0.0130552228369701,1.58639609232131e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40482,-0.0189163213091097,0.00394600669523406,-0.0266504944317685,-0.011182148186451,1.65749409853605e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,42586,-0.0253700248253563,0.00529821678092609,-0.0357545297159715,-0.0149855199347412,1.69908437267629e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40420,-0.014317122345432,0.00299345678244952,-0.020184297639033,-0.00844994705183094,1.75063825399504e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",40538,-0.00793026951951038,0.00165925555279007,-0.0111824104029789,-0.00467812863604185,1.78013349114168e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42310,-0.0314632749522907,0.00658694976957612,-0.0443736965006599,-0.0185528534039215,1.80206774850704e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,40450,-0.00998482179260978,0.00209363243574463,-0.0140883413666693,-0.00588130221855031,1.87337090112072e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42610,0.016382885546907,0.00344250392194731,0.00963557785989032,0.0231301932339238,1.9658122743766e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,42580,-0.0199818207856149,0.00420108648911943,-0.028215950304289,-0.0117476912669408,1.99185007734265e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40526,0.017393275349273,0.0036638984618067,0.0102120343641319,0.0245745163344141,2.087720376555e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40222,0.0358640597727173,0.00756485244927045,0.0210369489721472,0.0506911705732874,2.15454836823706e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,42356,0.0110046907976473,0.00232360432611224,0.00645042631846726,0.0155589552768272,2.20205497210332e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,40481,-0.0306575669001153,0.00647803860528247,-0.043354522566469,-0.0179606112337617,2.24421951007529e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42345,-0.0244474005071907,0.00517605037784962,-0.0345924592477759,-0.0143023417666054,2.34588968063976e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40438,0.0128210198942429,0.00271467587048007,0.00750025518810195,0.0181417846003838,2.35369617030551e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40448,-0.0507157815825863,0.0107385401419664,-0.0717633202608405,-0.029668242904332,2.35451475879418e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42369,-0.0317075841734723,0.00672287348689154,-0.0448844162077798,-0.0185307521391649,2.42548568916566e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42688,-0.0215072631521509,0.0045702729095147,-0.0304649980547998,-0.0125495282495021,2.55254197679008e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELN,Elastin,40510,-0.0170591915921447,0.00363049052454185,-0.0241749530202467,-0.00994343016404266,2.64691596640706e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42586,-0.0254767376740884,0.00543557611306228,-0.0361304668556905,-0.0148230084924864,2.79922344398578e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40538,0.00730020339715675,0.00155791323809906,0.00424669345048259,0.0103537133438309,2.81993521912897e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,42200,0.0126301643822294,0.00270572404937732,0.00732694524544988,0.017933383519009,3.07269842536692e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,42335,-0.0183061656131355,0.00392692014831234,-0.0260029291038276,-0.0106094021224433,3.16675991009645e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42793,0.0105037181234258,0.00225499835126191,0.00608392135495247,0.0149235148918992,3.22365536392467e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,42625,0.0305603705120942,0.00656317273545815,0.0176965519505963,0.0434241890735922,3.24961941198385e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42610,-0.0208099977193914,0.00447034947214315,-0.029571882684792,-0.0120481127539908,3.2689958527865e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42475,-0.050959683565731,0.0109560933993398,-0.072433626628437,-0.0294857405030251,3.33089228582885e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40482,-0.0291776069279927,0.00627946959234459,-0.0414853673289881,-0.0168698465269973,3.41420100473008e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,42793,0.00904505082351284,0.00194733372689949,0.00522827671878983,0.0128618249282359,3.43531722337903e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,42720,0.0292679164304416,0.00630756539127667,0.0169050882635393,0.0416307445973439,3.51459635713841e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40407,-0.0499110274496308,0.0107604862713603,-0.071001580541497,-0.0288204743577646,3.55154552606818e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,42635,0.0363350695019281,0.0078678036975806,0.0209141742546701,0.051755964749186,3.90677911505735e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42369,-0.0273892996755946,0.00593485159599769,-0.0390216088037501,-0.0157569905474391,3.96817711365435e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42585,0.0277271807462335,0.00601022399313424,0.0159471417196904,0.0395072197727766,3.99931174231881e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42617,0.0173593759419317,0.00376312251295233,0.00998365581654511,0.0247350960673182,4.00521066230181e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40181,-0.0549651824830146,0.0119242859910943,-0.0783367830255595,-0.0315935819404697,4.08157710966842e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40482,0.03223755964364,0.007010638969461,0.0184967072634965,0.0459784120237836,4.3042311821518e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,40510,-0.037404518112726,0.00813773042862084,-0.0533544697528229,-0.0214545664726292,4.3444073689989e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42356,-0.042780607426052,0.00932107758426781,-0.0610499194912169,-0.0245112953608871,4.48067265263502e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,40450,-0.0179660781935292,0.00391548631189963,-0.0256404313648524,-0.0102917250222059,4.51340236189313e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40301,-0.0207182015882647,0.00452008011074569,-0.0295775586053263,-0.0118588445712032,4.6204293889541e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42793,0.013542761010817,0.00296090184001863,0.00773939340438051,0.0193461286172535,4.83040418640711e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,42688,0.01398470088968,0.00305912569165626,0.00798881453403371,0.0199805872453262,4.88616989520199e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40222,0.011609503714356,0.00254292251458357,0.00662537558577223,0.0165936318429398,5.03895263505524e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,40510,-0.0289870675216831,0.0063504061796385,-0.0414338636337745,-0.0165402714095916,5.05720096070522e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42610,-0.0206445364794736,0.0045233850887085,-0.0295103712533423,-0.011778701705605,5.06439590490851e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40481,0.0413961195226583,0.00908532588956324,0.0235888807791144,0.0592033582662023,5.25909341823151e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLPS,Colipase,42589,0.0328359569522242,0.00721937447306228,0.0186859829850221,0.0469859309194263,5.45528662900478e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42345,-0.0228005875589242,0.00501672863914597,-0.0326333756916504,-0.0129677994261981,5.5448206225534e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40481,-0.0435943583746645,0.00961083960985264,-0.0624316040099756,-0.0247571127393533,5.79341286136105e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,40538,-0.01864186892451,0.00411096990371692,-0.0266993699357951,-0.0105843679132248,5.82864834915048e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40115,-0.0165172658016198,0.00364504527015879,-0.023661554531131,-0.00937297707210852,5.92079899239787e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42710,-0.0290384891501777,0.00640936301433214,-0.0416008406582687,-0.0164761376420867,5.93102854444033e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40222,-0.0323736842544169,0.00714825845714275,-0.0463842708304167,-0.0183630976784171,5.99161969024848e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42793,0.0142069937204571,0.00314127811046322,0.00805008862394918,0.020363898816965,6.15781500503254e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40510,-0.0282193665939226,0.00624655138152087,-0.0404626073017035,-0.0159761258861417,6.31804502353696e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42593,-0.0350834188468847,0.00777502929394264,-0.0503224762630123,-0.0198443614307572,6.46680294978619e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40198,-0.022287169326981,0.00495274612383902,-0.0319945517297055,-0.0125797869242565,6.86629295659931e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42356,0.0141233156181034,0.00313899874529381,0.00797087807732756,0.0202757531588793,6.87597785002295e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40448,0.0227703534494629,0.00506646447575807,0.0128400830769771,0.0327006238219487,7.04866732633374e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42494,-0.0193335908949958,0.00430908319469245,-0.027779393956593,-0.0108877878333986,7.29393470983203e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,42593,-0.0368533415946653,0.00822401085504487,-0.0529724028705532,-0.0207342803187774,7.48436270537525e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,40538,-0.00754582410940174,0.00168412852024875,-0.0108467160090893,-0.00424493220971419,7.51791769049659e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42745,-0.023383623572421,0.00522080920671732,-0.033616409617587,-0.0131508375272551,7.5632591206753e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40482,-0.0284387893933512,0.00635702111094218,-0.0408985507707979,-0.0159790280159045,7.7664463441556e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42356,0.0155681641322981,0.0034830275131261,0.00874143020657094,0.0223948980580253,7.89756208638966e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,42215,-0.033757561800181,0.00755693314405061,-0.0485691507625202,-0.0189459728378418,7.99557638665292e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,42753,-0.0411208071013488,0.00924460048122235,-0.0592402240445446,-0.023001390158153,8.73270650642449e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42565,0.0133241881710771,0.00299790944369102,0.00744828566144269,0.0192000906807115,8.88081011257448e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40115,-0.0125360324800591,0.00282284319178756,-0.0180688051359627,-0.00700325982415546,9.04535997063561e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40198,-0.037038641778582,0.00834806487733054,-0.0534008489381499,-0.0206764346190142,9.21960357241984e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELP,P-selectin,42688,-0.0245242471179343,0.00553130528902926,-0.0353656054844317,-0.013682888751437,9.33533598244577e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,40481,-0.0343142957822584,0.00774283520787704,-0.0494902527896974,-0.0191383387748194,9.43537753190988e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42586,-0.0335262993398594,0.00757299794195673,-0.0483693753060946,-0.0186832233736242,9.62712777136596e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40286,-0.0284006524123736,0.00642475065423999,-0.040993163694684,-0.0158081411300632,9.94057850669992e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40482,0.0164987440535217,0.00374320463543283,0.00916206296807335,0.02383542513897,1.05462314817725e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,42610,-0.0286800289780638,0.00651061969122835,-0.0414408435728714,-0.0159192143832562,1.06547083777083e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42675,-0.0175957923071685,0.00399612987308012,-0.0254282068584055,-0.00976337775593143,1.07482881906102e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40448,0.0307699140902229,0.00699206000355994,0.0170654764832454,0.0444743516972004,1.08898974866136e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,40481,-0.0239465971066861,0.00544175580360817,-0.0346124384817581,-0.0132807557316141,1.08979242763982e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,40181,-0.0296492319671874,0.00674024485261725,-0.0428601118783172,-0.0164383520560576,1.09857928468112e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40510,-0.0320432094909797,0.00728906044408421,-0.0463297679613848,-0.0177566510205747,1.1123448254016e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,40531,0.021437500527734,0.00488056420388752,0.0118715946881144,0.0310034063673535,1.1311176853287e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,42623,-0.0239146229368248,0.00544917417489973,-0.0345950043196282,-0.0132342415540213,1.14916777272745e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42593,0.0211058014516771,0.00481633252209248,0.0116657897083758,0.0305458131949784,1.1841778201137e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40450,-0.0292777654543059,0.00668975809886984,-0.0423896913280908,-0.016165839580521,1.21684016040677e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40450,-0.0342224872124026,0.00782025112583619,-0.0495501794190416,-0.0188947950057637,1.2188987286116e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,42586,0.0066292571871778,0.00151519693949653,0.0036594711857646,0.00959904318859101,1.22250798646878e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,40448,-0.0242812042082653,0.00554998195169224,-0.0351591688335821,-0.0134032395829485,1.2252247090273e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,40510,0.0158381588116849,0.00362311659748554,0.00873685028061324,0.0229394673427566,1.24543809153678e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40448,0.0243140273178835,0.00556935318999269,0.0133980950654978,0.0352299595702692,1.27858217985818e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,40450,-0.0264623343800808,0.00606527507451308,-0.0383502735261264,-0.0145743952340351,1.29478640651059e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42593,-0.0181674285876912,0.00416500687104935,-0.0263308420549479,-0.0100040151204345,1.29889106593258e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40448,-0.0363582468390789,0.00833694072775946,-0.0526986506654874,-0.0200178430126703,1.3056021172093e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42586,0.00918642964306253,0.00211348234635987,0.00504400424419719,0.0133288550419279,1.39293685909391e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40115,-0.0288955122511101,0.00665158135909595,-0.0419326117149381,-0.015858412787282,1.41074302101008e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40282,-0.0295953342052649,0.00681924119557632,-0.0429610469485945,-0.0162296214619353,1.43761943758683e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42612,-0.0204503925862507,0.00471328883995433,-0.0296884387125612,-0.0112123464599402,1.44258110369796e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,42793,-0.0251763588631643,0.00580508479828106,-0.0365543250677952,-0.0137983926585334,1.45514381414384e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,42345,-0.0121877378695996,0.00281801162358908,-0.0177110406518342,-0.00666443508736502,1.5369610833681e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,40268,0.00900401586796721,0.00208251482694612,0.00492228680715281,0.0130857449287816,1.5482757331993e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,40450,0.0180141698560546,0.00417197769060767,0.00983709358246359,0.0261912461296457,1.58871397443035e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,42584,-0.0373500977429114,0.00865400625557877,-0.0543119500038458,-0.020388245481977,1.60072432123851e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40172,-0.0117344742869587,0.00272005801507171,-0.0170657879964993,-0.00640316057741814,1.61690758789217e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42310,-0.0222685391130519,0.00516885035044371,-0.0323994857999216,-0.0121375924261822,1.65772595729353e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42581,0.0145492722428102,0.0033773807224728,0.00792960602676353,0.0211689384588569,1.66019512747607e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40222,0.0389865139726291,0.00905256093046375,0.0212434945489201,0.056729533396338,1.67154270376511e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40301,-0.0224849468009406,0.00522376043187583,-0.0327235172474172,-0.012246376354464,1.68904523286371e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,42710,-0.0192515818303236,0.00447344164115744,-0.0280195274469922,-0.010483636213655,1.69282107110312e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40057,-0.022631882365456,0.00526043747695835,-0.0329423398202944,-0.0123214249106176,1.70527438988824e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,40079,-0.0154044410830906,0.00358156011549416,-0.0224242989094592,-0.00838458325672206,1.71479373325772e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40115,0.024094761273678,0.00560837322644995,0.0131023497498361,0.0350871727975199,1.75245147850625e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40198,-0.0155090477717607,0.00361603431888682,-0.0225964750367789,-0.00842162050674254,1.81039020894972e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42635,-0.0117366078737888,0.00273988720509375,-0.0171067867957726,-0.00636642895180508,1.85163255981814e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,42345,-0.0401232303793747,0.00936759149809164,-0.0584837097156343,-0.021762751043115,1.85535987685466e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,40510,-0.0313899487976596,0.00733397160206787,-0.0457645331377126,-0.0170153644576066,1.88368529156143e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42653,-0.0320360261079779,0.00748551755074552,-0.0467076405074391,-0.0173644117085167,1.88410831741096e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,42494,-0.0291147305765069,0.00681309592936364,-0.0424683985980596,-0.0157610625549541,1.93899679250268e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42345,-0.0413007772081565,0.00967830445999051,-0.0602702539497379,-0.0223313004665751,1.99187657537378e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,40526,-0.0198075055917294,0.00464891078422242,-0.0289193707288054,-0.0106956404546535,2.05455722483156e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,42475,-0.0265800947819017,0.00625261316109789,-0.0388352165776535,-0.0143249729861498,2.14235990098684e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42610,-0.0211850567050301,0.00498886838269908,-0.0309632387351203,-0.0114068746749399,2.18632058284255e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42310,-0.0267723453622398,0.00630761188445498,-0.0391352646557716,-0.0144094260687081,2.20636917677513e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42494,0.050310262421862,0.0118567015459847,0.0270711273917321,0.073549397451992,2.21855431098449e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,42310,-0.0282383420472985,0.00665515899994155,-0.0412824536871839,-0.0151942304074131,2.21991641981604e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40526,-0.0215930865574629,0.00508966627337672,-0.0315688324532812,-0.0116173406616445,2.22766109022267e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,40448,-0.0281998996719322,0.00664868783350042,-0.0412313278255931,-0.0151684715182714,2.23882890553562e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,42607,0.0246862418048361,0.005820795031742,0.0132774835426218,0.0360950000670505,2.23975085738092e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40289,-0.0185657799550543,0.00438187207085431,-0.0271542492139288,-0.00997731069617988,2.28405445151888e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40282,-0.0277000030168663,0.00654622868919,-0.0405306112476787,-0.0148693947860539,2.34063154908746e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,40448,-0.0292164205640854,0.006918270360586,-0.042776230470834,-0.0156566106573369,2.42879934107373e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40222,0.0288929380339558,0.00685742556896561,0.0154523839187832,0.0423334921491284,2.53579351671504e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42586,-0.0569646569927059,0.0135218420262031,-0.083467467364064,-0.0304618466213479,2.53888550556572e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40526,0.011685881456265,0.002775034701943,0.00624681344045675,0.0171249494720733,2.56121268489622e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,42475,-0.0262278556711469,0.00623303062291513,-0.0384445956920606,-0.0140111156502333,2.59469580066135e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42691,-0.0100965320273343,0.00240087890614773,-0.0148022546833838,-0.00539080937128471,2.62361998219073e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42717,0.0105410322620918,0.00250886712784063,0.00562365269152419,0.0154584118326595,2.66840773442294e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,42753,-0.0144019455779075,0.00343261980748359,-0.0211298804005753,-0.00767401075523963,2.7386618955934e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42356,-0.0383366558867896,0.00914479172805647,-0.0562604476737803,-0.0204128640997989,2.78086921697791e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,42635,0.0293161105781227,0.00699313437078563,0.0156095672113828,0.0430226539448625,2.78119434282095e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42586,-0.0349450645338858,0.0083497151505087,-0.0513105062288828,-0.0185796228388887,2.86758566618465e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42586,-0.00880495453692745,0.00210572842232848,-0.0129321822446913,-0.00467772682916363,2.91525186973234e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40222,-0.0223892334383819,0.0053587963230238,-0.0328924742315086,-0.0118859926452553,2.96305333166017e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42294,-0.0237715241533898,0.00569252385630362,-0.0349288709117449,-0.0126141773950347,2.98704687745891e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,42635,-0.0112176195798679,0.00268816269569579,-0.0164864184634317,-0.00594882069630417,3.02546906292201e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",42720,0.0301601731785048,0.00724097431313168,0.0159678635247667,0.0443524828322429,3.12997585045014e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42753,-0.0274561019957739,0.00659863067916391,-0.0403894181269352,-0.0145227858646127,3.18980287776475e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42635,0.0130746997179424,0.00314371506536916,0.00691301818981889,0.019236381246066,3.21633871835951e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,42310,-0.0186969492263323,0.00450111869206538,-0.0275191418627805,-0.0098747565898842,3.2900556075424e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,42710,-0.0241011520015664,0.00580248958732844,-0.0354740315927301,-0.0127282724104027,3.29313239557008e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,42675,0.0177595967313282,0.0042835687196547,0.00936380204080497,0.0261553914218514,3.40431188357218e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40282,-0.0220924827180527,0.00532953336050366,-0.0325383681046399,-0.0116465973314655,3.41901973104747e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_A,,40481,0.013641188053663,0.00329411264990842,0.00718472725984246,0.0200976488474835,3.48188118730511e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42345,0.0213444275079606,0.00516574317391307,0.011219570887091,0.0314692841288303,3.61975937784885e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPARC,SPARC,42678,-0.0285230630304913,0.00692265916775162,-0.0420914749992845,-0.0149546510616981,3.80727765255322e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,42494,-0.0244059646149171,0.00592348544144654,-0.0360159960801523,-0.0127959331496819,3.80830516647176e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42593,0.0245294281095442,0.0059626025811102,0.0128427270505682,0.0362161291685201,3.91389746316635e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42635,0.0115874015193317,0.00281855728372786,0.00606302924322511,0.0171117737954383,3.96099770092164e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40282,-0.0234576537233051,0.00571605682661832,-0.034661125103477,-0.0122541823431332,4.09297001751028e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42610,0.0219023288556541,0.00535178203480274,0.0114128360674407,0.0323918216438674,4.29188668558447e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,40282,-0.0205675077042331,0.00502560871903654,-0.0304177007935448,-0.0107173146149215,4.29694716063956e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42494,-0.0232231495918795,0.00567791007445119,-0.0343518533378038,-0.0120944458459551,4.33749775455916e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,40510,-0.0183764576454782,0.00450747348632905,-0.0272111056786832,-0.00954180961227331,4.5954947134153e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,40222,-0.0292760773275184,0.00718467021722317,-0.0433580309532758,-0.0151941237017609,4.63769889718166e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,42345,-0.0300375760020883,0.00737567287181363,-0.044493894830843,-0.0155812571733336,4.67796895007104e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,42533,-0.0282259246751022,0.00693170451625849,-0.0418120655269689,-0.0146397838232356,4.68796116969807e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42635,-0.0294801586644587,0.00724720196317808,-0.0436846745122877,-0.0152756428166297,4.77302276271807e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAT,Catalase,40360,-0.0219083000226976,0.00538655459730661,-0.0324659470334185,-0.0113506530119766,4.79042526702502e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFD,Complement factor D,40538,0.00846305548893008,0.00208124154353164,0.00438382206360807,0.0125422889142521,4.80779354778507e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBIN,Erbin,42586,-0.0409286261170751,0.0100674594145399,-0.0606608465695733,-0.021196405664577,4.82164891420763e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42593,-0.0233751772561188,0.00575070719387171,-0.0346465633561073,-0.0121037911561302,4.83588451489106e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,40482,-0.0267590664560209,0.00658880373220443,-0.0396731217711416,-0.0138450111409002,4.91313284439124e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40222,-0.0175139271992106,0.00431824216053606,-0.0259776818338613,-0.00905017256455993,5.03067980780514e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,40135,-0.0161151949402213,0.00397598013426228,-0.0239081160033754,-0.00832227387706721,5.08849067759831e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,42635,0.0155726000699591,0.0038429913343044,0.00804033705472245,0.0231048630851957,5.10219199221515e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,40481,0.0143732676470547,0.00354834982228313,0.00741850199537972,0.0213280332987296,5.14083731229864e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42356,-0.0216493413836089,0.00535446753056306,-0.0321440977435124,-0.0111545850237053,5.30202567651808e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42635,0.0462357323079035,0.0114458316017542,0.0238019023684652,0.0686695622473417,5.38570682003533e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42564,0.0104547870741214,0.00259295962056109,0.00537258621782165,0.0155369879304211,5.56134182193745e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,40526,-0.011179115023692,0.00277277631390928,-0.0166137565989542,-0.00574447344842977,5.57277369196636e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,40222,0.0170177696829501,0.00422712250793021,0.00873260956740686,0.0253029297984933,5.71492073576811e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,42650,-0.0239534251857619,0.00595649333725743,-0.0356281521267864,-0.0122786982447373,5.8169743311905e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40481,0.018097755318424,0.00450018968333848,0.00927738353908059,0.0269181270977674,5.81918733987306e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,40450,-0.0179834146370389,0.00448105896250351,-0.0267662902035458,-0.00920053907053207,6.02874535176427e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,40450,0.0222174483814953,0.00554113275320236,0.0113568281852187,0.033078068577772,6.12272545532904e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOC,Myocilin,42610,0.0177561984950684,0.00442972342674412,0.00907394057864989,0.0264384564114868,6.14565036568534e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,42720,-0.0222949083777069,0.00556228330499658,-0.0331969836555002,-0.0113928330999136,6.15036994740136e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40198,-0.0174044516345585,0.00434322869310829,-0.0259171798730508,-0.00889172339606628,6.18316381776912e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40326,0.00325215464542647,0.000811727055959535,0.00166116961574578,0.00484313967510716,6.20357958665621e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40198,-0.0383109189176011,0.00957634881175528,-0.0570805625886414,-0.0195412752465607,6.36019580369835e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,42662,-0.00993858571128132,0.0024857169622019,-0.0148105909571971,-0.00506658046536559,6.41455849595688e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42653,0.0344398114292501,0.00861524779389809,0.0175539257532098,0.0513256971052903,6.43452071514664e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42369,0.0157158491861084,0.00393162903772398,0.0080098562721694,0.0234218421000474,6.44217582060154e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,42720,-0.0158598627580616,0.00396840290319513,-0.023637932448324,-0.00808179306779915,6.4617156165265e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40510,-0.0307396605561703,0.00769141141094949,-0.0458148269216313,-0.0156644941907093,6.46603955450226e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40448,0.0346168498821816,0.00868299309515241,0.0175981834156829,0.0516355163486803,6.74100982408031e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42688,-0.0166404258471421,0.00417890899962928,-0.0248310874864155,-0.00844976420786871,6.86953778910874e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,42586,0.0304895284436066,0.00765896059969047,0.0154779656682133,0.045501091219,6.90182154382123e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,40222,-0.0266350875637492,0.00669102274461024,-0.0397494921431853,-0.0135206829843131,6.91473018152932e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NBN,Nibrin,42369,-0.021071083190794,0.005298027077041,-0.0314552162617944,-0.0106869501197936,7.01170701857732e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,42475,-0.0315607349377331,0.00794282407955765,-0.0471286701336661,-0.0159927997418001,7.12012992119124e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40481,0.0142279457704356,0.00358335257195044,0.00720457472941269,0.0212513168114584,7.21461633452793e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42310,-0.0332017811969163,0.00836775808683659,-0.0496025870471161,-0.0168009753467166,7.29182576714818e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,42610,0.0151768874067228,0.00382553447658769,0.00767883983261095,0.0226749349808347,7.30819277139219e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,42573,-0.0132701433679844,0.00335709435527268,-0.0198500483043188,-0.0066902384316499,7.76179158263986e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,42361,-0.0235710737227863,0.00596312901895565,-0.0352588065999394,-0.0118833408456333,7.76447011819583e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,42653,0.0121496472043683,0.00307567613876186,0.00612132197239503,0.0181779724363415,7.84722579726198e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42599,0.00694489548215837,0.0017600769577172,0.00349514464503266,0.0103946463192841,7.99425460280187e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,40332,-0.0244328365947573,0.00620685949283877,-0.0365982812007213,-0.0122673919887933,8.32075877852278e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40482,-0.0126896416201791,0.00322436804727538,-0.0190094029928388,-0.00636988024751933,8.35063524683361e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40526,0.0154304252745392,0.00392540616672428,0.00773662918775956,0.0231242213613188,8.51276168819465e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42593,0.016297053204113,0.00414664578090469,0.00816962747353982,0.0244244789346862,8.53097515821104e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40531,0.010668642023124,0.00271543241305716,0.00534639449353198,0.015990889552716,8.58443002899719e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42688,-0.0221077469944293,0.00562953243191448,-0.0331416305609817,-0.0110738634278769,8.64032799925816e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40181,-0.0188258308013644,0.00480468676137003,-0.0282430168536496,-0.00940864474907913,8.97449849523791e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,40181,-0.0129725478885965,0.00331522139243927,-0.0194703818177775,-0.00647471395941554,9.16962375816217e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42678,0.0146231218690426,0.00373750994999286,0.00729760236705664,0.0219486413710287,9.17823042511944e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,40450,-0.0182803997203425,0.00470555915589354,-0.0275032956658938,-0.00905750377479116,0.000102978680834636
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,42637,0.0113846774725101,0.00293204516414092,0.00563786895079387,0.0171314859942263,0.000103735188744435
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,40198,-0.0216657998760415,0.00558573845312808,-0.0326138472441725,-0.0107177525079104,0.000105596904761817
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42369,-0.0165869365658786,0.00427955105764884,-0.0249748566388704,-0.00819901649288689,0.000106764306569971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,42635,-0.0136281636549661,0.00351903024512111,-0.0205254629354035,-0.00673086437452871,0.000108144288418643
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42637,-0.00993101887494244,0.00256505511402808,-0.0149585268984375,-0.00490351085144739,0.000108608589390706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42586,-0.022858022754981,0.00590774851638047,-0.0344372098470867,-0.0112788356628752,0.000109728558945095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42494,-0.0225521063276317,0.00582901844083258,-0.0339769824716636,-0.0111272301835999,0.000109832220394355
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42619,-0.0188406369144716,0.00487190095642927,-0.028389562789073,-0.00929171103987025,0.000110609514900031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42793,-0.00903345793729497,0.00233671638638247,-0.0136134220546046,-0.00445349381998533,0.000111205601702836
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40282,-0.0154422735594846,0.00399481800412788,-0.0232721168475752,-0.00761243027139392,0.000111459483327798
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40448,-0.0118411192136421,0.00306665111952977,-0.0178517554079204,-0.00583048301936373,0.000113437875183542
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42677,-0.025805183570994,0.00668753715801544,-0.0389127564007043,-0.0126976107412838,0.000114523913389061
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42675,-0.0395968350080468,0.0102883855513339,-0.0597620706886613,-0.0194315993274323,0.00011929770751022
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42369,-0.0175203226381472,0.00456704548953764,-0.026471731797641,-0.00856891347865346,0.00012551048351187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40515,0.00696562947009521,0.00181599799024364,0.00340627340921768,0.0105249855309727,0.000125884841027796
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,40450,-0.0313942119600546,0.00819430484254231,-0.0474550494514376,-0.0153333744686717,0.000128200476097944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,42710,0.00889061367807798,0.00232227293935638,0.00433895871693948,0.0134422686392165,0.000129555387514633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,42568,0.0108437366843479,0.00283461107934302,0.00528789896883557,0.0163995743998602,0.000131112936108775
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,40481,-0.0391839335090969,0.0102549344306279,-0.0592836049931275,-0.0190842620250662,0.0001336335988616
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,40198,-0.0160433095926152,0.004198941853954,-0.024273235626365,-0.00781338355886533,0.00013375219483068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,40222,-0.0200683387205687,0.00525413434646865,-0.0303664420396473,-0.00977023540149015,0.000134437644627502
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFH,Complement factor H,39955,-0.00867267437177464,0.00227409599236904,-0.013129902516818,-0.00421544622673132,0.000137677527438085
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,42213,-0.031299466072243,0.00821311648261912,-0.0473971743781765,-0.0152017577663096,0.000139092232406303
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40222,-0.0304918771567463,0.00800770977623116,-0.0461869883181593,-0.0147967659953332,0.000140959846610783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,40268,-0.0220985671923394,0.00580979403458478,-0.0334857635001256,-0.0107113708845533,0.000143331495142563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40181,-0.0269976439477375,0.00710611784297546,-0.0409256349199694,-0.0130696529755055,0.0001459400639692
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40222,0.0150702003265826,0.00396873565744493,0.00729147843799051,0.0228489222151746,0.000147106904752568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42345,-0.0171802564621655,0.00453478298335958,-0.0260684311095502,-0.00829208181478067,0.000152203828940251
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40448,-0.0109837036936157,0.00290330501946418,-0.0166741815317655,-0.00529322585546589,0.000155644331955783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42635,-0.0254569634155445,0.00674191996315249,-0.0386711265433234,-0.0122428002877656,0.000160103353529258
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42688,0.0161936342465171,0.00428962673269182,0.00778596585044113,0.0246013026425931,0.00016064926814491
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42345,-0.0314279156993545,0.00833294613693147,-0.0477604901277402,-0.0150953412709688,0.000162963761104143
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42710,-0.0194331524429721,0.0051583517118609,-0.0295435217982195,-0.00932278308772474,0.000165711124523519
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40331,-0.0212629492812425,0.00564643762058822,-0.0323299670175954,-0.0101959315448896,0.000166918872564089
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40481,-0.029595224042535,0.00786131011511099,-0.0450033918681526,-0.0141870562169175,0.000167616196277295
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,40198,-0.0212599208655359,0.00564932023124263,-0.0323325885187715,-0.0101872532123004,0.000168576787650617
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42602,0.0112633926358878,0.00299354561492836,0.0053960432306282,0.0171307420411474,0.000168899801294561
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,42593,0.0221788230770035,0.00589568660788943,0.0106232773255402,0.0337343688284668,0.000169364105618323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,40301,-0.019676820345513,0.00523098653950686,-0.0299295539629464,-0.00942408672807953,0.000169704970188187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42721,0.0105774404511595,0.0028158467900415,0.00505838074267815,0.0160965001596408,0.00017309991964505
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,42591,-0.024650805788445,0.0065666026753894,-0.0375213470322082,-0.0117802645446817,0.000174793806855283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,42345,-0.014940001011695,0.00398844187036649,-0.0227573470776133,-0.00712265494577665,0.000180570475494484
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40228,-0.0209304121035934,0.00560025321373314,-0.0319069084025104,-0.00995391580467644,0.000186868180420468
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,42356,-0.0197315191299136,0.00528386687724202,-0.030087898209308,-0.00937514005051929,0.0001890354437656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BGN,Biglycan,42327,0.0442428056072797,0.0118879471674189,0.0209424291591386,0.0675431820554208,0.000198749428019356
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,42635,-0.0442407822522799,0.0118893697977221,-0.0675439470558153,-0.0209376174487445,0.0001992150272496
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42586,-0.0201189923562418,0.00540882815454167,-0.0307202955391435,-0.00951768917334015,0.00020030726539584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42793,-0.0263522599634303,0.00708481355613023,-0.0402384945334456,-0.0124660253934151,0.000200387151019749
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,40450,-0.0146707870438926,0.00394581948158066,-0.0224045932277906,-0.00693698085999447,0.000201734111048833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42753,-0.0359580261915832,0.00968086471758915,-0.0549325210380579,-0.0169835313451085,0.000204551869132283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40481,-0.0315874124049899,0.00851329064357022,-0.0482734620663875,-0.0149013627435922,0.000207954702444428
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,42356,-0.0200160016114298,0.00539896949843093,-0.0305979818283544,-0.00943402139450519,0.000210278677796493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40482,0.0150825563104761,0.00406823659186877,0.0071088125904133,0.0230563000305389,0.000210405308159613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40482,-0.0259480014360894,0.00701199618427359,-0.0396915139572656,-0.0122044889149132,0.000216184593163916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,40481,-0.0176516666172218,0.00477284296798768,-0.0270064388344776,-0.00829689439996595,0.000218030775846397
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40198,-0.0179269708825137,0.00484784623678886,-0.0274287495066198,-0.00842519225840751,0.000218426426949721
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42615,-0.0161215388160392,0.00436409340578259,-0.0246751618913731,-0.00756791574070533,0.000221515014556972
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42314,0.0106705080775262,0.0028896063111354,0.0050068797077008,0.0163341364473516,0.000222767953218427
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,42748,-0.0100990877933553,0.00273775991686322,-0.0154650972304072,-0.00473307835630336,0.000226182752812666
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,42612,-0.0115297627580406,0.00312893221727638,-0.0176624699039023,-0.00539705561217889,0.000229704104398537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,42345,-0.0206425491171029,0.00560896795914108,-0.0316361263170195,-0.0096489719171864,0.000233912793110694
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,40222,-0.0110373419411598,0.00301140043138206,-0.0169396867866687,-0.00513499709565097,0.000248319143964913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40518,0.00719040403888618,0.00196555970127974,0.00333790702437789,0.0110429010533945,0.000255148671662081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42306,-0.0282090667941791,0.00771469115499926,-0.0433298614579777,-0.0130882721303806,0.000256643803655488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42623,-0.0272195867704165,0.00744427777457035,-0.0418103712085743,-0.0126288023322586,0.000256714589985261
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,42593,0.0223231205024161,0.00611830780755412,0.0103312371996101,0.0343150038052222,0.000264697435747262
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42593,-0.0140291878538095,0.003857460192645,-0.0215898098313937,-0.00646856587622527,0.000276976614996176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,40222,-0.0216910623759005,0.00596876991986413,-0.0333898514188342,-0.00999227333296678,0.000280228756534835
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,40282,0.0112366993139733,0.00309462420873449,0.0051712358648537,0.0173021627630929,0.000283555362247211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42675,-0.0108099891158997,0.00298231357171414,-0.0166553237164594,-0.00496465451533999,0.000290363227955774
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40510,0.00982854721168851,0.00271238486471625,0.00451227287684466,0.0151448215465324,0.000291824925291428
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42593,-0.0223365591557799,0.00616476481081317,-0.0344194981849737,-0.0102536201265861,0.000291986657480561
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42593,0.016473477241087,0.00454694374412472,0.00756146750260252,0.0253854869795714,0.000292307416456543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42345,-0.0323657303046322,0.00894458256107146,-0.0498971121243323,-0.0148343484849321,0.000297457679601027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,42612,-0.0154537193688266,0.00427152738535695,-0.0238259130441263,-0.00708152569352702,0.000298158492608975
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42494,-0.00845827700584512,0.0023386942334242,-0.0130421177033566,-0.00387443630833369,0.000299525834933667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42635,-0.0134358432021862,0.0037153345887522,-0.0207178989961405,-0.00615378740823189,0.000299913436616729
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42673,0.0125024788101263,0.00346002222436403,0.00572083525037282,0.0192841223698798,0.000303296097718725
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42720,-0.0288908833976205,0.00801223696335315,-0.0445948678457927,-0.0131868989494484,0.000312258560063388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,42753,-0.0217862008943278,0.00604759113811546,-0.0336394795250341,-0.00993292226362153,0.000316348283983485
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40222,-0.00847764939915911,0.00235510331163153,-0.0130936518899569,-0.00386164690836131,0.000319990293860777
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,40181,-0.0161942346637188,0.00449932553913353,-0.0250129127204205,-0.00737555660701709,0.000320530512302742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,40115,-0.0233783478426494,0.00651370483506534,-0.0361452093193775,-0.0106114863659213,0.000333273240637857
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,40301,-0.0122446725140449,0.00341559097798202,-0.0189392308308897,-0.00555011419720017,0.000338607776276501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42610,-0.0106376814858849,0.00297408357230101,-0.0164668852875949,-0.00480847768417492,0.000349059530265684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40448,-0.0362865399140978,0.0101450041713534,-0.0561707480899504,-0.0164023317382452,0.000349300374349125
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,42710,-0.0203513918677321,0.00569162652001397,-0.0315069798469595,-0.00919580388850474,0.000350547808514516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42610,0.0122004269407545,0.00341506898658142,0.00550689172705489,0.0188939621544541,0.000354791498284822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,40198,-0.0129356377912896,0.00362832308685625,-0.0200471510415278,-0.00582412454105133,0.000365143344673674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,40420,0.0254923607380389,0.00715166632845944,0.0114750947342584,0.0395096267418194,0.00036601652454071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40181,-0.0227555263053746,0.00639002291789513,-0.0352799712244491,-0.0102310813863002,0.000370862528554545
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,42753,-0.012523871860338,0.00351857781867301,-0.0194202843849371,-0.00562745933573889,0.00037303614463087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,40448,0.040096696224286,0.0112747518987845,0.0179981825026684,0.0621952099459036,0.000377621684890324
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42635,0.0101938801817611,0.00287155350670862,0.00456563530861224,0.01582212505491,0.00038661575825361
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40222,-0.0184093528075303,0.0051910687104665,-0.0285838474800446,-0.00823485813501595,0.000392225416852794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42593,-0.0149271644970832,0.00421083800654086,-0.0231804069899033,-0.00667392200426309,0.000394042061847504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42675,-0.0299285900289522,0.00844363406570844,-0.0464781127977407,-0.0133790672601637,0.000394667415785333
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,40482,-0.0373196737312553,0.0105531391173077,-0.0580038264011784,-0.0166355210613323,0.000407311790284583
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,40282,-0.0235467530066559,0.00666414130549835,-0.0366084699654326,-0.0104850360478791,0.000411996343780205
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NADK,NAD kinase,42635,-0.0191421597137178,0.0054231418470909,-0.029771517734016,-0.00851280169341967,0.000417394048899148
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,40498,-0.0153595883923038,0.00435192200445228,-0.0238893555210302,-0.0068298212635773,0.000418189379355093
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40448,-0.0481331324396876,0.0136652795852669,-0.0749170804268107,-0.0213491844525645,0.000429524561163795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42345,-0.0114854911941675,0.00326260799493208,-0.0178802028642344,-0.00509077952410063,0.000432451147550241
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,40538,0.00725564420318259,0.00206194384710595,0.00321423426285492,0.0112970541435102,0.00043514054647538
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,42493,-0.0242871351800035,0.00691203072113656,-0.0378347153934312,-0.0107395549665759,0.000443299294333218
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40482,-0.010775679216423,0.0030708027455369,-0.0167944525976753,-0.00475690583517069,0.000451418496311399
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,42645,-0.0159003978585327,0.00453828582962098,-0.0247954380845898,-0.00700535763247553,0.000460483004889806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,40053,-0.0251814151353775,0.00718694496380298,-0.0392678272644313,-0.0110950030063236,0.000460565282070642
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42753,-0.0140637596651923,0.00401770676332223,-0.0219384649213038,-0.00618905440908069,0.000465975025450544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,40115,-0.0168260934590015,0.00481469912646534,-0.0262629037468736,-0.00738928317112947,0.000476415775118331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40481,-0.0227360657371068,0.00651590117215918,-0.0355072320345388,-0.00996489943967477,0.000486097737934217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,42675,-0.0158018245024933,0.00453263910810635,-0.0246857971543817,-0.00691785185060483,0.000491437757951999
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,42453,0.00859058431175145,0.00246915851213914,0.00375103362795874,0.0134301349955442,0.000504613486235957
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40181,0.0109363999474546,0.00314425683764449,0.00477365654567143,0.0170991433492378,0.000506720258399711
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,40456,-0.0199043475719398,0.00573108955647611,-0.031137283102633,-0.00867141204124663,0.000516516951758002
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40448,-0.0136914041725786,0.00394917938290949,-0.0214317957630812,-0.00595101258207602,0.000528466865288841
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,40482,-0.0129559842070104,0.00373756521583745,-0.0202816120300518,-0.00563035638396903,0.000529394422811964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,40531,0.020118940747265,0.00580646163380939,0.00873827594499863,0.0314996055495314,0.000532345955045202
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42593,0.0164707069991005,0.00475419993481073,0.00715247512687144,0.0257889388713295,0.000532970863268394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,40198,-0.0149928809163037,0.00432855355508643,-0.0234768458842731,-0.00650891594833426,0.000534796299888312
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40480,-0.0136176045032828,0.00393497578146326,-0.0213301570349508,-0.0059050519716148,0.000540850624852094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,40470,-0.0288280146936014,0.00833311016815045,-0.0451609106231762,-0.0124951187640265,0.000543272259058127
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40198,-0.0120562002166381,0.00348822797045,-0.0188931270387202,-0.00521927339455614,0.000549808125450354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,40450,-0.0138578426576757,0.0040132230445605,-0.0217237598250143,-0.00599192549033711,0.000556334059070542
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42569,-0.0357975304770143,0.0103866298567176,-0.0561553249961808,-0.0154397359578479,0.000569641777816509
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,42610,0.0172301338274221,0.00500190311055147,0.00742640373074116,0.0270338639241029,0.000573408652458918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,42653,0.0282054627939662,0.00819807433038622,0.0121372371064092,0.0442736884815232,0.000582405483354821
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42345,-0.0135369860296801,0.00393629868081805,-0.0212521314440834,-0.00582184061527667,0.000585647403840396
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,42589,0.0103229333596968,0.00300456175178981,0.00443399232618877,0.0162118743932048,0.000592700897926807
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,42753,0.0148239826923914,0.00431809767199729,0.00636051125527675,0.0232874541295061,0.000598749369580715
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42635,0.00596011237811617,0.0017374709671634,0.00255466928247591,0.00936555547375642,0.000604641836560323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,42291,-0.0160063831419031,0.00466732707587984,-0.0251543442106276,-0.00685842207317865,0.000606660653510118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42720,-0.0285337022563175,0.00832815837466254,-0.044856892670656,-0.0122105118419789,0.000613972639211388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,40108,0.0213602672811893,0.00623644589172017,0.00913683333341781,0.0335837012289609,0.000616902052682156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42753,-0.0117546929771848,0.00343479311597549,-0.0184868874844968,-0.00502249846987285,0.000622904258125839
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,42291,-0.0206337882818076,0.00603473566794206,-0.0324618701909741,-0.0088057063726412,0.000630038165280229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40222,-0.0257495237889198,0.00753734657477222,-0.0405227230754734,-0.0109763245023663,0.000637170186472372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40266,-0.0286566613290086,0.00840021404318222,-0.0451210808536458,-0.0121922418043715,0.000648563818120475
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40198,0.0147379049712031,0.00432324570519766,0.00626434338901564,0.0232114665533905,0.000654375673263557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40481,0.0137958236590719,0.00405598917121406,0.00584608488349233,0.0217455624346514,0.000672873785664532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,40115,-0.0220250829849453,0.00649902040684385,-0.0347631629823592,-0.00928700298753134,0.000703999044789062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42593,0.0111051168757297,0.00327754230896808,0.00468113395015224,0.0175290998013071,0.000705438921248199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42753,-0.0190479955705001,0.00562199823587591,-0.0300671121128169,-0.00802887902818328,0.000705740878167407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,40461,-0.024457254072998,0.007222504043038,-0.0386133619973525,-0.0103011461486435,0.00071095143849334
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40079,-0.0140840223107751,0.00416321655870366,-0.0222439267658343,-0.00592411785571595,0.000719601016338147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42585,-0.0215719591998515,0.00638547577502095,-0.0340874917188926,-0.00905642668081044,0.000731472047424399
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,42369,0.0172198399693518,0.00510888054339055,0.00720643410430628,0.0272332458343972,0.000752282495265247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,42444,-0.0128578756655484,0.00381802583164411,-0.0203412062955708,-0.00537454503552592,0.00076020281935494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40448,-0.0274873057897806,0.00816322996606219,-0.0434872365232625,-0.0114873750562987,0.000761873592096114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,42474,-0.0113095243059653,0.00336601012041319,-0.0179069041419751,-0.00471214446995545,0.000781846203984228
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,40450,-0.0119687822907487,0.00356383970993182,-0.0189539081222151,-0.00498365645928236,0.000786564842135452
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,42261,0.0154025546156195,0.00459555284119113,0.00639527104688487,0.0244098381843541,0.00080567535711279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,42236,0.023370583185675,0.00697445942626362,0.00970064271019831,0.0370405236611517,0.000807836044223938
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42593,-0.0341861342640064,0.0102469548860547,-0.0542701658406736,-0.0141021026873393,0.000851556500033435
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42593,-0.0498407621770727,0.0149529432832109,-0.0791485310121659,-0.0205329933419794,0.000860938407377472
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,42635,-0.0156039094177599,0.00468581259701035,-0.0247881021079002,-0.00641971672761958,0.000870694771282215
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,42310,0.0148549124416558,0.00446262056610835,0.00610817613208347,0.0236016487512282,0.000874794530686825
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,40482,0.0139911978774618,0.00420423331705988,0.00575090057602445,0.0222314951788992,0.000877883253044695
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,40249,-0.0215869083271278,0.00648898610962338,-0.0343053211019896,-0.00886849555226594,0.000881675688641187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,42635,0.0115599682650172,0.00347712165173149,0.0047448098276235,0.0183751267024109,0.000887887828294161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,42641,-0.0224390193147061,0.0067732706732536,-0.0357146298342831,-0.00916340879512899,0.000925849570377837
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,40482,0.0122520286093056,0.00370172293237771,0.0049966516618453,0.0195074055567659,0.000936492525185719
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,42793,0.00827253182932867,0.00250588221193131,0.0033610026939433,0.013184060964714,0.000965046335548918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42494,0.0119121766891891,0.00361130645630848,0.00483401603482452,0.0189903373435537,0.000974309903330244
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42705,-0.0216720470031879,0.00657075427160726,-0.0345507253755381,-0.00879336863083763,0.000975378633134168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,40450,-0.0105988030209006,0.00321447843800711,-0.0168991807593945,-0.00429842528240663,0.000979538283971035
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40115,0.0127626158289603,0.00387739431512359,0.00516292297131811,0.0203623086866026,0.000999550441976671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42475,-0.00762135709261635,0.00231685274921018,-0.0121623884810683,-0.0030803257041644,0.00100616015402835
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,42291,-0.0234308257759382,0.00713707491317322,-0.0374194926057577,-0.00944215894611872,0.00102987571063656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42710,-0.0149817179376452,0.00456436493118287,-0.0239278732027636,-0.00603556267252679,0.00103216970364328
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,40282,0.00718182792485609,0.00219033048640506,0.00288878017150218,0.01147487567821,0.00104541551275704
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,42596,-0.0332611788391609,0.0101468228948406,-0.0531489517130484,-0.0133734059652733,0.00104815490388272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,42710,-0.019350228601886,0.00591623410428833,-0.0309460474462911,-0.00775440975748087,0.00107550174802293
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42579,-0.00663861155201931,0.00203057088378345,-0.0106185304842349,-0.00265869261980374,0.00108073667078672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42673,-0.0191982596774294,0.00588754343565474,-0.0307378448113127,-0.00765867454354608,0.00111363682063245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,40450,-0.0135852577874653,0.0041683262410178,-0.0217551772198602,-0.00541533835507044,0.00112072815707895
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,40079,-0.0170752160221782,0.005240453666471,-0.0273465052084614,-0.00680392683589505,0.00112406969924313
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40448,-0.0262699450632168,0.00806247739629122,-0.0420724007599476,-0.010467489366486,0.00112415487398468
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,42610,0.0101850668179141,0.00313514353367175,0.00404018549191745,0.0163299481439107,0.00116228563690284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,40482,0.00926458188527013,0.00285224972167581,0.00367417243078555,0.0148549913397547,0.001164908033277
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40482,-0.0138802497963001,0.00427817592639448,-0.0222654746120332,-0.00549502498056687,0.00118027747409128
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,42678,0.0111140800260205,0.00342727624393153,0.00439661858791472,0.0178315414641263,0.00118635896397552
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,40482,0.00985288684809682,0.003040401105868,0.00389370068059555,0.0158120730155981,0.00119601606671479
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,40481,-0.0183904363096503,0.00568149403721633,-0.0295261646225943,-0.00725470799670628,0.00121183853634353
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,42635,0.0115107040325428,0.00355748230471878,0.00453803871529397,0.0184833693497916,0.00121667374966223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42586,0.00752960868110185,0.00232832165778232,0.0029660982318485,0.0120931191303552,0.00122399101247766
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42345,0.0121502964780019,0.00375766353964338,0.00478527594030083,0.0195153170157029,0.00122597398998783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,42720,0.00953647557565252,0.00295036690027763,0.00375375645110837,0.0153191947001967,0.00123091517898863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42593,-0.0319921461897602,0.00991147923844399,-0.0514186454971104,-0.01256564688241,0.0012505181864336
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40282,-0.0132265693334388,0.00410339602426646,-0.0212692255410011,-0.00518391312587655,0.00127079255773023
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,42310,-0.0227954051187181,0.00708043161801678,-0.036673051090031,-0.0089177591474052,0.00128729772770778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNLY,Granulysin,42610,0.0170449770400499,0.00530533362140227,0.00664652314210145,0.0274434309379983,0.00131758109093608
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,40448,-0.0221096643927393,0.00689723505822694,-0.0356282451068641,-0.00859108367861452,0.00135165208246845
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42494,-0.0182176585125027,0.00569563122212537,-0.0293810957078684,-0.00705422131713695,0.00138452909204897
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40181,-0.0219938050322529,0.00687671856483312,-0.0354721734193258,-0.00851543664517994,0.00138632761051644
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,40481,0.0160587057606707,0.00504677798005638,0.00616702091976018,0.0259503906015812,0.00146672310342347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42678,-0.0174654466655225,0.00549214859218602,-0.028230057906207,-0.00670083542483787,0.00147569870392718
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40510,-0.00894099467757022,0.00281848283744232,-0.0144652210389572,-0.00341676831618327,0.00151655342470769
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42494,-0.0296730777180756,0.00935709132869646,-0.0480129767223207,-0.0113331787138306,0.00152162546523069
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42345,-0.0181784488227965,0.00573565209230938,-0.0294203269237229,-0.00693657072187013,0.00153115676610357
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,40462,-0.0308020332342889,0.00971961207800796,-0.0498524729071845,-0.0117515935613933,0.00153341721958499
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40134,-0.0133902078011547,0.00423123147126742,-0.0216834214848389,-0.0050969941174706,0.0015571506076884
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,40168,-0.00920951320974221,0.002911089261119,-0.0149152481615354,-0.00350377825794898,0.00156257501136209
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,40181,0.00985490865654244,0.00311952805669616,0.00374063366541797,0.0159691836476669,0.00158684788449001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,42688,-0.0310861755247342,0.00984451289464275,-0.050381420798234,-0.0117909302512344,0.00159360694282314
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42356,-0.0194988616511473,0.00617605436135441,-0.031603928199402,-0.0073937951028927,0.0015966729632111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42699,-0.0290632530015475,0.0092113423844473,-0.0471174840750642,-0.0110090219280308,0.00160762503165439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,42345,0.016854675215215,0.0053462659242359,0.00637599400371264,0.0273333564267174,0.00162183126752563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,40482,-0.0219086771357443,0.00694957363176915,-0.0355298414540119,-0.00828751281747682,0.00162290896177978
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,42710,0.00932218788183491,0.00295851343280187,0.00352350155354325,0.0151208742101266,0.00163084141551421
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,42676,0.013500206318611,0.00428909634340738,0.00509357748553258,0.0219068351516895,0.0016499564892571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,42310,-0.0113243955104194,0.00360226534372131,-0.0183848355841132,-0.00426395543672567,0.00167205635110822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40254,0.0150763404633654,0.00480386227953086,0.00566077039548493,0.0244919105312459,0.00170331524720547
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,42710,0.00885746507624505,0.00282592189119445,0.00331865816950392,0.0143962719829862,0.00172596225665761
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,42487,0.0110094209802556,0.003512498094772,0.00412492471450247,0.0178939172460087,0.00172606288628546
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,40135,0.0154693504032672,0.00494410378306169,0.0057789069884663,0.0251597938180681,0.00175953956872055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40198,-0.0275394944396415,0.00880437397052661,-0.0447960674218737,-0.0102829214574094,0.00176499459463734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42369,0.011169444173621,0.00358870081497614,0.00413559057626772,0.0182032977709742,0.00185974861375882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,40222,0.0167148050425188,0.00537340114016889,0.00618293880778775,0.0272466712772498,0.00187148180951804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,42591,0.0172910295045804,0.00556073884294675,0.00639198137240475,0.028190077636756,0.00187807286981165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42617,-0.0230346456347,0.00741108973341249,-0.0375603815121885,-0.0085089097572115,0.00188667295198159
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,42586,-0.0168828498555123,0.0054375114386552,-0.0275403722752765,-0.00622532743574812,0.00190749881108704
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42635,-0.0200426291324984,0.00646726277978302,-0.0327184641808732,-0.00736679408412371,0.00194516804819594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,40510,-0.016583173750678,0.00535088584308938,-0.0270709100031332,-0.0060954374982228,0.00194555665672879
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42291,0.0173057579995973,0.00559083185859565,0.00634772755674984,0.0282637884424448,0.0019697445617012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40115,-0.0203876701263679,0.00659516387497447,-0.0333141913213178,-0.00746114893141792,0.00199779838157518
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,40181,-0.0246882856427294,0.00798817640090529,-0.0403451113885037,-0.00903145989695501,0.00200249680926048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40526,-0.0194217458572597,0.00628817109497184,-0.0317465612034045,-0.00709693051111493,0.00201577537553727
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42369,-0.0258487441905684,0.00838029486874323,-0.0422741221333051,-0.0094233662478317,0.00204339214050507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40222,0.0135043014414562,0.00437984539403303,0.00491980446915143,0.0220887984137609,0.00205236192698999
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFP,Properdin,40538,0.00680578918466952,0.002209666765728,0.00247484232384263,0.0111367360454964,0.00207490727512698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,42494,-0.0290930560361209,0.00945308378747963,-0.0476211002595809,-0.0105650118126608,0.00209080999466594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,40531,-0.00729098987018066,0.00237407564826515,-0.0119441781407804,-0.00263780159958096,0.002137868667592
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40481,-0.0282563113688812,0.00921007251095369,-0.0463080534903504,-0.010204569247412,0.00216022195266008
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,40448,0.0201836976090294,0.00657898972614928,0.00728887774577681,0.033078517472282,0.00216079291978834
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42720,0.00810181477547788,0.00264195180268339,0.00292358924221843,0.0132800403087373,0.00216934208662248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,42733,-0.0209276591375875,0.00683437201463793,-0.0343230282862778,-0.00753228998889711,0.00220207224680617
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,40282,-0.0170840983663882,0.00558505594165798,-0.0280308080120378,-0.00613738872073853,0.00222685191543047
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40135,0.0195404570136045,0.00639617674007805,0.00700395060305154,0.0320769634241575,0.00225586050160421
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40181,0.0191735975410055,0.0063044806605282,0.00681681544637028,0.0315303796356408,0.0023614159265119
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42610,0.0177037475952171,0.00584537797223972,0.00624680676962725,0.0291606884208069,0.00246096116691365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42710,-0.00946432947433684,0.00312645192587488,-0.0155921752490516,-0.00333648369962208,0.00247312769600767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42610,-0.016949377632167,0.00560494280446416,-0.0279350655289168,-0.0059636897354173,0.00249923532966041
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40481,-0.0181731217556525,0.00603168709224944,-0.0299952284564614,-0.00635101505484356,0.00259302300107186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,40482,-0.0404047406748902,0.0134158090295858,-0.0666997263728784,-0.0141097549769021,0.0026034208067334
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C5,Complement C5,40538,0.00449302590460896,0.00149379935190032,0.00156517917488432,0.00742087263433359,0.00263737021691866
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40428,0.0257174283519555,0.00855381463125803,0.00895195167468974,0.0424829050292212,0.00264819099682957
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,40222,-0.00972729315572026,0.00323699144143877,-0.0160717963809403,-0.00338278993050027,0.00266141648092556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,42586,-0.00966620083182844,0.00321864065550544,-0.0159747365166191,-0.00335766514703777,0.00267655841148235
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,42275,0.0145152216846291,0.00483720560465633,0.00503429869950266,0.0239961446697555,0.00269827460396297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42345,-0.0185437570454485,0.00618015025409193,-0.0306568515434687,-0.00643066254742833,0.00270010981467707
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COCH,Cochlin,40510,-0.0139287109510201,0.00464288629076905,-0.0230287680809274,-0.00482865382111277,0.0027055745724838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40079,-0.0167994552271193,0.00560011858154034,-0.0277756876469384,-0.00582322280730026,0.0027073347021707
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42675,0.00860984994783709,0.00287293026592657,0.00297890662662101,0.0142407932690532,0.00273247531454042
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,42310,-0.012739351852822,0.00425280216938214,-0.021074844104811,-0.00440385960083299,0.0027448958420408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,40336,0.0101707294199492,0.00339858880189629,0.00350949536823251,0.016831963471666,0.00277188138289218
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40198,-0.0256065283450709,0.00857146216484671,-0.0424065941881705,-0.00880646250197136,0.00281966386526109
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40135,0.0182668685531044,0.00612370658297153,0.00626440365048021,0.0302693334557286,0.00286090172791287
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42678,-0.0205383881813011,0.00688618676846428,-0.0340353142474911,-0.00704146211511115,0.00286370318288666
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,40526,-0.0247332412238225,0.00829325316718088,-0.0409880174314971,-0.00847846501614803,0.00286669493680089
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,40115,0.0176002358640502,0.00591201313260627,0.00601269012414192,0.0291877816039585,0.00291694728560638
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40448,-0.0138162050558522,0.00464590110156789,-0.0229221712149252,-0.00471023889677913,0.00294714019647511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42610,0.0185392905941723,0.00624687535507409,0.00629541489822705,0.0307831662901175,0.00300498026689931
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42593,-0.0112175480199491,0.00379198612608268,-0.0186498408270712,-0.00378525521282706,0.00309956744163913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,42753,-0.0169048751628042,0.00571605047725394,-0.028108334098222,-0.00570141622738651,0.00310740304226915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42586,0.00733795623884243,0.00248570964137788,0.00246596534174178,0.0122099471359431,0.00316212328754683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,42635,0.00884023078914052,0.00299760177496278,0.00296493131021348,0.0147155302680676,0.0031924845648526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40301,-0.0164846379756413,0.0056086239857335,-0.027477540987679,-0.00549173496360368,0.00329781610250945
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,40526,0.00957059991946977,0.00325729454673312,0.00318630260787286,0.0159548972310667,0.00330783675582905
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40079,0.0123113888883225,0.00419903509903469,0.00408128009421453,0.0205414976824305,0.00337535005393982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,42753,-0.0119673488839538,0.00408614500273456,-0.0199761930893135,-0.00395850467859403,0.00340880631799535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,40282,0.0130128995238067,0.00444844123402064,0.0042939547051262,0.0217318443424871,0.0034485307767061
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40282,-0.00672868953263933,0.00230232566242089,-0.0112412478309843,-0.00221613123429439,0.00347865755998259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40482,-0.0259209674476876,0.0088808553581334,-0.0433274439496291,-0.00851449094574615,0.00352135674433476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42494,0.00839065751851001,0.00287747471641484,0.00275080707433692,0.0140305079626831,0.00355165902510467
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,42596,-0.0135149876378594,0.00463536633323804,-0.022600305651006,-0.00442966962471287,0.00355565546144123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,40478,-0.00892221436938771,0.00306342704117161,-0.0149265313700841,-0.00291789736869136,0.00359257357198066
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42657,-0.0147757067339838,0.0050736274801341,-0.0247200165950466,-0.00483139687292094,0.00359416664698817
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42456,0.0127522724163067,0.00437923743087483,0.00416896705179206,0.0213355777808214,0.00359738775014129
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40481,-0.0178331749917897,0.00612886674912455,-0.0298457538200738,-0.00582059616350554,0.0036248016046358
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,40115,0.0100994139014236,0.00347292437922365,0.00329248211814529,0.016906345684702,0.00364430702347599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,40282,-0.0156056032102301,0.00537309715422962,-0.0261368736325201,-0.00507433278794,0.00368688772968221
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,42129,0.00720653652564756,0.00248138991584764,0.00234301229058618,0.0120700607607089,0.00368776126883193
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,40510,-0.00926607936090195,0.00319272627463391,-0.0155238228591844,-0.00300833586261948,0.00371211587579708
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40418,-0.0148740924152376,0.00512663059118104,-0.0249222883739525,-0.00482589645652278,0.00372293962082118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,40282,0.00916358769107295,0.00316224554975128,0.00296558641356044,0.0153615889685855,0.00376513793175584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,40181,-0.0138569759325255,0.00478537917251474,-0.0232363191106543,-0.00447763275439658,0.00379071391963701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42345,-0.0185491781667191,0.00641740569987746,-0.0311272933384789,-0.00597106299495927,0.0038532239251533
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39982,-0.0141125619191242,0.00488262485194025,-0.0236825066289271,-0.00454261720932135,0.00385563687852096
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,42356,-0.0140940804625864,0.00487686951657763,-0.0236527447150786,-0.00453541621009425,0.00385889421046432
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42678,-0.0198088557160738,0.00688254897034715,-0.0332986516979542,-0.00631905973419344,0.00400671487157134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42617,0.00734550549176711,0.00255219815375141,0.00234319711041434,0.0123478138731199,0.00400697738954914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42310,-0.017922316627344,0.00623250191983252,-0.0301380203902158,-0.00570661286447227,0.00403882121954499
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCT,Secretin,40181,-0.0142600403701643,0.00496354565473527,-0.0239885898534454,-0.00453149088688316,0.00407431829665133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40222,-0.0105560045042749,0.00367918145282856,-0.0177672001518189,-0.00334480885673095,0.00412400454475596
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,42653,-0.0165681983191215,0.00577535949594091,-0.0278879029311657,-0.00524849370707729,0.00412707723190787
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40481,-0.0204097064583586,0.00711887570581043,-0.0343627028417471,-0.00645671007497021,0.00415170244394574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40448,-0.0214589159421227,0.00750459214129482,-0.0361679165390606,-0.00674991534518488,0.00425172635390158
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40450,-0.00819065597559823,0.00286825843296872,-0.0138124425042169,-0.00256886944697953,0.0043031471679208
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,42476,0.0197113544394949,0.00690318434961967,0.00618111311424032,0.0332415957647494,0.00430492331403492
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42345,-0.00891943013178339,0.00312375315033592,-0.0150419863064418,-0.00279687395712498,0.00430557719078613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42442,-0.0324650922845186,0.0113729975623018,-0.0547561675066302,-0.010174017062407,0.00431611306945693
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,40531,0.00710187530206883,0.00249570499733812,0.00221029350728612,0.0119934570968515,0.00444019074367127
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40198,-0.0160125453770364,0.00563268168428254,-0.0270526014782302,-0.00497248927584264,0.00448025017441114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,42593,-0.0192226615410069,0.00676849765069555,-0.0324889169363702,-0.00595640614564367,0.0045178813633097
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42593,-0.0168973784742131,0.00595366218890734,-0.0285665563644715,-0.00522820058395473,0.00454442363188611
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40181,-0.0226372788849218,0.00797756277374085,-0.0382733019214539,-0.00700125584838976,0.00455347416739546
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,42369,0.0170908430571285,0.00602364311362231,0.00528450255442878,0.0288971835598282,0.00455672419803975
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,40531,-0.0227016487351242,0.00802173629908695,-0.0384242518813347,-0.00697904558891381,0.0046627383556871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42710,0.0129207702594825,0.00456912884907901,0.00396527771528769,0.0218762628036774,0.00469319715280674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42675,0.00925391804501292,0.0032812991961645,0.00282257162053051,0.0156852644694953,0.00480638799386014
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,40198,-0.02615930188716,0.00928648193764817,-0.0443608064849504,-0.00795779728936954,0.00485725520071817
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,40481,-0.00819044985652245,0.0029085586944148,-0.0138912248975755,-0.00248967481546944,0.00487126818202218
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,40079,-0.0103288046770452,0.00367188511798213,-0.0175256995082901,-0.00313190984580018,0.00491782469834135
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40301,-0.0183202199461489,0.00651662197351068,-0.0310927990142298,-0.00554764087806796,0.0049427241950973
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42635,0.0127986554609731,0.00455410882933517,0.00387260215547612,0.02172470876647,0.00495586703133613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,40198,0.00484246229997892,0.00172522955252216,0.00146101237703548,0.00822391222292236,0.00501163370822686
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40198,-0.0150595979227915,0.00537471215580723,-0.0255940337481737,-0.00452516209740931,0.00508857446010189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,40538,0.00639781234775462,0.00228557173507209,0.00191809174701332,0.0108775329484959,0.00513131354189333
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40510,-0.0134582248674275,0.00480848552691393,-0.0228828565001788,-0.00403359323467625,0.00513719001743001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,42310,-0.0145604724643384,0.00521618743721848,-0.0247841998412866,-0.00433674508739013,0.00525562406942219
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42593,-0.0306028616633289,0.0109652948955932,-0.0520948396586916,-0.00911088366796629,0.00526387205726568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42594,0.0080697728728831,0.00289252953217852,0.00240041498981321,0.013739130755953,0.00528041654918709
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42586,-0.0163847199896479,0.00587387939064959,-0.0278975235953211,-0.00487191638397468,0.00528770297434373
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42680,0.00753676921734102,0.002703873788584,0.00223717659171637,0.0128363618429657,0.00532077024613142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42712,0.00798250476060209,0.00287183495273064,0.00235370825325003,0.0136113012679542,0.00545038739448061
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42345,0.0105085176039863,0.00379516811901551,0.00306998809071595,0.0179470471172567,0.00563211866927951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42793,-0.0112687629798226,0.00407184995054214,-0.0192495888828852,-0.00328793707675999,0.00565678984898609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,42617,0.0100766052697623,0.00364110543626009,0.00294003861469253,0.0172131719248321,0.00565727547773593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42619,-0.0155151524096549,0.00560727426685057,-0.026505409972682,-0.00452489484662777,0.00566576198456315
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,42610,-0.0246612239093909,0.008919889990828,-0.0421442082914138,-0.00717823952736804,0.00570450473338552
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40448,0.0309124040245766,0.0112005814755069,0.00895926433258315,0.0528655437165701,0.00579138682773841
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,40448,-0.0159727259376577,0.005788691653183,-0.0273185615778964,-0.00462689029741902,0.00580192992139443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,40181,-0.0187673109335168,0.00681646416019567,-0.0321275806875004,-0.00540704117953333,0.0059106898196416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39837,-0.0308894000423304,0.0112195666002582,-0.0528797505788366,-0.00889904950582431,0.00591209018435679
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,42345,-0.0116999499987209,0.00425048850917068,-0.0200309074766954,-0.00336899252074637,0.00592028014012955
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCN,Decorin,42356,0.00656619692112632,0.00238629995607042,0.00188904900722829,0.0112433448350243,0.00593819534321468
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42675,-0.0107237885636536,0.00390083180579122,-0.0183694189030044,-0.00307815822430276,0.0059838163996319
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,42635,0.0231441544505366,0.00842245669364301,0.00663613933099634,0.039652169570077,0.00600564066487106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42673,-0.0195336174856325,0.00711363778090277,-0.033476347536202,-0.0055908874350631,0.00604179450674855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42675,-0.0283621885250438,0.0103288253666156,-0.0486066862436103,-0.00811769080647722,0.00604204079763668
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FN1,Fibronectin,40538,-0.00723633003164592,0.00264005163619191,-0.0124108312385821,-0.00206182882470978,0.0061352048264436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,42369,0.0128112750114227,0.00467812868181662,0.00364214279506209,0.0219804072277833,0.00617942690779225
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42565,0.0105057022718852,0.00383682355646486,0.00298552810121403,0.0180258764425563,0.00618723597738682
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40448,0.0096434694961316,0.00352342946699975,0.0027375477408121,0.0165493912514511,0.00621080355416098
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,42436,-0.0115314159329505,0.00421597418604121,-0.0197947253375913,-0.00326810652830973,0.00624306080216266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,42356,-0.00962518272858766,0.00352226592463779,-0.0165288239408777,-0.00272154151629758,0.00629075058143456
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,40482,-0.0202046988613189,0.00739467674385962,-0.0346982652792838,-0.00571113244335409,0.00629859006561884
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40282,0.0102094914272517,0.00374467139890542,0.00286993548539705,0.0175490473691063,0.0064128962558058
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40115,0.0129803632028572,0.00476435655031205,0.00364222436424554,0.0223185020414688,0.00645065869458412
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40382,-0.0160559381682924,0.00589450557093251,-0.0276091690873201,-0.00450270724926465,0.00646196801110687
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40198,-0.00905360026170939,0.00332556698642803,-0.0155717115551083,-0.00253548896831045,0.00649071946665309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,42586,-0.0221058388214647,0.00812385559832528,-0.0380285957941822,-0.00618308184874715,0.00651487596991845
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,40292,-0.00662660752142425,0.00243843790771292,-0.0114059458205416,-0.00184726922230693,0.0065866775125755
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42369,-0.0115961629958144,0.00427175611635077,-0.0199688049838619,-0.00322352100776691,0.00664397278486652
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42369,0.0116412032868981,0.00429019176840171,0.00323242742083072,0.0200499791529654,0.00666739994382274
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40115,0.0133367741770264,0.00492538432175099,0.00368302090639449,0.0229905274476584,0.00678437860371899
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42586,-0.0224452046627595,0.00829298596797923,-0.0386994571599988,-0.00619095216552024,0.00680768613679822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40450,-0.00921389357436139,0.00340909973513524,-0.0158957290552265,-0.00253205809349631,0.00688746987028327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40448,-0.0131665956054181,0.00487270313079292,-0.0227170937417722,-0.00361609746906398,0.00690035916460208
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,42504,0.0347594066011944,0.0128779162106956,0.00951869082823096,0.0600001223741578,0.00696049479041659
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,42345,0.0147913866259402,0.00548031038288867,0.00404997827547843,0.025532794976402,0.00696359298949403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,42133,-0.0162517195756745,0.00602185788490616,-0.0280545610300906,-0.00444887812125843,0.00696827763065094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42610,0.0100734345775664,0.00373984590974263,0.00274333659447089,0.017403532560662,0.00707849927973482
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,40481,-0.0172836753481575,0.00644911371445966,-0.0299239382284985,-0.00464341246781661,0.0073727294108976
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,42720,-0.010042491208246,0.00374924185075795,-0.0173910052357316,-0.00269397718076041,0.00740334620111493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42593,0.0129781028025216,0.00484622945041006,0.00347949307971787,0.0224767125253253,0.00741580788957929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40482,-0.0283559822796766,0.0105939111619185,-0.0491200481570368,-0.00759191640231633,0.007447411742372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRELP,Prolargin,42617,0.0064658814957292,0.00241587661390714,0.00173076333247121,0.0112009996589872,0.00745054586303631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,40526,0.0127210346669086,0.00475461945039885,0.00340198054412689,0.0220400887896904,0.00747227436923199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42356,-0.0129786156845688,0.00486079548401953,-0.0225057748332471,-0.00345145653589056,0.00759308335092859
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGRN,Agrin,42675,-0.00961215712342047,0.00360097624506618,-0.0166700705637502,-0.00255424368309076,0.00760960985703365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40222,0.0120515702684468,0.00452323037942526,0.0031860387247733,0.0209171018121203,0.00772443299092828
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40481,-0.0282216226871864,0.010636264158672,-0.0490687004381835,-0.00737454493618921,0.00798112173639767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42593,0.0151839685693684,0.0057231575950162,0.00396657968313669,0.0264013574556002,0.00798561130020872
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40198,-0.00916654358061366,0.00345658510666777,-0.0159414503896825,-0.00239163677154483,0.00801532461259406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,40079,-0.0146531898760143,0.00552688175461132,-0.0254858781150525,-0.00382050163697616,0.00803086706720855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,40197,0.0182865917829381,0.00691309106884488,0.00473693328800219,0.0318362502778741,0.008175574648431
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42657,-0.0182915413770628,0.0069169017741969,-0.0318486688544887,-0.00473441389963689,0.00819138022077931
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,42369,-0.0205492087535262,0.00777073936255458,-0.0357798579041331,-0.0053185596029192,0.00819246189354556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42610,0.0104960621821577,0.00397332804593645,0.00270833921212222,0.0182837851521931,0.00826038448988816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40165,-0.014694243657329,0.005565599795598,-0.0256028192567011,-0.00378566805795692,0.00829767245942124
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42593,0.00922268897859159,0.00349746560987118,0.00236765638324408,0.0160777215739391,0.00837483676870328
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42550,-0.0157585926670733,0.0059763776266219,-0.0274722928152522,-0.00404489251889439,0.00837857085457537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,40481,-0.0143229813631462,0.00543319106888234,-0.0249720358581556,-0.0036739268681368,0.0083954889061473
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,40282,0.0115744615706219,0.00439892672624473,0.00295256518718226,0.0201963579540616,0.00852013524040744
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42586,0.00885137125610889,0.00336514907546339,0.00225567906820066,0.0154470634440171,0.00854056855141576
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40282,0.00644664986913932,0.0024557204280936,0.00163343783007587,0.0112598619082028,0.00867280603630822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,40135,0.0239341023071525,0.00912877301877999,0.00604170719034377,0.0418264974239613,0.00875798081769793
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42643,-0.0128184831374987,0.00489582380018712,-0.0224142977858655,-0.00322266848913196,0.00884814787616679
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40510,-0.0276092118638826,0.0105465876666246,-0.0482805236904668,-0.00693790003729829,0.00886077435589235
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,42593,0.0241744538189915,0.00923745053545191,0.00606905076950576,0.0422798568684773,0.00888046708898941
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42637,0.00933820895503366,0.00356838088436968,0.00234418242166908,0.0163322354883982,0.00888234020560558
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42678,0.0207957275831644,0.0079576830948204,0.00519866871731638,0.0363927864490123,0.00897749411839594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42610,0.00863565098251846,0.00330765517501929,0.00215264683948064,0.0151186551255563,0.00904291794754211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42675,-0.0318566107335977,0.0122066059316394,-0.0557815583596109,-0.00793166310758444,0.00906994154127156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42793,0.0169155162326965,0.00648627766313876,0.00420241201294456,0.0296286204524485,0.0091201062072309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,40538,0.0131922826286234,0.00505914498467938,0.00327635845865185,0.023108206798595,0.00912958830751309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,40222,-0.00781744557695489,0.00299916347030494,-0.0136958059787526,-0.0019390851751572,0.00915846371523766
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40115,-0.0181202307785973,0.00695270357673116,-0.0317475297889904,-0.00449293176820426,0.00916736465418197
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,42645,0.0144001648077689,0.00552936537698394,0.00356260866888037,0.0252377209466574,0.00921614770893651
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42678,-0.024597145692405,0.0094456257675682,-0.0431105721968387,-0.0060837191879713,0.00922228090433735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,42635,-0.0269068894351073,0.0103335286190998,-0.0471606055285429,-0.00665317334167165,0.00922862532373409
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42637,0.00899750470268034,0.0034561194459895,0.00222351058854092,0.0157714988168198,0.00924178230217385
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,40482,-0.0180070252669559,0.00692117194562361,-0.0315725222803782,-0.00444152825353366,0.00928757648231027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42678,0.0115504338869679,0.00445057864873985,0.00282729973543784,0.020273568038498,0.00946202227358728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42494,-0.0205312689014242,0.00791819861184978,-0.0360509381806497,-0.00501159962219861,0.00952686170028024
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42635,0.00658508079350575,0.00254036449073511,0.00160596639166494,0.0115641951953466,0.0095473196735334
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40481,-0.0198408007083256,0.00765479984511994,-0.0348442084047607,-0.00483739301189056,0.00955586824398044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42424,0.044219429295091,0.0170690199132932,0.0107641502650363,0.0776747083251457,0.0095906929386317
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,42369,-0.0144540294879357,0.00559139519040659,-0.0254131640611327,-0.00349489491473884,0.00974716551781534
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,42333,0.0150573940035734,0.00582925087545011,0.00363206228769117,0.0264827257194556,0.00980310010695414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42635,-0.0170760083920796,0.00661396426861766,-0.0300393783585702,-0.00411263842558896,0.00983881283566863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42356,0.00795571127942296,0.00308187082924891,0.0019152444540951,0.0139961781047508,0.00984919106174297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42310,-0.0170042104295784,0.00660790752126376,-0.0299557091712553,-0.00405271168790139,0.0100839078468824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42364,-0.0121855298937189,0.00474829843524214,-0.0214921948267935,-0.00287886496064436,0.0102901201170132
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42610,0.0301745543425053,0.01176648162435,0.0071122503587794,0.0532368583262312,0.0103447288154829
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42688,0.00821696918046797,0.00320731863746614,0.00193062465103432,0.0145033137099016,0.0104195859683559
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40222,-0.0259017441896221,0.0101186080677848,-0.0457342160024802,-0.00606927237676391,0.0104860611134133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40115,0.0123168317090639,0.00481177804489656,0.00288574674106668,0.0217479166770612,0.0104888237760049
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40282,-0.0262301819381164,0.0102549321880308,-0.0463298490266568,-0.00613051484957594,0.0105464997904263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40135,0.0150445131393502,0.00588595039418834,0.00350805036674107,0.0265809759119594,0.0106015792217429
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42310,-0.0106271235223874,0.00416102393082377,-0.0187827304268019,-0.00247151661797277,0.0106614967500429
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,42369,0.0158655370895449,0.0062145572348815,0.00368500490917721,0.0280460692699127,0.0106922425525514
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42356,-0.0182597913478833,0.00715723634124788,-0.0322879745767292,-0.00423160811903747,0.0107454041502786
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,42635,-0.00977235634640574,0.00383891490078889,-0.017296629551952,-0.00224808314085951,0.0109199614046402
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,42593,-0.0168876750505035,0.00664859120860875,-0.0299189138193767,-0.00385643628163034,0.0110952335711958
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40198,-0.00613071263197467,0.00241805379520883,-0.010870098070584,-0.00139132719336536,0.0112459016044906
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42345,-0.0193191198479526,0.00762575877326997,-0.0342656070435618,-0.00437263265234348,0.0113076179388858
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42793,0.0057909451572791,0.00228777247023415,0.00130691111562017,0.010274979198938,0.011376553955698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,42593,0.0138529995254787,0.00547809266170983,0.00311593790852743,0.0245900611424299,0.011456709041923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,40198,0.0141633475757198,0.0056015206129617,0.00318436717431489,0.0251423279771248,0.0114695383945895
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,40538,0.00487467177990872,0.00192816736664137,0.00109546374129164,0.00865387981852581,0.0114804049635581
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,40181,-0.0324226737518242,0.0128259011886384,-0.0575614400815554,-0.00728390742209299,0.011488399871018
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,42710,0.00901081179018506,0.00356597836467501,0.00202149419542204,0.0160001293849481,0.0115192800009087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40482,0.00502245561295267,0.00199112297647506,0.00111985457906155,0.00892505664684379,0.0116685588621472
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,42593,-0.0143325621354294,0.00568817919203336,-0.0254813933518147,-0.00318373091904398,0.0117566843004481
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40448,-0.0191091383285798,0.00758949050737715,-0.033984539723039,-0.00423373693412056,0.0118213902676204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42310,-0.0181442435100548,0.00721254204616715,-0.0322808259205424,-0.00400766109956717,0.011893101143155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42593,-0.0194674064347584,0.00774600543929127,-0.0346495770957693,-0.00428523577374752,0.0119751485304145
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42593,-0.0152189234595288,0.0060590161651557,-0.0270945951432339,-0.0033432517758236,0.0120240119968601
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,42369,0.00857479217991385,0.00341686103640386,0.00187774454856228,0.0152718398112654,0.0121003213601831
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,42733,0.00855431895647926,0.00342045772655593,0.00185022181242963,0.0152584161005289,0.0123985507337366
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,42675,-0.0104610898940925,0.00418583163976524,-0.0186653199080324,-0.00225685988015267,0.0124603826841337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,40135,-0.0133891599340477,0.00537258547640406,-0.0239194274677997,-0.00285889240029579,0.0127127818841002
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,42292,0.0140579680117387,0.00564136906996948,0.00300088463459853,0.0251150513888789,0.0127169241888683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42753,0.0118235169465038,0.00475361216119488,0.00250643711056182,0.0211405967824458,0.0128846943387674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42474,0.00845905769733429,0.003401741190845,0.00179164496327808,0.0151264704313905,0.012906151763964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40222,0.0097636909472993,0.00393225662622086,0.00205646795990641,0.0174709139346922,0.0130438144153159
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40079,-0.00715121966859178,0.00288229547140528,-0.0128005187925461,-0.00150192054463743,0.0131133060283424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,40301,-0.0315785656800273,0.0127704533038879,-0.0566086541556477,-0.00654847720440696,0.0134213918594521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40115,0.00800145370918942,0.00323820861478201,0.00165456482421669,0.0143483425941622,0.01349058915201
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,40531,-0.0114846130371848,0.00465147719424445,-0.020601508337904,-0.00236771773646571,0.013562809593362
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,42499,0.0118198658616869,0.00479538808583952,0.00242090521344146,0.0212188265099324,0.0137199703147723
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40301,0.017114554959244,0.00694804302827047,0.00349639062383383,0.0307327192946541,0.0137846120369597
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42345,-0.0105878952554803,0.00430601507624111,-0.0190276848049129,-0.00214810570604778,0.0139506203684501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,42641,-0.0228492324075224,0.00929652123217112,-0.0410704140225778,-0.00462805079246697,0.0139906085298699
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,42475,0.00817145472137052,0.00332834790083181,0.00164789283574018,0.0146950166070009,0.014096940133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40135,0.00707062085023347,0.0028845656466675,0.00141687218276518,0.0127243695177018,0.014253975948605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,42651,0.011094455011073,0.00454056282480143,0.0021949518744622,0.0199939581476838,0.0145619713254881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42547,0.00988623989558486,0.00404960656574051,0.00194901102673346,0.0178234687644363,0.0146480335679
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40531,-0.00656894819231296,0.00269352238796899,-0.0118482520727322,-0.00128964431189374,0.0147515752712463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42345,0.0186223606991764,0.0076530216523527,0.00362243826056512,0.0336222831377877,0.0149737095019032
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42369,0.0117837873640438,0.00484614622193008,0.00228534076906082,0.0212822339590268,0.0150464078543056
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,40115,0.0173018110664902,0.00711691959318767,0.00335264866384238,0.031250973469138,0.0150698121497321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,42345,-0.0156437098242901,0.00643605364927437,-0.0282583749768678,-0.00302904467171231,0.0150855874016857
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42356,0.00856202222716697,0.00352621307418585,0.0016506446017627,0.0154733998525712,0.0151911814480795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,42586,0.00682507594093479,0.00282092959369088,0.00129605393730066,0.0123540979445689,0.0155575653082204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,40510,-0.0128046653042104,0.00529278405870854,-0.0231785220592792,-0.00243080854914168,0.0155674232750969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42593,-0.0198209509274978,0.00820151137432875,-0.0358959132211822,-0.00374598863381347,0.0156733110078256
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40181,-0.0164579208628799,0.00681405873338655,-0.0298134759803175,-0.00310236574544221,0.015738946669815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40448,-0.0152646068273561,0.00632743170229934,-0.0276663729638628,-0.00286284069084939,0.0158616398305532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,42369,-0.0178639330767243,0.0074127883362335,-0.032392998215742,-0.00333486793770669,0.0159713694883206
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40115,-0.0109398558882037,0.0045410066535635,-0.0198402289291881,-0.00203948284721922,0.016007233061353
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,42720,0.0106566565962719,0.00442601185288968,0.00198167336460808,0.0193316398279356,0.0160651983247444
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,40482,0.0186228747765065,0.00775785911951742,0.00341747090225232,0.0338282786507606,0.0163880040010412
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42494,0.016398817295785,0.00683808654417736,0.00299616766919735,0.0298014669223726,0.0164914136761298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40448,-0.0118991852103834,0.00496533756483018,-0.0216312468374506,-0.00216712358331627,0.0165709516383703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42593,-0.0225750964689213,0.00942869373861297,-0.0410553361966027,-0.00409485674123988,0.0166659009414354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42710,-0.0148734419591604,0.00621701438267691,-0.0270587901492072,-0.00268809376911369,0.0167532128942504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,40222,-0.0215037067146443,0.00899210896102763,-0.0391282402782585,-0.00387917315103016,0.0168010271542789
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40448,-0.00968666078742206,0.00405458296581021,-0.0176336434004101,-0.00173967817443405,0.0169077001080909
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42637,-0.00752449895118418,0.00315352837757938,-0.0137054145712398,-0.0013435833311286,0.0170438598378968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,42494,-0.00774764405220546,0.00324970699792587,-0.0141170697681402,-0.00137821833627076,0.0171346350375029
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENG,Endoglin,42793,0.00410850269287214,0.00172443658101652,0.00072860699407977,0.00748839839166451,0.0172083090326823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",40301,-0.0107555714032297,0.00451425172950057,-0.0196035047930508,-0.00190763801340859,0.0172084609068477
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERVV_1,,40115,0.0103347842612957,0.00433841339921883,0.00183149399882684,0.0188380745237646,0.0172285474263574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,42473,0.00679753892507907,0.00285443282921725,0.00120285057981325,0.0123922272703449,0.0172611014546214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,42720,0.0108842134793726,0.00457420589893063,0.00191876991746861,0.0198496570412767,0.0173510528181373
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGRN,Neugrin,40482,-0.00545290417989524,0.00229536673364841,-0.00995182297784612,-0.000953985381944355,0.0175364006679141
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,40448,-0.0102566103660906,0.0043221887624088,-0.0187281003404118,-0.00178512039176932,0.0176603409601678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40301,-0.0115330036195069,0.00486792968928297,-0.0210741458105016,-0.00199186142851233,0.0178445573182497
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42475,-0.0170099094366552,0.00719836110823817,-0.031118697208802,-0.00290112166450835,0.0181407581513741
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,42586,-0.0138627313483326,0.00588046191809874,-0.0253884367078062,-0.0023370259888591,0.0184166166975226
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,42672,0.00884382434696272,0.00375698683177227,0.00148013015668908,0.0162075185372364,0.0185885153681211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,42655,0.00740835073958773,0.00314743476231954,0.00123937860544143,0.013577322873734,0.0185981903899092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,42356,-0.01328937788311,0.00565577068223577,-0.0243746884202921,-0.0022040673459279,0.0188031178895357
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40198,-0.0104070477579108,0.00443373212050352,-0.0190971627140977,-0.00171693280172388,0.0189305279292685
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42356,-0.0203632313447868,0.00868396083978657,-0.0373837945907685,-0.00334266809880517,0.0190457154046011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIM,Vimentin,42356,-0.026961976090838,0.0115005159074044,-0.0495029872693506,-0.00442096491232551,0.0190717646221769
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42593,0.00834910318398237,0.00356181299224491,0.00136794971918235,0.0153302566487824,0.0190896342925645
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42494,-0.0180409573946147,0.00771054869123298,-0.0331536328294313,-0.00292828195979807,0.0193100169262533
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40448,-0.0176753252791236,0.00755579341841319,-0.0324846803792135,-0.00286597017903376,0.0193369146634999
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40282,0.00876539490928101,0.00374990282810622,0.00141558536619283,0.0161152044523692,0.0194309373978087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42356,-0.00774782821566064,0.00332547306269321,-0.0142657554185393,-0.00122990101278195,0.0198295233416289
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,42610,-0.0119196205008764,0.00511862833007757,-0.0219521320278285,-0.00188710897392439,0.0198910809029818
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40282,-0.0163435525787221,0.00702577668615792,-0.0301140748835916,-0.00257303027385256,0.0200243673959258
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSPN,Persephin,42593,-0.0214538332774256,0.00922335356161541,-0.0395316062581918,-0.00337606029665935,0.0200315832859114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42310,0.00933270145751404,0.00401606614215326,0.00146121181889366,0.0172041910961344,0.0201491881892496
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40481,-0.0142206397562347,0.00612278681992406,-0.0262213019232858,-0.0022199775891835,0.0202196145969434
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,40198,-0.011469628790168,0.00493850253411254,-0.0211490937570286,-0.00179016382330746,0.0202246485370539
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42582,0.00758738462523406,0.00326787049663297,0.00118235845183344,0.0139924107986347,0.0202579278140885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,42586,0.0177179792840322,0.00763300438876578,0.00275729068205126,0.0326786678860131,0.0202892224267839
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,42016,-0.00647590920778543,0.00279155487686987,-0.0119473567664504,-0.00100446164912049,0.0203661549221311
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42720,0.00946806132200012,0.00408151972138392,0.00146828266808764,0.0174678399759126,0.0203698007121914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,42113,0.0112470004565003,0.00485043560320521,0.00174014667421811,0.0207538542387825,0.0204235288064968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,40510,0.00694507980808233,0.00299670285688286,0.00107154220859192,0.0128186174075727,0.0204902481817417
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,40198,-0.0184492872015636,0.00796769372784384,-0.0340659669081375,-0.00283260749498969,0.020603246426662
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,42341,-0.00930467118169858,0.00402036306504941,-0.0171845827891954,-0.00142475957420173,0.0206619021420419
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,42494,0.0100479188617056,0.00434886587185827,0.00152414175286344,0.0185716959705478,0.0208774396044497
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,40135,0.00645660592621169,0.00279623153545246,0.000975992116724862,0.0119372197356985,0.0209599903083616
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40481,-0.0110563881003926,0.00479646446448918,-0.0204574584507913,-0.00165531774999377,0.0211783490734126
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,40433,0.0136660833926884,0.00593062219149128,0.00204206389736548,0.0252901028880113,0.0212225282133444
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40222,-0.00950948493293719,0.00412725629091051,-0.0175989072631218,-0.0014200626027526,0.0212372450602007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40198,-0.0207702756762288,0.00901618582219137,-0.0384419998877238,-0.00309855146473368,0.0212599771956168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,42753,-0.0141028070310438,0.0061273487799527,-0.0261124106397511,-0.00209320342233654,0.0213718949298853
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40115,0.0163986680208057,0.00712564052961941,0.00243241258275164,0.0303649234588597,0.0213899956413606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40450,-0.0134541857839122,0.00584833204741479,-0.0249169165968452,-0.0019914549709792,0.0214371575584683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,40531,0.0332036183766466,0.0144444244605373,0.00489254643399342,0.0615146903192997,0.0215392181151847
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,42345,0.019184540845624,0.00834629885962588,0.00282579508075725,0.0355432866104907,0.0215450536785272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40448,0.0106128245210684,0.00462323859961945,0.00155127686581425,0.0196743721763225,0.0217205555045307
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42659,0.0120176070098767,0.00524513729061999,0.00173713792026148,0.0222980760994918,0.021967788198704
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,42709,0.0101089799480485,0.00441923799070771,0.00144727348626144,0.0187706864098356,0.0221823886838838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,40482,-0.0185920419635994,0.0081303660716738,-0.03452755946408,-0.00265652446311873,0.0222293686135227
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42680,0.00680117116302101,0.00298132493018809,0.000957774299852344,0.0126445680261897,0.0225487060138629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,40115,0.010809945993341,0.00474265397674328,0.00151434419892421,0.0201055477877579,0.0226682573450981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42494,0.010236313901451,0.00449341166261502,0.00142922704272556,0.0190434007601764,0.0227380970578241
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,42610,-0.0166521268996172,0.00731846542326492,-0.0309963191292164,-0.00230793467001792,0.0229001794048307
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,39925,0.0157953354963842,0.00695219684597552,0.00216902967827223,0.0294216413144963,0.0231066968268927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42345,-0.0115473780605339,0.00510038173101028,-0.0215441262533141,-0.00155062986775379,0.0235889586708386
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,40448,-0.0252003895800004,0.0111387197619092,-0.0470322803133425,-0.00336849884665837,0.0236908529557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPSE,Heparanase,40407,-0.0209346130403678,0.00926271195868103,-0.0390895284793826,-0.00277969760135299,0.0238344285753398
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,41778,0.0112053995242062,0.00495993097034901,0.0014839348223221,0.0209268642260902,0.0238889420210698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40482,-0.00633949345772629,0.00280768841535565,-0.0118425627518234,-0.000836424163629212,0.0239706066549271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42793,0.00723405409895148,0.00321587189163595,0.000930945191345014,0.0135371630065579,0.0244976139939046
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,40538,-0.00581911236560283,0.0025904054953448,-0.0108963071364786,-0.000741917594727021,0.0246969269534487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40135,0.00759536498960531,0.00338194910245585,0.000966744748791836,0.0142239852304188,0.0247332158696859
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40115,0.0223006289196662,0.0099370631377821,0.00282398516961328,0.0417772726697191,0.0248403120881604
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42753,0.00813499167483507,0.00362660181231037,0.00102685212270675,0.0152431312269634,0.0249035851080013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,40115,-0.0120729050003557,0.00539383597200829,-0.0226448235054919,-0.00150098649521946,0.0252229951994358
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42610,0.00813620810230674,0.00364253091284304,0.000996847513134386,0.0152755686914791,0.0255212817357185
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40450,-0.00640338005787601,0.00286678066513537,-0.0120222701615413,-0.00078448995421068,0.025525783917859
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F3,Tissue factor,42635,0.00604699502926266,0.00270826529888546,0.000738795043447156,0.0113551950150782,0.025579017830743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40301,-0.0165542590337446,0.00741993530860008,-0.0310973322386008,-0.00201118582888849,0.0256975904349171
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42585,-0.0149180222488012,0.00668905665261044,-0.0280285732879177,-0.00180747120968475,0.025749800500518
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,42260,0.0197357642934247,0.00886192351424691,0.00236639420550076,0.0371051343813487,0.0259622808505338
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40198,-0.00628657023069849,0.00282385546107448,-0.0118213269344045,-0.000751813526992507,0.0260185109340155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40222,0.00738108179721914,0.0033254173768455,0.000863263738601951,0.0138988998558363,0.0264664940841023
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42678,-0.00541922877421761,0.00244516290414734,-0.0102117480663464,-0.000626709482088826,0.0266871924611728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,42653,-0.0187900956880246,0.00847815195920363,-0.0354072735280638,-0.00217291784798553,0.0266878841605318
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,42770,0.00677921348292789,0.00306037258265997,0.000780883220914347,0.0127775437449414,0.0267656510198507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,40481,-0.00603864244964985,0.00272835330677405,-0.011386214930927,-0.000691069968372715,0.0268974486039593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40222,-0.00735449644261322,0.0033272888481988,-0.0138759825850829,-0.00083301030014358,0.0271008442670311
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42601,-0.00763227465472059,0.00345388389460449,-0.0144018870881454,-0.000862662221295794,0.0271382515554413
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42369,-0.0116215767819636,0.00525994079271571,-0.0219310607356864,-0.00131209282824084,0.0271604846319805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42700,0.00482501361219464,0.00218587829498015,0.00054069215403355,0.00910933507035573,0.0273058837287432
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42523,0.00948433023055406,0.0042984393555241,0.00105938909372682,0.0179092713673813,0.0273688663446302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42571,0.00748880378753393,0.00339409200686522,0.000836383454078104,0.0141412241209898,0.0273713015576039
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42345,0.00695793004581047,0.00315644910353662,0.000771289802878686,0.0131445702887422,0.0275167390194405
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,40538,0.0158744983108382,0.00721454444679673,0.00173399119511657,0.0300150054265597,0.0278023976413995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,40135,0.00918160947361994,0.00418261230735733,0.000983689351199584,0.0173795295960403,0.0281712313513527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,40135,0.0104738137164136,0.0047779418048563,0.00110904777889529,0.019838579653932,0.0283919583741989
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,42610,-0.00593401424311274,0.00270833166967748,-0.0112423443156806,-0.000625684170544888,0.0284673398534582
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,40301,-0.00655071199692212,0.00299013375212662,-0.0124113741510903,-0.000690049842753938,0.0284887436629547
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40079,0.0103976749635546,0.00475047590057133,0.00108674219843484,0.0197086077286744,0.0286351020547692
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSPN,Claspin,42291,0.00761947157393546,0.00348188680894754,0.000794973428398291,0.0144439697194726,0.0286641329125288
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,42356,0.0107222318933588,0.00490451510877088,0.00110938228016792,0.0203350815065498,0.0288188119671829
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40481,-0.014501324544896,0.00663586579973259,-0.0275076215123719,-0.00149502757742012,0.0288877073796741
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,42675,-0.0197760060242629,0.00905154214736426,-0.0375170286330969,-0.00203498341542898,0.028919079073116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,42438,-0.010366463316783,0.00474672197667432,-0.0196700383910647,-0.00106288824250135,0.0289855738640503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42438,0.0129479109856567,0.00593843278842004,0.00130858272035342,0.02458723925096,0.0292484575337928
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,42321,-0.0185400892343737,0.0085040060428064,-0.0352079410782743,-0.0018722373904732,0.0292633451281316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,40435,-0.0189570259872069,0.00870668979854298,-0.0360221379923511,-0.00189191398206266,0.0294793458921751
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,40282,0.0200254917879089,0.00920056915432975,0.00199237624542264,0.0380586073303952,0.0295352461381296
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,42310,-0.0132255888155431,0.00608680906413462,-0.0251557345812469,-0.00129544304983922,0.0298111108612854
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,40531,-0.00570803016643566,0.00262748443065586,-0.0108578996505212,-0.000558160682350169,0.0298437739556561
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40531,0.00876868639436972,0.00403991474969861,0.000850453484960455,0.016686919303779,0.0299887121564166
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40115,-0.00984720435182101,0.00453722891096212,-0.0187401730173068,-0.000954235686335257,0.0300046638254305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40448,-0.0102755569082176,0.00473614695101934,-0.0195584049322155,-0.00099270888421972,0.0300578190007551
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40135,0.00650839643268302,0.00300020954561202,0.00062798572328346,0.0123888071420826,0.0300803166151147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40531,0.00587235592396191,0.00270809789683797,0.000564484046159487,0.0111802278017643,0.0301457246434468
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,42310,0.0114538705427293,0.00528257275798083,0.00110002793708686,0.0218077131483717,0.030158566402655
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42657,-0.0139852319537929,0.0064551734825058,-0.0266373719795043,-0.00133309192808153,0.0302893198073221
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,40482,0.00905612139909948,0.0041811157274191,0.000861134573358038,0.0172511082248409,0.0303352567216236
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,42635,-0.00806207107758626,0.00372464072305831,-0.0153623668947806,-0.000761775260391965,0.0304417691767341
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40198,-0.0122401311003992,0.00565810009733199,-0.0233300072911699,-0.00115025490962846,0.0305400722841969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42586,-0.00849425703975672,0.00392873106920004,-0.0161945699353888,-0.000793944144124643,0.0306291490014304
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40481,-0.0160690225446531,0.00743857490157592,-0.0306486293517419,-0.00148941573756429,0.030775954843952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,42310,0.015993648868779,0.00740677740753872,0.00147636515000308,0.0305109325875549,0.0308429352622038
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,42574,-0.0111863148920576,0.00518148424517031,-0.0213420240125914,-0.00103060577152379,0.0308755182907529
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42680,0.0112328392332702,0.00522333687744392,0.000995098953480079,0.0214705795130603,0.0315325985287915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40115,-0.0146637437919956,0.00683725615657737,-0.0280647658588872,-0.00126272172510393,0.0320002365964372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40481,-0.0112516356304854,0.00525179479872018,-0.021545153435977,-0.000958117824993863,0.0321797200265405
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42310,-0.00812967301677229,0.00379680264646603,-0.0155714062038457,-0.000687939829698857,0.0322771536734818
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42617,-0.0629512546078873,0.0294310456348245,-0.120636104052143,-0.00526640516363133,0.0324584803677631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40222,-0.00656897173283807,0.00307260026370288,-0.0125912682496957,-0.000546675215980419,0.0325452029954685
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40222,-0.0193278755304497,0.00905304115705451,-0.0370718361982765,-0.00158391486262283,0.0327863012845307
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,42555,-0.0175025416753434,0.0082233686984605,-0.033620344324326,-0.00138473902636084,0.0333229471309892
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,40526,-0.0116019362268843,0.00546989937957541,-0.0223229390108521,-0.000880933442916518,0.0339391531587714
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42635,-0.016503317256587,0.00778384838208031,-0.0317596600854644,-0.0012469744277096,0.0340074303697634
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42369,-0.0122043604000283,0.00575682955746384,-0.0234877463326574,-0.000920974467399202,0.0340264189301016
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40482,-0.00803675238324314,0.00379204205847479,-0.0154691548178537,-0.000604349948632558,0.0340807074410136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,40282,-0.0164969540519162,0.00778448935143225,-0.0317545531807234,-0.00123935492310899,0.0340950364854982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,40282,0.0174622991674435,0.0082504178407872,0.00129148019950061,0.0336331181353864,0.0343215378443564
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40135,0.0156408516758388,0.00739336772657646,0.00114985093174895,0.0301318524199287,0.0344077914399971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,40538,-0.00679938143766832,0.00321622096984229,-0.0131031745385592,-0.000495588336777437,0.0345293202954702
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42500,-0.0061229487090769,0.00289980506368864,-0.0118065666339066,-0.000439330784247165,0.0347476467054053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RETN,Resistin,42597,0.00904621048489021,0.00429039178686344,0.000637042582637868,0.0174553783871425,0.0350078938567164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,42248,-0.021549947114457,0.0102584520823812,-0.0416565131959241,-0.00144338103298994,0.0356862946093138
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,42310,0.00694469577500164,0.00331486456808849,0.000447561221548204,0.0134418303284551,0.0361886613472845
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40481,0.00930476393377679,0.0044487458705096,0.00058522202757798,0.0180243058399756,0.0365012957757078
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPART,Spartin,40282,-0.0158534752676555,0.00758252797766628,-0.0307152301038814,-0.00099172043142959,0.0365695839099712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40481,-0.0241245675649834,0.0115417413653281,-0.0467463806410265,-0.0015027544889403,0.0366220041962914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42705,-0.00747223302773881,0.00357503838274342,-0.0144793082579159,-0.000465157797561711,0.0366263270971613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42610,-0.0157424625608402,0.00754461566466774,-0.0305299092635889,-0.000955015858091395,0.0369447306695156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42617,-0.00828784592871818,0.00397616866085688,-0.0160811365039977,-0.000494555353438692,0.037144486262461
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,42369,0.0288125775928096,0.0138377300124812,0.00169062676834638,0.0559345284172728,0.037345723077433
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,42369,-0.0135822070623203,0.00652866596721114,-0.0263783923580542,-0.000786021766586495,0.0375085521458263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,40481,-0.00999545003948817,0.00481040781120571,-0.0194238493494514,-0.000567050729524978,0.0377429639303349
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42369,0.00809682351574546,0.00389691208000963,0.00045887583892658,0.0157347711925643,0.0377513684829864
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42494,-0.0161889918967223,0.00779526998435254,-0.0314677210660533,-0.000910262727391321,0.037841837636278
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40198,-0.0156196075358031,0.0075232431887707,-0.0303651641857936,-0.000874050885812508,0.037900460345379
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42586,0.0114939159022105,0.00553711884546866,0.000641162965091983,0.0223466688393291,0.0379320799231058
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,40531,0.00544890859787767,0.00262783374214732,0.000298354463268919,0.0105994627324864,0.0381449264690134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40416,-0.00890719637652905,0.00431131918367414,-0.0173573819765304,-0.000457010776527735,0.0388511368662486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGN,Mimecan,42610,0.00907231841768685,0.00439448371894645,0.000459130328551799,0.0176855065068219,0.038991518695866
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,40301,0.00727732745794961,0.00352561116829587,0.000367129568089697,0.0141875253478095,0.0390283543317311
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40482,-0.0107362944311418,0.00520737604911988,-0.0209427514874168,-0.000529837374866851,0.0392546240385757
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,42369,-0.0165218260048582,0.00801806563258101,-0.032237234644717,-0.000806417364999444,0.0393631857377424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40222,-0.0106448638657413,0.00517070078058591,-0.0207794373956896,-0.000510290335792892,0.039547493460449
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,40510,0.0196953845556756,0.00957694736975937,0.000924567710947233,0.0384662014004039,0.0397532794127941
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,40079,0.0164202882414569,0.00798668780570037,0.000766380142284181,0.0320741963406296,0.0398104364973478
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LXN,Latexin,42460,0.0137924530758731,0.00671765170874462,0.000625855726733612,0.0269590504250125,0.0400760610802619
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42610,-0.00790477809259063,0.00385335936593048,-0.0154573624498144,-0.000352193735366892,0.0402474662599125
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42678,-0.00730077289721575,0.003560732511248,-0.0142798086192618,-0.000321737175169669,0.040348895672301
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42345,0.0117104236914027,0.00571271287443764,0.00051350645750496,0.0229073409253005,0.0403951123642457
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,40115,0.0116107999705494,0.0056676930394565,0.000502121613214637,0.0227194783278841,0.0405257177395432
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40222,0.0113157284001063,0.00552548968876785,0.000485768610121338,0.0221456881900913,0.040592046830089
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40282,0.0108138842714599,0.00528050786928362,0.00046408884766401,0.0211636796952558,0.0405945623198945
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40181,0.00871540487252605,0.00425988111250407,0.000366037892018068,0.017064771853034,0.0407873315933982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40282,-0.00542683545310224,0.00265594995616991,-0.0106324973671953,-0.000221173539009212,0.0410488373201304
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,42688,0.00970693763690875,0.00475392302968278,0.000389248498730507,0.019024626775087,0.0411828959905756
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42586,0.0071418292530491,0.00349932991691073,0.00028314261590407,0.0140005158901941,0.0412790028033096
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42310,-0.0132973727912782,0.00652456166958301,-0.0260855136636609,-0.000509231918895469,0.0415651083383709
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTG,Protogenin,42720,-0.00503364219842333,0.0024700528455641,-0.00987494577572896,-0.000192338621117703,0.0415825297140423
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42345,-0.0119431110755452,0.00586536320887142,-0.0234392229649332,-0.000446999186157261,0.0417492699250654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40115,-0.0110909375077338,0.00544993749243984,-0.0217728149929159,-0.000409060022551724,0.041869161808811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,42494,0.0181820647191672,0.00893579911522388,0.000667898453328354,0.035696230985006,0.0418964189365225
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40222,-0.0147175501898562,0.007244860134081,-0.028917476052655,-0.000517624327057433,0.0422335891867065
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40135,0.0157887552125161,0.0077990271145947,0.000502662067910492,0.0310748483571217,0.0429479222872009
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,42369,0.00987299407952403,0.00488085971358929,0.000306509040889011,0.019439479118159,0.04311411935273
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,42610,0.00673727060521919,0.00333562790610962,0.000199439909244329,0.013275101301194,0.0434249303516941
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,40135,0.0154463220676077,0.00765511485448218,0.000442296952822635,0.0304503471823928,0.0436387547870936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40510,0.00666213645960099,0.00330388621186151,0.000186519484352441,0.0131377534348495,0.0437760430348662
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,42635,-0.00840943155710759,0.00417530636703597,-0.0165930320364981,-0.000225831077717085,0.044020253080434
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,40538,0.0055182588542853,0.00273986416792528,0.000148125085151746,0.0108883926234188,0.044026488490254
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,40079,0.0158597302266005,0.00790157501537024,0.000372643196474813,0.0313468172567261,0.0447572397591418
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42604,-0.0224855896523513,0.0112130306108368,-0.0444631296495914,-0.000508049655111219,0.044950094519151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,40181,0.0134150633220165,0.00669796556192298,0.000287050820647452,0.0265430758233855,0.045217224231667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,42301,-0.00694465395310143,0.00346789435996108,-0.0137417268986251,-0.000147581007577714,0.0452454865761876
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42635,-0.0251048866369857,0.0125626619300168,-0.0497277040198187,-0.000482069254152815,0.0456963253440659
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42593,0.0160990759996463,0.00806434997200106,0.000292950054524243,0.0319052019447684,0.0459185891326476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,40282,-0.0145207745827709,0.00727439529573048,-0.0287785893624027,-0.000262959803139199,0.0459421544467464
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42310,-0.00756776690294952,0.0037916126563824,-0.014999327709459,-0.000136206096440022,0.0459629463108878
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40181,-0.00848857871062782,0.00425809663117964,-0.0168344481077399,-0.000142709313515722,0.0462297855412309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42610,0.00757001448726608,0.00379820109605893,0.000125540338990571,0.0150144886355416,0.046275909893994
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,42658,-0.00596573168031975,0.00299373508545829,-0.011833452447818,-9.80109128214945e-05,0.0463102224983667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42458,0.00820923029821895,0.0041222558293807,0.00012960887263277,0.0162888517238051,0.0464528724987503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40115,-0.0229827243253767,0.0115669737751645,-0.0456539929246991,-0.000311455726054247,0.0469555093814736
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40482,-0.00762275014600439,0.00384035659921434,-0.0151498490804645,-9.56512115442894e-05,0.0471790014360674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40198,-0.00764001164182288,0.00385470790543777,-0.0151952391364809,-8.47841471648455e-05,0.0475046432588037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40510,-0.00788489539822212,0.00397892949596163,-0.0156835972103069,-8.61935861373314e-05,0.0475411853061649
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42564,0.00848686681854112,0.00429053009226024,7.74278377110565e-05,0.0168963057993712,0.0479439901028783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42568,-0.0173269607811675,0.00876024722991663,-0.0344970453518041,-0.000156876210530909,0.0479596086948377
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40115,-0.00768877069082851,0.003895217955603,-0.0153233978838104,-5.41434978466376e-05,0.048418278502337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42557,0.00687891641414512,0.00348761529863911,4.31904288124684e-05,0.0137146423994778,0.0485863783538442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,40531,-0.00525327205327588,0.00266928096198856,-0.0104850627387735,-2.14813677783011e-05,0.0490868911726827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42720,0.0119454841401675,0.00607203117645731,4.43030343112074e-05,0.0238466652460238,0.0491694722537626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40222,-0.0108398601117098,0.00552156372916492,-0.0216621250208731,-1.7595202546565e-05,0.0496495853844507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40481,0.0140912151012299,0.0071966724762612,-1.42629522421056e-05,0.0281966931547018,0.0502524857261952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42239,0.00782983399678145,0.00400051042089068,-1.11664281642956e-05,0.0156708344217272,0.0503442254252985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,40115,0.00617874218535733,0.00316081969564777,-1.6464418112306e-05,0.012373948788827,0.0506332085631117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42675,0.00539444034611235,0.00276088631078786,-1.68968230318603e-05,0.0108057775152566,0.0507360684402958
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40531,0.0139461799190899,0.00714388491403994,-5.58345124284099e-05,0.0279481943506082,0.0509409094181652
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40481,-0.0112327084248158,0.00575627778475021,-0.0225150128829263,4.95960332945692e-05,0.051036084566963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,40135,0.00987668281685839,0.00508149597499804,-8.30492941377679e-05,0.0198364149278545,0.051962490582887
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40448,-0.0120876168223001,0.00626285206274282,-0.024362806865276,0.000187573220675823,0.0536257584949534
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42310,0.0107763063328333,0.00558989798549373,-0.000179893718734394,0.021732506384401,0.0538993245796358
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARTN,Artemin,42369,0.00854548761876122,0.00443785481876401,-0.000152707826016238,0.0172436830635387,0.0541771199651349
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,39872,-0.0046567648120363,0.00242237644700653,-0.0094046226481691,9.10930240965082e-05,0.0545826246687756
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42447,0.00415844688414486,0.00216662907286361,-8.81460986678099e-05,0.00840503986695753,0.0549657421928031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42369,0.0135903693850631,0.00708392471554799,-0.000294123057410981,0.0274748618275371,0.0550717348452921
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42438,0.00552961445979971,0.00288525071000627,-0.000125476931812578,0.011184705851412,0.0553215938375303
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,40450,0.0114920901192397,0.00600240883583962,-0.000272631199005911,0.0232568114374854,0.0555714485712853
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42586,0.0159681501690295,0.00835024385707113,-0.000398327790829895,0.0323346281288889,0.0558593621013147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,42793,0.00591241913558284,0.00309846986311597,-0.00016058179612447,0.0119854200672901,0.0563897875794767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,42369,0.00590871327108312,0.00309745717199072,-0.000162302786018679,0.0119797293281849,0.0564644893250378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40301,-0.0132219553821074,0.00693173898955013,-0.0268081638016256,0.000364253037410884,0.0564879223438522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40301,-0.0144155956340823,0.00756130051136251,-0.0292357446363528,0.000404553368188228,0.0566115535133784
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40448,-0.0274347016616457,0.0143951665768293,-0.0556492281522311,0.000779824828939766,0.0566980666047391
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40482,0.0113620901260331,0.00596480460146249,-0.00032892689283338,0.0230531071448996,0.0568242627967962
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,42637,0.00639952514491383,0.00336339179405735,-0.000192722771438571,0.0129917730612662,0.0571010634534005
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,40198,-0.00776072043200677,0.00407922291730041,-0.0157559973499156,0.000234556485902034,0.0571319354685687
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40448,0.0219996142658788,0.0115850485873448,-0.00070708096531694,0.0447063094970745,0.0575944858922951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,40198,-0.00901995528730913,0.00475122464296333,-0.0183323555875173,0.000292445012899,0.0576631634546637
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42593,-0.00713276015046454,0.00376047960972724,-0.0145033001855299,0.000237779884600857,0.0578799525384349
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,40115,0.00756793450261954,0.00399112138161986,-0.000254663405355391,0.0153905324105945,0.0579609606083802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40450,0.00993228186847266,0.00524118546153587,-0.000340441636137653,0.020205005373083,0.0581120507673558
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42581,0.00506615054812876,0.00268256489612797,-0.00019167664828206,0.0103239777445396,0.0589741210678996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,42593,0.00660914058313802,0.00349987938467352,-0.000250623010822086,0.0134689041770981,0.0589950664598333
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,42593,-0.0125264835101587,0.00663637611105888,-0.0255337806878341,0.000480813667516736,0.0591081460446864
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42586,-0.0215038803059371,0.011409021746882,-0.0438655629298257,0.000857802317951576,0.0594766311338774
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42494,-0.0173448559135038,0.00922176900177304,-0.035419523156979,0.000729811329971356,0.0600128025588176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40198,-0.0148112808148131,0.00790448861013011,-0.0303040784906682,0.000681516861041884,0.0609870920519898
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42586,0.00779419379908308,0.00416739297566619,-0.000373896433222659,0.0159622840313888,0.06146667341605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,42338,0.00711721888341459,0.0038126335302534,-0.000355542835882069,0.0145899806027113,0.0619592960825381
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40115,0.00384612710169876,0.00206577574736978,-0.000202793363146003,0.00789504756654352,0.0626536353753793
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,40135,0.0203929499556824,0.0109697783755312,-0.00110781566035877,0.0418937155717236,0.0630522624460552
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42474,0.00489934408410653,0.00264611394672556,-0.000287039251475574,0.0100857274196886,0.0641163557782966
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42578,-0.00449037637684679,0.00242849557358379,-0.00925022770107102,0.00026947494737744,0.0644746137272034
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,42487,-0.00947324828906311,0.00513276573604659,-0.0195334691317144,0.000586972553588208,0.0649664193057003
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,40450,0.0071737374827798,0.00388874564547338,-0.000448203982348036,0.0147956789479076,0.0651011444402288
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,40481,0.0139927051177024,0.00759714776302351,-0.000897704497823656,0.0288831147332285,0.0655252675581222
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,42628,0.033907792591429,0.0184105290675965,-0.00217684438106017,0.0699924295639181,0.0655321610239665
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,40181,0.00898535413072244,0.00487948839229102,-0.000578443118167953,0.0185491513796128,0.0655819738625606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,40181,0.0108487663464466,0.00589712738598388,-0.000709603330081843,0.022407136022975,0.0658437117471332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42586,0.012503504064771,0.00679685057622033,-0.000818323064620881,0.0258253311941628,0.0658487211430425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42586,-0.00619910552686469,0.00337181350251709,-0.0128078599917982,0.00040964893806881,0.0660097404610549
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42345,-0.0079610035036139,0.00433015265661944,-0.016448102710588,0.000526095703360204,0.0660106921612413
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,42635,0.00858857209147081,0.00467368137680631,-0.000571843407069554,0.0177489875900112,0.0661366386982969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,42459,0.0103268302823648,0.00563264647308844,-0.000713156804888527,0.0213668173696181,0.0667671847437782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,40526,0.016419701934594,0.00896597492916086,-0.00115360892656132,0.0339930127957492,0.0670768250022212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,40222,-0.0160185062585855,0.00874882573003002,-0.0331662046894443,0.00112919217227333,0.0671376388981503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42345,-0.0104115328130707,0.00568851146565416,-0.0215610152857529,0.000737949659611433,0.0672316454039105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,40135,0.0134839937281615,0.00736870639290243,-0.000958670801927231,0.0279266582582503,0.0672921301370816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,40222,-0.00527062735503784,0.00288094357879194,-0.0109172767694701,0.000376022059394369,0.0673547849943777
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40482,-0.00980403193132462,0.00536661505722156,-0.0203225974434789,0.000714533580829638,0.0677478443386138
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42793,0.00569296217186749,0.00311812811817525,-0.000418568939755995,0.011804493283491,0.0679079248309891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRNN,Cornulin,42208,0.012526651987918,0.00686425473074963,-0.000927287284351253,0.0259805912601873,0.0680374167146981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,42310,-0.0129685493716459,0.00711151946671712,-0.0269071275264114,0.000970028783119673,0.0682356864802535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42356,0.00555890087327902,0.0030491363011126,-0.000417406276901668,0.0115352080234597,0.0683099016846052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41947,0.00793552220943645,0.00435287678477869,-0.000596116288729791,0.0164671607076027,0.0683188639661719
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42586,-0.0161145858535203,0.00884370100966038,-0.0334482398324546,0.00121906812541404,0.0684539023797277
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,42345,-0.006392326064575,0.00351042583342636,-0.0132727606980907,0.000488108568940661,0.0686364708427211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,40450,-0.00881013216291531,0.00484285715165851,-0.018302132180166,0.000681867854335369,0.0689072761333983
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,42542,0.00904152236987131,0.00497190801580791,-0.000703417341112195,0.0187864620808548,0.0690068409735717
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40282,-0.00755704984636316,0.0041585834339467,-0.0157078733768987,0.000593773684172368,0.0692108247130792
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,42345,-0.00697812280250571,0.00384024793334635,-0.0145050087518646,0.000548763146853138,0.0692242220344953
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42494,-0.0178458758395578,0.00983101609601818,-0.0371146673877534,0.00142291570863782,0.0695060755722949
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40135,0.00585770215031482,0.0032273893100706,-0.000467980897423568,0.0121833851980532,0.0695517282636183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,40123,-0.017776727090749,0.00979925330492105,-0.0369832635683943,0.0014298093868962,0.0696912855260203
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,40198,-0.00697784499032951,0.00384894774628637,-0.0145217825730508,0.000566092592391762,0.0698709703007206
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,42586,-0.0160996727108476,0.00888913054625875,-0.0335223685815147,0.00132302315981957,0.0701378736448772
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40064,-0.0157864472593468,0.0087417120227904,-0.032920202824016,0.00134730830532235,0.0709653741616988
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40135,0.01397488225134,0.00774640358116321,-0.00120806876773992,0.0291578332704199,0.0712513076937012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42710,0.00912703050205722,0.00507421639382954,-0.000818433629848684,0.0190724946339631,0.0720872817476514
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40481,-0.0085540962372251,0.00475673999157094,-0.0178773066207041,0.000769114146253943,0.0721545013706215
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,40135,0.011150158156966,0.00620139401585975,-0.00100457411411913,0.0233048904280511,0.072203244280952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40481,-0.00730810955236422,0.00408212094950503,-0.0153090666133941,0.000692847508665641,0.0734368815311211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,42356,0.00936465353912707,0.00523574591513614,-0.000897408454539774,0.0196267155327939,0.0737022981431673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40301,-0.0120058976450281,0.00671524027421181,-0.0251677685824832,0.00115597329242706,0.073826134347513
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,40282,0.00717610799627661,0.00401687934933952,-0.000696975528428838,0.0150491915209821,0.0740475414891535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,42561,-0.0134554869828103,0.00754894352674169,-0.0282514162952241,0.00134044232960337,0.0747013184693825
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,42710,-0.0231673031659902,0.0129987999796729,-0.0486449511261491,0.00231034479416881,0.0747285076560263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40135,0.0112969035788644,0.00634107160501605,-0.00113159676696705,0.0237254039246959,0.0748512124706025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,42369,0.0110745477567796,0.00622071003631204,-0.00111804391439201,0.0232671394279512,0.0750547105058239
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40135,0.0101767919347527,0.00572082103285695,-0.00103601728964689,0.0213896011591523,0.0752832448078513
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42619,0.0163622892540829,0.0092133716828785,-0.00169591924435892,0.0344204977525248,0.0757673502596472
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42653,0.0154906850162646,0.00875490723510567,-0.00166893316454253,0.0326503031970717,0.076854507491636
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40366,-0.00600300822883889,0.00339309802327471,-0.0126534803544573,0.000647463896779556,0.0768907705501805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40135,0.00584748354742827,0.00330693256072335,-0.000634104271589491,0.012329071366446,0.0770469785807801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40182,-0.0146328432437552,0.00828210362782035,-0.030865766354283,0.00160007986677273,0.0772890294156675
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42793,-0.00664309422459379,0.00376317509172578,-0.0140189174043763,0.000732728955188741,0.0775375290823681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,40459,-0.0160978013267309,0.00912092573365935,-0.0339748157647032,0.00177921311124146,0.0776025145091961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,42458,0.0117036148762278,0.00663876634194669,-0.00130836715398772,0.0247155969064433,0.0779369844786541
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,40181,0.0122133858805352,0.00694325015424409,-0.00139538442178324,0.0258221561828536,0.0786002317177365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40301,-0.0183122223084793,0.0104208882962027,-0.0387371633690366,0.0021127187520779,0.0789008516033511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42494,0.00695262522664569,0.00396309579003716,-0.000815042521827156,0.0147202929751185,0.0793949577113963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40481,0.00627153483851222,0.00357748033319626,-0.000740326614552447,0.0132833962915769,0.0796189899796021
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C7,Complement component C7,40250,0.00572581012037603,0.00326865607419968,-0.000680755785055331,0.0121323760258074,0.0798475903789157
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40181,0.00868848002262644,0.00496230224946268,-0.0010376323863204,0.0184145924315733,0.079991563002359
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,42759,0.00493973831755381,0.00282202117885955,-0.000591423193010916,0.0104708998281185,0.0800674952790815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40135,0.00728859925877915,0.00416759859099754,-0.000879893979576022,0.0154570924971343,0.080341073606668
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,42345,-0.0125807266820966,0.00719629374286287,-0.0266854624181078,0.00152400905391459,0.0804487433891144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42663,-0.0205222066159618,0.0117444856306317,-0.043541398452,0.00249698522007637,0.0805923539750113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40267,-0.0110499498239049,0.00632454786622316,-0.0234460636417023,0.00134616399389253,0.0806386048373547
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42586,0.00453464543202617,0.00259607040354324,-0.000553652558918569,0.00962294342297092,0.0807063479309916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,40198,0.00783470683148324,0.00448629394408946,-0.000958429298932095,0.0166278429618986,0.0807754460806114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42569,0.0149655173354927,0.00857422349679076,-0.00183996071821719,0.0317709953892026,0.080936856443665
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,40450,0.010009911771032,0.00573713675765465,-0.0012348762739711,0.0212546998160351,0.0810543997686819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40135,0.00871965732996183,0.00500062773447321,-0.00108157302960566,0.0185208876895293,0.0812373124322944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,40301,0.0299644267665683,0.0171871048330278,-0.00372229870616608,0.0636511522393027,0.0812870884484808
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,42310,0.0115973405363781,0.00665816245518349,-0.00145265787578156,0.0246473389485377,0.0815628622031757
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,40181,0.00681775562717567,0.00391511712828297,-0.000855873944258958,0.0144913851986103,0.0816427893850883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42356,-0.0072800588651235,0.0041826704524324,-0.015478092951891,0.000917975221644007,0.0817895568582443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40481,-0.00560249917733491,0.00323043940704057,-0.0119341604151344,0.000729162060464609,0.0828950181785016
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40198,-0.0154259350729969,0.00892555953898655,-0.0329200317694105,0.00206816162341676,0.0839647037322891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,42637,0.00419161623921379,0.00243140765402394,-0.000573942762673136,0.00895717524110071,0.0847405280030445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40181,0.0122942936560219,0.00713224016533203,-0.00168489706802891,0.0262734843800727,0.0847787188135527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,40482,-0.0142154653102249,0.00825977396684456,-0.0304046222852402,0.00197369166479048,0.0852695632679695
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,42587,0.0134219874323002,0.00780773984361067,-0.00188118266117669,0.0287251575257771,0.0856262240890896
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40181,-0.0106750949155059,0.00621176715669291,-0.022850158542624,0.00149996871161224,0.0857285489731307
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40181,0.00621873579460114,0.0036250394771913,-0.000886341580693814,0.0133238131698961,0.0862827714177053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40427,-0.0070215785704719,0.00410601058756671,-0.0150693593221027,0.00102620218115885,0.0872799575108715
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,40301,-0.0126084512345358,0.00737428770626748,-0.0270620551388201,0.00184515266974844,0.0873334498623571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42593,-0.0120326024927123,0.00703803015342199,-0.0258271415934194,0.00176193660799481,0.0873528673436112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,40482,-0.00966255917954845,0.00565623429794978,-0.02074877840353,0.00142366004443312,0.087607721191248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40448,0.00502627053200841,0.00294888598682452,-0.000753546002167651,0.0108060870661845,0.088322005159646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42593,-0.0152468395957198,0.00894664500314187,-0.0327822638018778,0.00228858461043831,0.0883675994700599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,42356,-0.0074856135221032,0.00439489836265746,-0.0160996143129118,0.00112838726870542,0.0885447785020373
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,40135,0.00595138407629579,0.00349676007502306,-0.000902265670749415,0.012805033823341,0.0887892228395756
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,40450,0.00576061961962004,0.00339367408463417,-0.000890981586262942,0.012412220825503,0.0896377269180327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,40531,-0.0152439323272356,0.00899787978450513,-0.0328797767048656,0.00239191205039447,0.0902605705504544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,40082,0.0147910255723832,0.00873306896545394,-0.00232578959990649,0.0319078407446729,0.0903546810637199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40181,0.01326044837741,0.00783939929826855,-0.00210477424719638,0.0286256710020163,0.0907671640717128
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,40198,-0.0104858805192782,0.00620544217782548,-0.0226485471878162,0.00167678614925973,0.0910968838592358
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,40198,-0.00794730700469666,0.00470593548598953,-0.0171709405572361,0.00127632654784282,0.0912892267227889
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40482,-0.00380258172417539,0.00225495164727926,-0.00822228695284273,0.000617123504491957,0.0917608197262143
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42345,-0.00906594343838145,0.00538011586384917,-0.0196109705315258,0.00147908365476293,0.0919962256377357
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,40115,0.0101116719314539,0.00600562978434385,-0.00165936244586001,0.0218827063087679,0.0922684638278803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,42380,-0.00770560782602213,0.0045785185858865,-0.0166795042543597,0.0012682886023154,0.0924004120326711
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,40198,-0.0104740453579273,0.00623876616830866,-0.0227020270478122,0.00175393633195771,0.093206774339576
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42705,0.00491421581169868,0.00292767092921482,-0.000824019209562368,0.0106524508329597,0.0932646507124607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,40450,-0.00875827755731084,0.00521926759832778,-0.0189880420500333,0.00147148693541161,0.0933618993321391
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40115,0.0102531114163537,0.00611141492122432,-0.00172526182924596,0.0222314846619534,0.0934345943992728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42586,-0.00332743653437665,0.00198641899033282,-0.00722081775542897,0.000565944686675669,0.0939393343297042
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42546,0.0046693660010932,0.00278857417358705,-0.000796239379137426,0.0101349713813238,0.0940629386577562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40115,0.0146489154313381,0.00874855228880457,-0.00249824705471886,0.031796077917395,0.0940730251564333
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40526,0.00386287276946121,0.00230725884963442,-0.000659354575822258,0.00838510011474468,0.0941137861283858
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40448,0.0157086080592155,0.00938651564199817,-0.00268896259910092,0.0341061787175319,0.0942509531203486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALLD,Palladin,40198,0.00646571897381522,0.00387447421708301,-0.00112825049166749,0.0140596884392979,0.0951856549885953
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,42635,-0.0195492384709777,0.0117197337181049,-0.0425199165584634,0.00342143961650798,0.0953267806599494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40510,0.00460568337364612,0.00276548782968076,-0.000814672772528162,0.0100260395198204,0.0958577809195068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,40181,-0.00691438493777562,0.0041536133301409,-0.0150554670648518,0.00122669718930054,0.0960076328717039
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40079,0.00973950780463142,0.00585135921715371,-0.00172915626098985,0.0212081718702527,0.0960440497367635
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42635,0.00811550981118501,0.00487630610184617,-0.00144205014843349,0.0176730697708035,0.0960809809974676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40079,-0.0131723175022332,0.00794888625005166,-0.0287521345523345,0.00240749954786802,0.0975225319682587
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42612,0.00534778324964114,0.0032283890784793,-0.000979859344178291,0.0116754258434606,0.0976466975879939
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39939,0.0174301040317948,0.0105551337027404,-0.0032579580255763,0.038118166089166,0.0986985933109728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,40115,0.00806047498751465,0.0048830092238564,-0.0015102230912439,0.0176311730662732,0.0988247671037736
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,40115,0.00826600717382542,0.00501126782198742,-0.00155607775726992,0.0180880921049208,0.0990772339307556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42369,-0.00569873124233649,0.00345664386449033,-0.0124737532167375,0.00107629073206456,0.0992470365019819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40450,-0.0175770923005416,0.0106616041812721,-0.038473836495835,0.00331965189475183,0.0992503703368967
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40115,0.00718151630839924,0.00435755357180193,-0.00135928869233254,0.015722321309131,0.0993688162250144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40115,-0.00611332863583264,0.00371385031504614,-0.0133924752533231,0.00116581798165779,0.0997741846812114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42675,0.00938303526687859,0.00570219340562989,-0.00179326380815599,0.0205593343419132,0.0998873083021231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40115,-0.0112627570689449,0.00684499765629847,-0.0246789524752899,0.00215343833740012,0.099916189747092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42710,-0.00938028446762543,0.00570129350326212,-0.0205548197340192,0.00179425079876832,0.0999331554674422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42759,-0.0054346434924593,0.00330638983065773,-0.0119151675605484,0.00104588057562985,0.100265702857714
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLG,Plasminogen,40284,-0.00348409789092395,0.00212583765151617,-0.00765073968789565,0.000682543906047755,0.101256323364927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40301,-0.0140790979165001,0.00859054314618819,-0.0309165624830289,0.0027583666500288,0.101261034002468
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,40079,0.00859687605755099,0.00524937874545754,-0.00169190628354579,0.0188856583986478,0.101514448452326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,40403,-0.00784201467218193,0.00479215349407693,-0.0172346355205727,0.00155060617620884,0.101778094860627
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42356,-0.00567114449956797,0.00346699683846095,-0.0124664583029514,0.0011241693038155,0.101915564088756
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,40448,-0.00709842231059757,0.0043496353673227,-0.0156237076305501,0.00142686300935492,0.102716309043833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42586,0.00515818758649556,0.00316421368167274,-0.00104367122958302,0.0113600464025741,0.103090333742805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,40481,0.00621730039530158,0.00381575930136658,-0.0012615878353769,0.0136961886259801,0.10326169752485
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42494,-0.00766357306039107,0.00470464778294455,-0.0168846827149624,0.00155753659418025,0.103350120135224
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,40482,-0.00624998986617223,0.00385110485876867,-0.0137981553893588,0.00129817565701436,0.104636943313706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40482,0.0385031778851706,0.0237839055889123,-0.0081132770690975,0.0851196328394386,0.105502028068537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,42680,-0.0117082246478644,0.00724259146222056,-0.0259037039138167,0.00248725461808786,0.105992476475323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40448,-0.00934917673249452,0.00578651943201268,-0.0206907548192394,0.00199240135425033,0.10619106152231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42554,-0.00523191626546794,0.00324222745224786,-0.0115866820718738,0.00112284954093787,0.106620560224773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42793,0.00421728164841252,0.00261750992784469,-0.000913037810163071,0.0093476011069881,0.107163536413436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40115,-0.00625651697462761,0.00388347929284241,-0.0138681363885987,0.0013551024393435,0.107195610112522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40510,0.00838674628099813,0.00520727324846982,-0.00181950928600272,0.018593001847999,0.107298511278309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,40198,0.0091968928779726,0.00572296075182378,-0.002020110195602,0.0204138959515472,0.108079419813771
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,40531,0.00356454955713288,0.00221845022616384,-0.000783612886148248,0.007912712000414,0.108131662919712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42494,-0.0170352708308773,0.0106358346499553,-0.0378815067447897,0.00381096508303506,0.109248741105391
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,42682,-0.00585225457284729,0.00365522452136781,-0.0130164946347282,0.00131198548903361,0.10938578914437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40115,0.00649420449927978,0.00405614791533824,-0.00145584541478318,0.0144442544133427,0.109388823868102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,40467,-0.00541418823897791,0.00338223478387635,-0.0120433684153756,0.00121499193741974,0.10945535008672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40448,-0.0137375951185727,0.00859398330892535,-0.0305818024040664,0.00310661216692102,0.109956899732266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40222,-0.00514004528098896,0.00321553473617696,-0.0114424933638958,0.00116240280191789,0.109959494381888
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40282,0.0139739047691768,0.0087421041389231,-0.00316061934311246,0.0311084288814661,0.109969108989998
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42593,0.00771480756595613,0.00483637354156252,-0.00176448457550641,0.0171940997074187,0.11069921597467
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42753,-0.00866381117849508,0.00543919955792692,-0.0193246423120318,0.00199701995504169,0.111217890985114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,40531,0.00919817879857325,0.00577732407015492,-0.0021253763789304,0.0205217339760769,0.111386183694283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,40115,-0.00729946659796206,0.00458566711201037,-0.0162873741375024,0.00168844094157827,0.111458509631915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,40510,0.010049381069066,0.00631423171584879,-0.00232651309399763,0.0224252752321296,0.111515010415536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWC2,Brorin,42455,0.00648597154356616,0.00407834928583734,-0.00150759305667502,0.0144795361438073,0.111781497258797
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,42369,0.00796275402744813,0.00501730837798014,-0.00187117039339295,0.0177966784482892,0.112523749081368
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40181,0.00586399807003381,0.00369854694867115,-0.00138515394936164,0.0131131500894293,0.112884509310099
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40510,0.00548132271854747,0.00346027529020693,-0.00130081685025811,0.012263462287353,0.113205442643404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,42673,0.00960697067057111,0.00606953936639141,-0.00228932648755605,0.0215032678286983,0.113486620451653
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42291,-0.010410495255644,0.00658013271915974,-0.023307555385197,0.00248656487390915,0.113648556316528
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40181,0.00795150695090353,0.00502939419266211,-0.0019061056667142,0.0178091195685213,0.113905243826442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,40198,0.00460537559850441,0.00291303761230182,-0.00110417812160715,0.010314929318616,0.113917521653135
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40198,-0.00580527025412984,0.0036768194702397,-0.0130118364157997,0.00140129590753997,0.114391483371973
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40489,0.00352395041884931,0.00223369856564638,-0.0008540987698176,0.00790199960751622,0.114678583663553
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40135,0.00805570765215895,0.00510683681293038,-0.00195369250118459,0.0180651078055025,0.114724174104833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,42675,-0.00654152336374631,0.00415307453617352,-0.0146815494546464,0.00159850272715379,0.115255959162326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,40301,0.00878718351414123,0.00559666854178141,-0.00218228682775034,0.0197566538560328,0.11642639221015
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42678,-0.00940954813299288,0.00599499480468377,-0.0211597379501731,0.00234064168418731,0.116539262594014
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40482,-0.00651180857331636,0.00414973306968538,-0.0146452853898997,0.00162166824326698,0.116626710445521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,42698,0.0240030734045375,0.0153132790323612,-0.00601095349889041,0.0540171003079653,0.117028793102974
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40135,0.0117781025471059,0.00751727073385102,-0.00295574809124214,0.0265119531854539,0.117189037123124
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40222,-0.00758605613984331,0.00485236017314466,-0.0170966820792069,0.00192456979952023,0.117993228784235
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,42753,0.00614409783437432,0.00393527525679329,-0.00156904166894053,0.0138572373376892,0.118479163801506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40450,-0.0135333374537326,0.00867665543561996,-0.0305395821075477,0.00347290720008252,0.118849151876001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40301,-0.0105946483210984,0.0068055938461803,-0.0239336122596118,0.00274431561741496,0.119556944272455
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,40383,-0.00687102438899984,0.00442064761994769,-0.0155354937240973,0.00179344494609764,0.120140520183238
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,42593,0.00626756773094136,0.00404476973557809,-0.0016601809507917,0.0141953164126744,0.121273488854504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42345,0.00799061340098714,0.00516036054499946,-0.0021236932672118,0.0181049200691861,0.121535577304696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40282,-0.0126188988326839,0.00815146871289086,-0.02859577750995,0.00335797984458215,0.121638275886942
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,42345,-0.00883233056549274,0.00572009135380013,-0.020043709618941,0.00237904848795552,0.122590816592166
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,40383,0.00482514930347315,0.00312754080269015,-0.00130483066979955,0.0109551292767459,0.122909191621076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,42586,-0.00490421942590218,0.00318096535085572,-0.0111389115135794,0.00133047266177503,0.123160574974719
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,42369,-0.00738422079849031,0.00479643880133321,-0.0167852408491034,0.00201679925212278,0.123701041430794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,40482,-0.00694873772412708,0.00451706329402418,-0.0158021817804145,0.00190470633216032,0.123995774481342
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42494,-0.00896525837580674,0.005828702409927,-0.0203895150992637,0.00245899834765018,0.124042452153443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,42586,0.00453141733009493,0.00296204178359509,-0.00127418456575145,0.0103370192259413,0.126082687790677
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,42565,-0.00702769034877661,0.00459559241351697,-0.0160350514792699,0.00197967078171665,0.126232570979924
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,40181,0.00737063798947414,0.00482603844439617,-0.00208839736154235,0.0168296733404906,0.126723997991011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42618,-0.00885218634969753,0.00579795476398245,-0.0202161776871031,0.00251180498770808,0.126839930680406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40222,0.00428120621865493,0.0028047881629302,-0.00121617858068825,0.00977859101799812,0.126940946053892
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40481,0.00359939681455502,0.00235834850019134,-0.00102296624582001,0.00822175987493005,0.126979074652283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42697,0.00625334002079069,0.00410055738479879,-0.00178375245341493,0.0142904324949963,0.127283125217543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,42310,0.00538695541910644,0.00353373356390049,-0.00153916236613851,0.0123130732043514,0.127423606842915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,40135,-0.00964341441621101,0.00632624222729883,-0.0220428491817167,0.0027560203492947,0.127449926813393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40450,-0.00691981357092307,0.00454293187806244,-0.0158239600519254,0.0019843329100793,0.127735682152868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,40301,0.00577849956433953,0.00379628962877374,-0.00166222810805701,0.0132192272367361,0.128001465428546
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,40115,-0.0188645445720852,0.0123939774750239,-0.0431567404231321,0.00542765127896172,0.12801961971681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,42552,0.0089519299646599,0.00591886535848583,-0.00264904613797232,0.0205529060672921,0.130445568908384
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,40418,0.00510854505874105,0.0033844589628174,-0.00152499450838106,0.0117420846258632,0.131221519218782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,40222,-0.00658428456311589,0.00436709601557784,-0.0151437927536485,0.00197522362741669,0.131659155436186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,40181,-0.00731345636931248,0.00485247715480927,-0.0168243115927386,0.00219739885411369,0.13179856469955
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,40301,0.0061339782991804,0.00407593159827149,-0.00185484763343172,0.0141228042317925,0.132371357272313
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,40429,-0.00637543083021151,0.00424243842998557,-0.0146906101529832,0.00193974849256021,0.132925155260494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,40079,0.00709085669543592,0.00473107249942192,-0.00218204540343104,0.0163637587943029,0.133958625062036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALB2,Calretinin,42310,-0.00476620025739585,0.00318210514002509,-0.011003126331845,0.00147072581705332,0.134205758939212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40115,0.00779554610111402,0.00521197237248701,-0.00241991974896053,0.0180110119511886,0.134760794553897
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42457,0.00514275242801369,0.00344177723416987,-0.00160313095095925,0.0118886358069866,0.135143431018533
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,42246,0.00990761991543419,0.00663114275774641,-0.00308941988974877,0.0229046597206172,0.135172494497667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,40135,0.00811468073747468,0.00543263488400137,-0.00253328363516802,0.0187626451101174,0.135285099000999
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,40222,-0.0113166137969085,0.00757985230311904,-0.0261731243110218,0.00353989671720479,0.135469444229279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40450,0.00666750881232287,0.00446612509048547,-0.00208609636502865,0.0154211139896744,0.135489595258746
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,40079,0.0077906192519764,0.00523372080223775,-0.00246747352040958,0.0180487120243624,0.13663668086332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,40198,-0.00736202475045416,0.00496067621232356,-0.0170849501266083,0.00236090062570002,0.137817174582118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40481,-0.00434059234272766,0.00292729633595173,-0.0100780931611931,0.00139690847573773,0.138155717501979
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42310,0.00581474096087132,0.0039327152292214,-0.00189338088840261,0.0135228628101453,0.139282947726344
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,42678,-0.0090628399867596,0.00613257365402622,-0.021082684348651,0.0029570043751318,0.139479320397167
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,40282,-0.00998906013324521,0.00677128840781019,-0.0232607854125532,0.00328266514606275,0.140184973192903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42345,-0.0122608488380146,0.0083307677175298,-0.028589153564373,0.00406745588834381,0.141110984505487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,40181,-0.00457124441834201,0.00311081788405766,-0.010668447471095,0.001525958634411,0.141734781417653
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40135,0.00891124704639793,0.006064765560948,-0.00297569345306014,0.020798187545856,0.141767359167712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,40115,-0.00878714999112255,0.00599287742512225,-0.0205331897443622,0.00295888976211707,0.142604736184298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,40198,-0.00582290736031837,0.00397300726957485,-0.0136100016086851,0.00196418688804834,0.142781204292401
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,40266,-0.0147947378576522,0.0100951625124896,-0.0345812563821317,0.00499178066682733,0.142805462736116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,40481,-0.00374857542712489,0.00256245594657345,-0.00877098908240886,0.00127383822815909,0.143527007392217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40222,-0.0111507652306011,0.00763726386302315,-0.0261198024021265,0.00381827194092429,0.144305605469285
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,40469,-0.00469740656891919,0.00321867790982656,-0.0110060152721792,0.00161120213434086,0.144477091241413
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40510,-0.00438809344554854,0.00300865321746441,-0.0102850537517788,0.0015088668606817,0.144733025679155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40301,-0.0063863238545904,0.0043788913771322,-0.0149689509537695,0.00219630324458872,0.144749243886515
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42635,0.00544413040335161,0.0037338145993882,-0.00187414621144926,0.0127624070181525,0.14484702393179
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,42610,0.00291437602186822,0.00200361248022705,-0.0010127044393768,0.00684145648311324,0.145814305261752
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40135,0.0130873241547822,0.00903189189753077,-0.00461518396437813,0.0307898322739425,0.147362754364144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,40198,-0.00311248313487492,0.00214805529444693,-0.0073226715119909,0.00109770524224105,0.147372446509169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40115,-0.00642826924253181,0.00444610140442279,-0.0151426279952005,0.00228608951013686,0.148255954418748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40450,-0.00740132059034428,0.00511989584379105,-0.0174363164441747,0.00263367526348618,0.148317313127163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,42593,0.00556347285181422,0.00385960094626799,-0.00200134500287103,0.0131282907064995,0.149477227503931
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40115,0.0157648594923327,0.0109610820033769,-0.00571886123428591,0.0372485802189514,0.150389632243639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42586,0.00309954207400889,0.00215613279508251,-0.00112647820435283,0.00732556235237062,0.150586013205269
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40198,-0.00506322388269962,0.00352351005973969,-0.0119693035997894,0.00184285583439018,0.150751269522142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42310,0.0087607405681581,0.00609755132065953,-0.00319046002033457,0.0207119411566508,0.150808992417825
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42710,-0.00439300109596311,0.003060195219078,-0.010390983725356,0.00160498153342977,0.151159354754407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,40234,-0.00590616960623954,0.00412802818427387,-0.0139971048474163,0.00218476563493724,0.152530647380874
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40115,0.00720055781835467,0.00506165896667021,-0.00272029375631894,0.0171214093930283,0.154889772711334
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40450,-0.00628388707597568,0.00442920324445321,-0.014965125435104,0.00239735128315261,0.156002566859759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40115,0.00578572829444399,0.0040812534430538,-0.00221352845394145,0.0137849850428294,0.156325845008783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42586,0.00532132289305117,0.00375453986381128,-0.00203757524001893,0.0126802210261213,0.156417444782562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,40526,-0.0116099049173805,0.00819379193299155,-0.0276697371060439,0.00444992727128292,0.156535334236325
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,42769,-0.0083651529546367,0.00590809496305613,-0.0199450190822267,0.00321471317295331,0.156833611074638
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,40115,0.0103627953910763,0.00732145564971896,-0.00398725768237282,0.0247128484645255,0.156979481738911
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,42593,0.00772693166853083,0.00546734952446223,-0.00298907339941515,0.0184429367364768,0.157594710390203
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42356,0.00777840837141114,0.00550530137848154,-0.00301198233041269,0.018568799073235,0.157710481486183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40115,-0.00938466129031932,0.00664838823284838,-0.0224155022267021,0.0036461796460635,0.15810528104199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40079,-0.00779062971578524,0.00553419511976214,-0.018637652150519,0.00305639271894854,0.159240810735129
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40428,0.00551902709224796,0.00392594410730399,-0.00217582335806786,0.0132138775425638,0.159816105951811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40282,-0.0045465248484957,0.0032349213057259,-0.0108869706077185,0.00179392091072706,0.159915093580162
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40079,-0.00514808444452207,0.00366360434997704,-0.0123287489704771,0.00203258008143293,0.159991357827562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,40222,0.00253320230141731,0.00180712609624265,-0.00100876484721829,0.00607516945005291,0.161007595314466
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,40135,0.0135638504488771,0.00969355722580632,-0.00543552171370333,0.0325632226114574,0.161762031945798
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42710,0.00990998236969478,0.0070829014309557,-0.00397250443497839,0.023792469174368,0.161793458783399
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,42345,-0.0102490685104933,0.00732729494546012,-0.0246105666035951,0.00411242958260855,0.161910944831396
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40282,-0.00415817192008024,0.00297341702612549,-0.00998606929128621,0.00166972545112573,0.162006259725227
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,40450,-0.00560111727061556,0.00400720439393106,-0.0134552378827204,0.00225300334148932,0.162212150839403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40469,0.00567631460545657,0.00406517669621989,-0.00229143171913441,0.0136440609300475,0.162643636701908
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40079,-0.00851032852693518,0.00610591589750841,-0.0204779236860517,0.00345726663218131,0.163411262860002
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40115,-0.00478954589556116,0.00345196368374992,-0.011555394715711,0.00197630292458868,0.165322403237044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40301,0.00398738063500422,0.00288223228097871,-0.00166179463571406,0.00963655590572249,0.166559369555846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42356,-0.0102811331092905,0.00745189529775047,-0.0248868478928814,0.00432458167430043,0.167712673301823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DMD,Dystrophin,40222,-0.00703960538420317,0.00510719428409195,-0.0170497061810234,0.00297049541261705,0.168116921863868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42653,-0.00706262961699594,0.00512680741538985,-0.0171111721511601,0.00298591291716817,0.16835335903499
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,42291,-0.00499423108756194,0.00363429747394907,-0.0121174541365021,0.00212899196137824,0.169404866492805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40538,0.00268743852606142,0.0019637870324428,-0.00116158405752647,0.00653646110964931,0.171183364327302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40135,0.00840990842805419,0.0061463589443801,-0.00363695510293081,0.0204567719590392,0.171254153691401
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,42678,0.00297913461012489,0.00217808601915205,-0.00128991398741313,0.0072481832076629,0.171404877927281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40450,-0.00589060558112724,0.00430998521334237,-0.0143381765992783,0.0025569654370238,0.171735830318391
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40456,-0.00513396940309936,0.00376111081212794,-0.0125057465948701,0.0022378077886714,0.17227587682873
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,42577,0.0148748148398876,0.0109087232501833,-0.00650628273047173,0.0362559124102469,0.172725670768388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40198,0.0122634382034628,0.00900396748424082,-0.00538433806564922,0.0299112144725748,0.173224556219408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,42596,-0.00553456296026923,0.00406656885606692,-0.0135050379181604,0.00243591199762192,0.173539468405427
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40448,-0.00601709685177259,0.00442227771031267,-0.0146847611639854,0.00265056746044024,0.173656955661908
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40079,-0.00612570229196741,0.00450701730122659,-0.0149594562023715,0.00270805161843671,0.174127941971095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40448,0.00750831834877721,0.00552767019523386,-0.00332591523388115,0.0183425519314356,0.174390922333885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40448,-0.00619910683877275,0.00456580513559691,-0.0151480849045427,0.0027498712269972,0.174578248393325
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,40135,0.00481902337924978,0.00355537788120407,-0.0021495172679102,0.0117875640264098,0.175312379070477
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40222,-0.0034448703855143,0.00254505795217718,-0.00843318397178158,0.00154344320075297,0.175906826495029
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42586,0.00516700323444176,0.00382904830198196,-0.00233793143744287,0.0126719379063264,0.177224167954103
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40282,-0.00800680399761365,0.00594249058547467,-0.019654085545144,0.00364047754991671,0.17788481283573
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,40222,-0.00933423026553581,0.0069336037254633,-0.0229240935674439,0.00425563303637227,0.178255794427163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40482,-0.00899895176053406,0.00670414604822335,-0.0221390780150518,0.00414117449398371,0.179526873699269
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,40301,0.00312614822680575,0.00233005405605972,-0.0014407577230713,0.0076930541766828,0.179732590841169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,40450,0.00352473656725218,0.00262747611082957,-0.00162511660997377,0.00867458974447814,0.17978802889184
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42655,0.0123184130504824,0.00920308122438856,-0.00571962614931917,0.030356452250284,0.180752962172855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40450,-0.00500746768504674,0.00374340699304835,-0.0123445453914215,0.00232961002132803,0.181028930532326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,42617,-0.0053440525785641,0.00400040028192448,-0.0131848371311361,0.00249673197400788,0.181611322877976
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42688,-0.003932642076151,0.00294486200798711,-0.00970457161180573,0.00183928745950374,0.181759842256951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40301,-0.00462112027033765,0.00346416167802415,-0.011410877159265,0.00216863661858969,0.182237963366434
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42599,0.00636853561063583,0.00477948154187824,-0.00299924821144551,0.0157363194327172,0.182727079574823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40282,-0.011081451169739,0.00835138488627927,-0.0274501655468464,0.00528726320736835,0.184569145315134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,42475,-0.00978841491094264,0.00738598159828869,-0.0242649388435885,0.0046881090217032,0.185104634219188
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40079,0.00763360686419672,0.00577152244266191,-0.00367857712342063,0.0189457908518141,0.185985194220605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42661,0.00646347288036652,0.00488916666298935,-0.0031192937790926,0.0160462395398256,0.186190976000038
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40301,-0.00931136742000084,0.00704340791197481,-0.0231164469274715,0.00449371208746978,0.186196219221452
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,40481,0.00628269628457011,0.00476137306500008,-0.00304959492283005,0.0156149874919703,0.187024246774107
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,40079,0.00450871108867753,0.00341908905441489,-0.00219270345797566,0.0112101256353307,0.187301244084088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40481,-0.0108969300232066,0.00827088064695019,-0.0271078560912289,0.00531399604481583,0.187696010381316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40481,-0.0052514322403242,0.00398987666376473,-0.0130715905013031,0.00256872602065467,0.18813730404318
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40198,-0.00810557104915506,0.00617445279385499,-0.0202074985251108,0.00399635642680072,0.189291406225772
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,40135,0.012381957568927,0.00943455816671216,-0.00610977643782886,0.0308736915756828,0.189411185218089
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42710,-0.00813721056786252,0.00620508165484372,-0.0202991706113562,0.00402474947563117,0.189752200976865
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,40135,0.00855120036492508,0.00652477962420207,-0.00423736769851098,0.0213397684283611,0.190029557362084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40510,-0.00424434528854091,0.0032421357193929,-0.010598931298551,0.00211024072146918,0.190520227391202
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40286,0.00653476133859506,0.00499502500613295,-0.00325548767342551,0.0163250103506156,0.190814287910321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,42345,0.00558409114746933,0.00428237236869429,-0.00280935869517147,0.0139775409901101,0.192266152693549
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40181,-0.00663799407536521,0.0050946459748207,-0.0166235001860138,0.00334751203528336,0.192624157688299
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42678,-0.0107394849274529,0.00825349945144611,-0.0269163438522873,0.00543737399738146,0.193210934627648
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,42678,0.00479853844373711,0.00369248039162772,-0.00243872312385321,0.0120358000113274,0.193779733625171
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40526,0.0182625707874638,0.0140883019102472,-0.00935050095662057,0.0458756425315483,0.194900868492724
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BSND,Barttin,40079,-0.00441025974887014,0.003402768085982,-0.0110796851973949,0.00225916569965459,0.19497539528832
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,40301,0.00474516056971357,0.00367217442758411,-0.00245230130835128,0.0119426224477784,0.196316965155043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,40448,-0.0340893709834739,0.0264276431497027,-0.0858875515568912,0.0177088095899434,0.197107233509419
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42475,-0.0121576447683265,0.0094304240795794,-0.0306412759643021,0.00632598642764914,0.197353153634831
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40135,0.0107031537878886,0.00835738837846652,-0.00567732743390577,0.027083635009683,0.200332661417619
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40181,-0.00508021640021094,0.00397201462838546,-0.0128653650718464,0.00270493227142457,0.200923209115305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,40115,0.00684731218518375,0.00536157624563825,-0.00366137725626721,0.0173560016266347,0.201591254301201
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,42793,-0.010918681277963,0.00857009646642076,-0.0277160703521477,0.00587870779622165,0.202669541912568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,40481,0.00862299634964963,0.00676921117727098,-0.00464465755780149,0.0218906502571008,0.202740889696713
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,40059,0.00558581741483352,0.00439434484876194,-0.00302709848873988,0.0141987333184069,0.203706877169696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40079,-0.00339744571639332,0.00268090135701513,-0.00865201237614298,0.00185712094335634,0.205083227782511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,42688,0.00625653882295675,0.00494733947998859,-0.00344024655782088,0.0159533242037344,0.206026929274299
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,40135,0.00575248350198606,0.00454884982942702,-0.0031632621636909,0.014668229167663,0.206041058335134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,42710,-0.00288396337337563,0.00228510847712245,-0.00736277598853563,0.00159484924178437,0.206945924658385
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42310,0.00618157488264137,0.00490218896965518,-0.00342671549788277,0.0157898652631655,0.207337553355116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40222,0.00657784811255585,0.00522157478355958,-0.00365643846322092,0.0168121346883326,0.207788343956886
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,42310,0.00479738518978487,0.0038113752051365,-0.00267291021228268,0.0122676805918524,0.208160430112278
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42635,-0.00785536856085563,0.00624791620336481,-0.0201012843194507,0.0043905471977394,0.208674776600356
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40222,-0.0126262134208137,0.0100729755993328,-0.0323692455955059,0.00711681875387848,0.210059813971342
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,40301,0.00678263536883325,0.00541386195899598,-0.00382853407079887,0.0173938048084654,0.210294851361113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42345,-0.00822742107607589,0.00656736817063998,-0.0210994626905302,0.00464462053837847,0.210310630587251
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,42260,-0.00901897395230298,0.00720443549052461,-0.0231396675137312,0.00510171960912527,0.210641807806897
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,42310,-0.00611123470886287,0.00490627464976811,-0.0157275330224084,0.00350506360468264,0.212935104506164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,42310,0.00610195990919061,0.00489890737995016,-0.0034998985555117,0.0157038183738929,0.212942464213511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,42593,-0.00386423138579245,0.00310427191790889,-0.00994860434489388,0.00222014157330898,0.213223055756733
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40135,0.00391053189857841,0.00314698163219479,-0.00225755210052339,0.0100786158976802,0.214031061859187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42494,0.00430445913756423,0.0034692149807733,-0.00249520222475144,0.0111041204998799,0.214716738030725
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40115,0.00641111799588168,0.00516826306481357,-0.0037186776111529,0.0165409136029163,0.214825197704882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40301,0.00913510778435025,0.00736884923266203,-0.00530783671166732,0.0235780522803678,0.215115310715516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42310,0.0050307661370171,0.00406742593002086,-0.00294138868582377,0.013002920959858,0.216167625168617
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40198,-0.00658864958119561,0.0053337965732382,-0.0170428908647425,0.00386559170235126,0.216758451989026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,42635,0.00821415905043884,0.00665314939555057,-0.00482601376484028,0.021254331865718,0.216990873400639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42345,0.00375551399139228,0.00304304189102926,-0.00220884811502506,0.00971987609780962,0.217175943730283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42678,-0.00872988991857722,0.00710204582394965,-0.0226498997335185,0.00519011989636409,0.219015365479762
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,40526,0.0119594277539757,0.00974170107728857,-0.00713430635750985,0.0310531618654613,0.219602788059721
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,40198,0.00365089766016707,0.00297969861477635,-0.00218931162479458,0.00949110694512871,0.220504493145645
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40510,-0.0109589234413691,0.00894643203118601,-0.0284939302224937,0.00657608333975546,0.220619914033837
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,39041,-0.0134245662881693,0.010960625553125,-0.0349073923722943,0.00805825979595569,0.220680154554588
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42753,0.00874183852480655,0.0071661774704788,-0.0053038693173319,0.022787546366945,0.222533598902095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,40448,-0.0122456287837272,0.0100885207887993,-0.0320191295297738,0.00752787196231939,0.224842678592694
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42356,-0.00700460284509324,0.00577188539586109,-0.018317498220981,0.0043082925307945,0.224932693926673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,40135,0.00580397420641616,0.00478713225627118,-0.00357880501587535,0.0151867534287077,0.225381079565603
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPGN,Epigen,40450,-0.00548434103134926,0.00452695926076883,-0.0143571811824562,0.00338849911975765,0.225735199454536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42610,-0.0031950312841336,0.00264615873143988,-0.00838150239775575,0.00199143982948856,0.227290805411707
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,40115,-0.00758674769806749,0.00629737919991164,-0.0199296109298943,0.00475611553375932,0.228327153810557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42345,0.0146523647190982,0.0121671180922894,-0.00919518674178896,0.0384999161799853,0.228511058276869
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42494,-0.00362459866014837,0.00301224343906306,-0.00952859580071197,0.00227939848041523,0.228886016565922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40198,0.00584423276051835,0.0048669515259116,-0.00369499223026837,0.0153834577513051,0.229854848788036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42610,-0.00357593990782876,0.00298022635760527,-0.00941718356873509,0.00226530375307757,0.230203760395795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,42705,0.00714636796986095,0.00598938076314789,-0.00459281832590892,0.0188855542656308,0.23282254168316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,42345,0.0196672398727451,0.0165323539269639,-0.0127361738241042,0.0520706535695944,0.234216758752343
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42710,0.00355061699851048,0.00298994600217729,-0.00230967716575701,0.00941091116277797,0.235043926096281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42586,0.008548107003745,0.00720650636808394,-0.00557664547769953,0.0226728594851895,0.235578113414743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40115,0.00820118023984139,0.00691674511467555,-0.0053556401849227,0.0217580006646055,0.235766845488917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,42558,0.00852073539279482,0.00718823903883004,-0.00556821312331205,0.0226096839089017,0.235891578444149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,40079,0.0111649398890117,0.00944578631040463,-0.00734880127938138,0.0296786810574048,0.237230661665818
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,42331,0.00593957902741175,0.00502611629429487,-0.00391160890940619,0.0157907669642297,0.237328980693395
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,42651,0.00448716461484562,0.00380099817786966,-0.00296279181377891,0.0119371210434702,0.237813254897316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40079,-0.0030743406084755,0.00260588293587224,-0.00818187116278508,0.00203318994583409,0.238117777964755
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40115,-0.00801836060751254,0.00680021707416722,-0.0213467860728803,0.00531006485785521,0.238370892852674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEXN,Nexilin,40531,-0.00803379190130138,0.00683325595548914,-0.0214269735740601,0.00535938977145733,0.239743394311521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,40448,-0.00709264891481873,0.00603366216153317,-0.0189186267514237,0.00473332892178629,0.239814367094673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLGN,Calmegin,40181,-0.00540649617371787,0.00461746063628541,-0.0144567190208373,0.00364372667340154,0.241672072653658
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,42356,0.00717043991672696,0.00612464993895342,-0.00483387396362176,0.0191747537970757,0.24172008272401
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,42580,0.00724666140483603,0.00619647439247846,-0.00489842840442175,0.0193917512140938,0.242230563381762
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,42494,-0.00462998080910313,0.00396433147050621,-0.0124000704912953,0.00314010887308903,0.242864164299952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,40198,0.00543313111434694,0.00465521057040166,-0.00369108160364031,0.0145573438323342,0.243192254427026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42753,0.00761863413064087,0.00653654374970945,-0.00519299161878966,0.0204302598800714,0.24381906747589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,42753,0.00566850114785359,0.00486702685289054,-0.00387087148381185,0.015207873779519,0.244171341840914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40115,-0.00717190214368537,0.00615887416441018,-0.0192432955059293,0.00489949121855858,0.244253904981853
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,42482,0.0118388009616504,0.0101892761567466,-0.00813218030557289,0.0318097822288737,0.245301700601882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,42678,0.00510556718077065,0.00439646783309768,-0.0035115097721008,0.0137226441336421,0.245545184297811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,42583,0.00821694453474401,0.00707580494874852,-0.00565163316480309,0.0220855222342911,0.245551409220732
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42710,0.00918176727177526,0.00790826711718125,-0.0063184362779,0.0246819708214505,0.245648563781544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40450,-0.00601472620583948,0.00518526927928191,-0.016177853993232,0.00414840158155306,0.246088026685862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,42356,0.0122426041053243,0.0105553622461922,-0.0084459058972123,0.032931114107861,0.246132186912734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42740,0.00602798717505862,0.00519866037496989,-0.00416138715988235,0.0162173615099996,0.246261867061284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,40198,0.004094631109997,0.00353548877384727,-0.00283492688674364,0.0110241891067376,0.246827411324069
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,40481,0.00679966946235781,0.00587822511769827,-0.0047216517683308,0.0183209906930464,0.247396732808494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42675,-0.00317158971206931,0.00274280384344006,-0.00854748524521182,0.0022043058210732,0.247566194273333
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42753,0.00313249633765985,0.00271403713305822,-0.00218701644313426,0.00845200911845395,0.248445369681615
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40481,-0.00547464036000628,0.00474971095584816,-0.0147840738334687,0.00383479311345611,0.249088335373169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40481,-0.00909096979531645,0.00796979577807124,-0.0247117695203361,0.00652982992970319,0.254028195005515
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,42594,0.0148553239323721,0.0130745821665501,-0.0107708571140661,0.0404815049788103,0.255893712372573
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,42331,0.00837034387227573,0.00738721861312462,-0.00610860460944851,0.022849292354,0.257199393569094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40079,-0.00385110206453647,0.00340530317710186,-0.0105254962916561,0.00282329216258318,0.258116573960855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40282,0.00697691036227752,0.0061883356994843,-0.00515222760871171,0.0191060483332667,0.259585455828145
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42678,-0.0108969745727703,0.0096681452362415,-0.0298465392358036,0.00805259009026308,0.259719906684079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,42753,-0.00864731445595969,0.00767368064013682,-0.0236877285106279,0.00639309959870848,0.25981331606591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,42345,0.00435546734189846,0.00386749740152077,-0.00322482756508224,0.0119357622488792,0.26011326637543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,40079,0.00458469841713533,0.00408090547585991,-0.0034138763155501,0.0125832731498208,0.261270664597351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40181,0.00795945262670702,0.00708977412919867,-0.00593650466652237,0.0218554099199364,0.261603649738018
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40135,0.00794071447925566,0.00707936316243876,-0.00593483731912431,0.0218162662776356,0.262027080649965
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,40510,-0.0108734704015707,0.00970867459478327,-0.0299024726073459,0.00815553180420453,0.262748292191068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40115,0.00287871708624537,0.00257213354197442,-0.00216266465602449,0.00792009882851523,0.263081890233321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40510,0.00437552316625498,0.00391972426845066,-0.00330713639990832,0.0120581827324183,0.264324543803323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,42260,-0.00340615010115888,0.00305241951915312,-0.00938889235869901,0.00257659215638124,0.264491752244117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42350,0.00607870232453233,0.00544932166168792,-0.004601968132376,0.0167593727814407,0.264657850201016
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,42586,0.00813725134499681,0.00731445503480224,-0.00619908052321558,0.0224735832132092,0.265947892434391
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42793,-0.00459790611210689,0.00413962338620603,-0.0127115679490707,0.00351575572485693,0.266714392384599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,40153,-0.00756416055559703,0.00683861114518303,-0.0209678384001558,0.0058395172889617,0.268709242200086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40499,-0.0052142959502327,0.00471587586132647,-0.0144574126384326,0.00402882073796718,0.268884325480723
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42617,0.00321260838695415,0.00291056297347133,-0.00249209504104966,0.00891731181495796,0.269710279224213
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42356,0.00481221141226879,0.0043645124993893,-0.00374223308653424,0.0133666559110718,0.270231031341066
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40482,-0.00370585410544503,0.00336167151945897,-0.0102947302835846,0.00288302207269455,0.27031811101679
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,40301,0.00822595669788725,0.00746634289076567,-0.00640807536801347,0.022859988763788,0.270599289442668
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40481,-0.00729945251538427,0.00664123189606357,-0.0203162670316689,0.00571736200090033,0.271742998176079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,40135,0.00375255416363764,0.00341716376135689,-0.00294508680862186,0.0104501951358972,0.27216370027907
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42678,-0.00306835762336881,0.00279646029882583,-0.00854941980906743,0.00241270456232981,0.272560848083287
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42753,-0.00508673931945263,0.00466476070798606,-0.0142296703071053,0.00405619166820005,0.275529530885849
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,42310,-0.00398823689778613,0.0036579466474317,-0.0111578123267523,0.00318133853118,0.275603733395237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42310,0.00550429907143622,0.00504882176507648,-0.00439139158811368,0.0153999897309861,0.275638663268173
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,42653,0.0118734522021242,0.0108946554533389,-0.00948007248642007,0.0332269768906685,0.275802297214113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42345,-0.00811422186949452,0.00745636575862166,-0.022728698756393,0.00650025501740394,0.276514653420425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42593,-0.00260279358095743,0.00239409130417777,-0.00729521253714585,0.002089625375231,0.276979519292593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,42579,0.00311082333251091,0.00286883123400842,-0.00251208588614559,0.0087337325511674,0.278228219367783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42675,0.00303903886896056,0.00280382472393956,-0.00245645758996098,0.0085345353278821,0.278432754389507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42593,-0.00390150198832573,0.0036029156341338,-0.010963216631228,0.00316021265457651,0.278884046611479
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,40282,-0.00906328115992239,0.00839099409948074,-0.0255096295949046,0.00738306727505987,0.280112207476325
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42635,0.00371594707374688,0.00344144484249823,-0.00302928481754965,0.0104611789650434,0.280266812838631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40510,-0.00286292498087256,0.0026533161115258,-0.00806342455946313,0.002337574597718,0.280611247174512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,40510,0.00287365991032022,0.00266405520765127,-0.00234788829667627,0.00809520811731671,0.280753925451934
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40115,0.0041612958766571,0.00386402284862832,-0.00341218890665441,0.0117347806599686,0.2815337377393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,40115,0.0119773487849123,0.0111273923977124,-0.00983234031460408,0.0337870378844286,0.281779266073621
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40079,0.00706208859964455,0.00657801949502001,-0.00583082961059465,0.0199550068098838,0.28303078152211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,40198,-0.00348591561113051,0.00325106169757415,-0.00985799653837585,0.00288616531611483,0.28363614728252
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40316,0.00143418662955937,0.00133854824709094,-0.00118936793473887,0.00405774119385761,0.283990689117073
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40450,-0.00870313914125518,0.00812759365226437,-0.0246332226996933,0.00722694441718299,0.284276137237724
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40482,-0.00342012735099396,0.00319700378955224,-0.00968625477851635,0.00284600007652842,0.284736061895261
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42593,-0.00919111741723911,0.00860351299049284,-0.0260540028786051,0.00767176804412686,0.285405267420106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,42310,-0.00691436305385146,0.00647301086282941,-0.0196014643449971,0.00577273823729418,0.285457429444026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40481,-0.00705850727056548,0.00662408396013292,-0.020041711832426,0.00592469729129504,0.28663525296716
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40518,0.00268079182146521,0.00251583771084318,-0.00225025009178741,0.00761183373471784,0.286642469204564
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42569,-0.0193846479397909,0.0181949882067681,-0.0550468248250564,0.0162775289454747,0.286721460194643
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,42310,0.00364739897887573,0.00343145360313044,-0.00307825008325992,0.0103730480410114,0.287832737827245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42586,0.00553175114863111,0.0052386557165065,-0.00473601405572164,0.0157995163529839,0.291010748849531
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2,Complement C2,42662,0.00239235494866829,0.00227116947861226,-0.00205913722941173,0.00684384712674832,0.292195760535864
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40481,0.00754521959362214,0.00716451014300669,-0.00649722028667098,0.0215876594739152,0.292300183888111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42675,0.00440715845425534,0.00419505201202312,-0.00381514348930998,0.0126294603978207,0.293479046933416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,42599,0.00316079814803298,0.00301186375019799,-0.00274245480235508,0.00906405109842105,0.293990321521184
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40450,0.00382191232340636,0.00364215433611675,-0.00331671017538247,0.0109605348221952,0.294037358961411
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,40135,-0.00461684850440718,0.00440358787914134,-0.0132478807475242,0.00401418373870984,0.294464233628363
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,42345,0.00815811823922251,0.0077943137106383,-0.00711873663362856,0.0234349731120736,0.295268442214306
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,40478,-0.00268607246132659,0.00256756796007957,-0.00771850566308254,0.00234636074042935,0.295512171333612
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,40301,0.00292392031324345,0.00279661982172818,-0.00255745453734378,0.00840529516383069,0.295805725911469
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,40514,-0.0113810660439075,0.0108997108556187,-0.0327444993209202,0.00998236723310514,0.296432650150697
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,40079,0.00649001588172455,0.00623393267448336,-0.00572849216026284,0.0187085239237119,0.297862045773728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,40382,0.0031094026281879,0.00298692661374544,-0.00274497353475317,0.00896377879112897,0.297896174891968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40181,-0.0079775145267019,0.00766414592144169,-0.0229992405327276,0.00704421147932381,0.297950616864288
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40115,0.00447642495555033,0.00430671079728318,-0.00396472820712471,0.0129175781182254,0.298638543346077
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,42345,0.00905284194071258,0.00871765672035404,-0.00803376523118133,0.0261394491126065,0.299080157369492
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,42610,-0.00256876008139295,0.0024770826774276,-0.00742384212915106,0.00228632196636515,0.299749778920467
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,42369,-0.00433031078936182,0.00417919556205085,-0.0125215340909815,0.00386091251225785,0.300147021913683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40079,0.0052996645466078,0.00513354802183361,-0.00476208957618608,0.0153614186694017,0.301926903666182
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42720,0.00617485112562278,0.00598258868372518,-0.00555102269447858,0.0179007249457241,0.30202639800728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42675,0.00290160834437062,0.00281196802251495,-0.00260984897975868,0.00841306566849991,0.302147717115536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40115,-0.00450914676160149,0.00437988164379277,-0.0130937147834353,0.00407542126023233,0.303261294766052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,40510,0.00529900795785156,0.00515432758365924,-0.00480347410612055,0.0154014900218237,0.303939021405658
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39844,0.00525038921646387,0.00512594926370703,-0.00479647134040192,0.0152972497733297,0.305727973002881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40481,0.0100575532887886,0.00982112653719741,-0.00919185472411831,0.0293069613016956,0.305822610028823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42494,0.00610922261232202,0.00598471560533836,-0.00562081997414117,0.0178392651987852,0.307365798423725
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42345,-0.0128343926363127,0.0125732229558127,-0.0374779096297055,0.0118091243570801,0.307381299581337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,40198,-0.00547651111667602,0.00537174372017039,-0.01600512880821,0.00505210657485793,0.307986441766993
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,40079,0.0119354889293554,0.0117751548738236,-0.0111438146233388,0.0350147924820496,0.310788406008054
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAG,S-arrestin,40135,0.00526999784199298,0.005209887578113,-0.00494138181110851,0.0154813774950945,0.311781502578302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,40198,-0.00448333342192976,0.00443265007646745,-0.013171327571806,0.00420466072794643,0.311830948005788
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42635,-0.00650322867944627,0.00644153547707867,-0.0191286382145205,0.00612218085562793,0.312715972502053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,40282,0.00361542071132659,0.00358516059951367,-0.00341149406372021,0.0106423354863734,0.313265102396895
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,42310,0.00324645502596219,0.00322023667283762,-0.00306520885279954,0.00955811890472392,0.31340501622767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40181,-0.00608565024544948,0.00603684097726281,-0.0179178585608846,0.00574655806998564,0.313435746195281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,40181,0.00598946088464716,0.00594757191119364,-0.00566778006129237,0.0176467018305867,0.313936270099726
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40301,-0.00540863901191029,0.00537857659908276,-0.0159506491461125,0.00513337112229193,0.314635085315175
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40450,0.00418860068900669,0.00417284529500967,-0.00399017608921226,0.0123673774672256,0.315508319291894
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,40450,0.00356815860896965,0.00356065193462351,-0.00341071918289243,0.0105470364008317,0.316312865138052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,42310,0.00387394989627749,0.00386646966284784,-0.00370433064290428,0.0114522304354593,0.316393644032521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,40181,0.00404087675539993,0.00403564401423522,-0.00386898551250111,0.011950739023301,0.316705472589475
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,40115,0.00508457963265099,0.00510993800097147,-0.00493089884925309,0.0151000581145551,0.319740100531216
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRN,Progranulin,42551,0.0024191868798954,0.00243384959229466,-0.00235115832100214,0.00718953208079295,0.320252798255434
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40222,0.00852900768311989,0.00858248630904871,-0.00829266548261558,0.0253506808488554,0.320357210885506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42793,-0.00319195677345842,0.00321650664323387,-0.00949630979419681,0.00311239624727996,0.321035925719928
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,40526,0.00433352629102031,0.00437151604189972,-0.00423464515110315,0.0129016977331438,0.321555540094466
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40181,-0.00381146677852206,0.0038458359242039,-0.0113493051899617,0.00372637163291759,0.321676505333912
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40144,-0.00376695383385175,0.0038074006514385,-0.0112294591106712,0.00369555144296771,0.322500687438301
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40282,-0.00690211348950963,0.0069953286334496,-0.0206129576110708,0.00680873063205157,0.323823686774411
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40481,0.00438429115877356,0.00444358092044956,-0.00432512744530758,0.0130937097628547,0.323831862792266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42586,-0.00855571935040688,0.00868177556884291,-0.025571999465339,0.00846056076452523,0.324405975589218
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40526,-0.00287327668901786,0.0029163362346871,-0.00858929570900457,0.00284274233096885,0.324529660426477
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42639,-0.00391063962242856,0.00397162335290571,-0.0116950213941238,0.00387374214926664,0.324816128227144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40115,0.00729317449765692,0.00740745617130952,-0.00722543959810974,0.0218117885934236,0.324856123285991
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,42369,0.00629943260777423,0.00640132365493872,-0.00624716175590566,0.0188460269714541,0.325092866275026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40181,0.00450737186720664,0.00458438954866286,-0.00447803164817257,0.0134927753825858,0.325530657891564
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40115,0.00479107125779727,0.00488114935415179,-0.00477598147634024,0.0143581239919348,0.326345443185579
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40115,0.00367873463068981,0.00375935229861413,-0.00368959587459388,0.0110470651359735,0.327821363077255
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40448,-0.00873427978445084,0.00892744822084797,-0.0262320782973129,0.00876351872841118,0.327916141521389
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,40115,0.0039539687063198,0.00404875439861516,-0.0039815899149659,0.0118895273276055,0.328794335502024
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42112,0.00364890907244437,0.00373702342697037,-0.00367565684441755,0.0109734749893063,0.328874041217103
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,42635,0.00729100377344043,0.00747711137067633,-0.00736413451308518,0.021946142059966,0.329523399654434
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42494,0.00523095403942554,0.00538326643706663,-0.00532024817722505,0.0157821562560761,0.331214341084699
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,40135,0.00909039839626234,0.00937148817421637,-0.00927771842520175,0.0274585152177264,0.33206501641033
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,42720,-0.00379273622578376,0.00391375899361054,-0.0114637038532604,0.0038782314016929,0.332523793803465
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42586,-0.0053817456635633,0.00555765614663934,-0.0162747517109764,0.0055112603838498,0.332888047092729
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,42345,-0.00633147152695952,0.00654088615267237,-0.0191516083861974,0.00648866533227832,0.333070284784036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40181,0.00394601219188349,0.00407714472175687,-0.00404519146275997,0.0119372158465269,0.33314700281122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,42593,-0.00453391626291279,0.00469782846364986,-0.0137416600516665,0.00467382752584094,0.334507666085911
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40301,-0.00705953707291308,0.00732061263123046,-0.0214079378301248,0.00728886368429863,0.33489802892475
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,40482,0.00500388899977572,0.00519641508346966,-0.00518108456382481,0.0151888625633763,0.335593137527871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40181,0.00521935513294746,0.00542208508905829,-0.00540793164160679,0.0158466419075017,0.335764294914344
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42310,-0.00696892383509814,0.0072419881465469,-0.0211632206023301,0.0072253729321338,0.335919537009407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40472,0.00656304008110034,0.00682392913096871,-0.00681186101559834,0.019937941177799,0.336186524263555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,42530,0.00434152203291149,0.00452147042458655,-0.00452055999927814,0.0132036040651011,0.336971292661196
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40301,0.00363900095174017,0.00379347646165737,-0.00379621291310827,0.0110742148165886,0.337439272297954
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40135,0.00476031606078886,0.00496530695393153,-0.00497168556891695,0.0144923176904947,0.337723341286035
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,42753,-0.00870320443168597,0.00908839213204229,-0.0265164530104888,0.00911004414711691,0.338272685499463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42345,-0.00437873625153224,0.0045814499663413,-0.0133583781855612,0.00460090568249671,0.339214419125184
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,40481,-0.00593847687160359,0.00621897263927621,-0.0181276632445849,0.00625070950137778,0.339650354672673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,40301,-0.00789004331721832,0.00826515850479131,-0.0240897539866093,0.00830966735217264,0.339793263241129
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40301,-0.00693062471494833,0.00726627006321528,-0.0211725140388503,0.00731126460895362,0.340201721535053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40079,-0.00617796889090724,0.00650145458362656,-0.0189208198748153,0.00656488209300082,0.342009330444288
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,40115,0.00325096784251757,0.00342996990211283,-0.00347177316562358,0.00997370885065871,0.343245962488624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,42369,-0.0043925215694649,0.00463797593597001,-0.0134829544039661,0.00469791126503632,0.343616777932389
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42369,-0.00307271738196935,0.0032495741221913,-0.00944188266146431,0.0032964478975256,0.344382532194352
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,42310,-0.0067747817916219,0.00717416489673692,-0.0208361449892263,0.00728658140598246,0.345018245789969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40115,0.00896138167567242,0.00951189085886101,-0.00968192440769517,0.02760468775904,0.346149943308274
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40222,-0.00373857264729154,0.00397055798620545,-0.0115208663002542,0.00404372100567115,0.346431606737007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,40079,-0.00611094729425776,0.00650433620845443,-0.0188594462628284,0.00663755167431292,0.347485201590083
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,42720,-0.00451073526766357,0.0048116045552963,-0.0139414801960443,0.00492000966071717,0.348533549875546
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42310,-0.0102805784475987,0.0109666730922765,-0.0317752577084606,0.0112141008132633,0.348550452283416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,42793,0.00666190834960641,0.00712555876136909,-0.007304186822677,0.0206280035218898,0.349840274747189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42675,-0.0120293322974369,0.0128754296801859,-0.0372651744706014,0.0132065098757275,0.350173173864807
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,40301,0.0050548356822214,0.00541607768452623,-0.00556067657945002,0.0156703479438928,0.350684393805648
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40526,0.00581593424503327,0.00625868351910773,-0.00645108545241787,0.0180829539424844,0.352774981096997
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,42562,-0.00351433027851947,0.00378625741041801,-0.0109353948029388,0.00390673424589982,0.353330708498154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40450,-0.00495089348676428,0.00534039300154302,-0.0154180637697886,0.00551627679626004,0.353912464946351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40448,-0.00469669570413555,0.00506825047406815,-0.0146304666333091,0.00523707522503802,0.354107519232214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBN1,Drebrin,40198,-0.00458401653522664,0.00495402379607074,-0.0142939031755253,0.005125870105072,0.354824048674714
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40135,0.00674668895051767,0.00729246240463265,-0.00754653736256234,0.0210399152635977,0.354903488476533
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40510,-0.00817702544018022,0.00883974319211148,-0.0255029220967187,0.00914887121635828,0.35497015787929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42736,0.00390604808191974,0.00422504904857314,-0.00437504805328361,0.0121871442171231,0.355243727099036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40135,0.00433913789148569,0.00470061477591327,-0.00487406706930432,0.0135523428522757,0.355975407368947
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40222,-0.00882692445518744,0.00959851902573243,-0.027640021745623,0.00998617283524812,0.357795058877025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,42668,-0.00272260713616732,0.00296567405092275,-0.00853532827597592,0.00309011400364128,0.358614404978543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40198,0.0053354944690742,0.00581243498965039,-0.00605687811064057,0.016727867048789,0.358667884822941
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42345,0.00433600283741876,0.0047246062735902,-0.00492422545881804,0.0135962311336555,0.358767101292807
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40181,0.00463340228842201,0.00506731668294601,-0.00529853841015218,0.0145653429869962,0.360542532522603
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,40481,-0.00681229162992707,0.0074557154274161,-0.0214254938676626,0.00780091060780849,0.360893707685498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40135,-0.00548129889621883,0.00602056977082057,-0.0172816156470272,0.0063190178545895,0.362616578009692
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,42345,0.00771722844543057,0.00848271138149378,-0.00890888586229725,0.0243433427531584,0.362965957129563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40301,0.00360938986523936,0.00397374574662994,-0.00417915179815532,0.011397931528634,0.363734584380445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40301,0.00594416888076807,0.00654807822798693,-0.00689006444608631,0.0187784022076225,0.364017839599332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,40064,-0.00323347659051354,0.00356294527442659,-0.0102168493283896,0.00374989614736257,0.364147175614554
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,40282,0.00263067386039854,0.0028987684876282,-0.00305091237535274,0.00831226009614982,0.364154612217783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40115,-0.00462456403521419,0.00510131847113928,-0.0146231482386472,0.00537402016821881,0.364668570173383
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42675,0.00251671050863691,0.00278112453596078,-0.00293429358184623,0.00796771459912005,0.365521028712927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,40079,0.00597990468165837,0.00661695986354237,-0.00698933665088468,0.0189491460142014,0.366161829589701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,40181,-0.00475494371321893,0.00526362444618508,-0.0150716476277417,0.00556176020130383,0.366355077045172
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42356,-0.00755424175261263,0.00837481020352205,-0.0239688697515159,0.00886038624629059,0.367063037851169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_E,,42593,0.0027456717969723,0.00305445304954261,-0.00324105618013122,0.00873239977407582,0.368717904227725
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40510,-0.00644781274569494,0.00720611883289302,-0.0205718056581653,0.00767618016677538,0.370929541423111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40448,0.00190966932895125,0.00213673544504924,-0.00227833214334526,0.00609767080124776,0.371484289487871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42793,0.00306358265679306,0.00342908497513474,-0.00365742389447104,0.00978458920805715,0.371652858348545
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,42619,0.00285013521805984,0.00319363346902018,-0.0034093863812197,0.00910965681733939,0.372171631014858
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42710,0.00421534477366399,0.0047274184469537,-0.00505039538236527,0.0134810849296932,0.372580316611668
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,40079,-0.00281929746378968,0.00316500968974392,-0.00902271645568777,0.00338412152810841,0.373071958411259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,40450,-0.0038514501635894,0.00432928814810257,-0.0123368549338704,0.00463395460669164,0.373685397514859
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42345,-0.00497403739895318,0.0055954704581134,-0.0159411594968554,0.00599308469894909,0.374051596364685
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,40181,0.00369078014441766,0.0041613435650882,-0.00446545324315522,0.0118470135319905,0.375141216767187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42777,-0.00251600389313119,0.00283738494544364,-0.00807727838620073,0.00304527059993835,0.375238171271996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,42369,-0.00488714716314929,0.00552890658908724,-0.0157238040777603,0.00594950975146171,0.376752009284214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRN1,Neuritin,40481,-0.00319347849665016,0.00361491574659966,-0.0102787133599855,0.00389175636668518,0.377029753918219
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,42369,-0.00989305967053627,0.011205375384825,-0.0318555954247932,0.0120694760837207,0.377314429484189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,42586,0.00289593146741439,0.00328669385609969,-0.00354598849054101,0.00933785142536979,0.37827530911036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40135,0.00980277096766014,0.0111364113435407,-0.0120245952656796,0.0316301372009999,0.378745907080579
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40115,0.00342141400259275,0.00389468371066034,-0.00421216607030152,0.011054994075487,0.379700906415416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40208,-0.00483133205073166,0.00550930137805288,-0.0156295627517153,0.00596689865025198,0.38053783245071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,42710,-0.00247006722185896,0.00282206490691461,-0.00800131443941159,0.00306117999569367,0.381442861522689
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42610,-0.00280158915288124,0.0032029993814068,-0.00907946794043856,0.00347628963467609,0.381765460942377
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42489,0.00870233632184284,0.010017055114148,-0.0109310917018872,0.0283357643455729,0.384998493287381
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,40450,-0.00669369434133009,0.0077139083834256,-0.0218129547728443,0.00842556609018409,0.385553231281532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40181,-0.00654875696896591,0.00756266604091296,-0.0213715824091553,0.00827406847122349,0.386546184653543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41947,0.00252264113587031,0.00291351893935353,-0.00318785598526261,0.00823313825700323,0.386594217418048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,40198,-0.00225814942685396,0.00260927912432662,-0.00737233651053413,0.0028560376568262,0.386821478720071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40115,0.0052741918106126,0.00609500924247632,-0.00667202630464099,0.0172204099258662,0.386876925534849
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,42561,0.00307602035887405,0.00356116371662267,-0.00390386052570639,0.0100559012434545,0.387730679202397
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42356,-0.00935163261830445,0.0108311515376742,-0.030580689632146,0.0118774243955371,0.387932480756544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40135,0.00462129610863295,0.00535414136465789,-0.0058728209660965,0.0151154131833624,0.388087371452011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,40439,-0.00247829901217557,0.00287154271915616,-0.00810652274172164,0.00314992471737049,0.388125689618205
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,40450,-0.00599347833891667,0.00694468763326062,-0.0196050661001075,0.00761810942227415,0.388138998643605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40283,0.00458976646562538,0.00532468959168483,-0.00584662513407689,0.0150261580653276,0.388718141676026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40135,-0.0064814569693229,0.00752368424311181,-0.021227878085822,0.00826496414717624,0.388996016002561
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTTG1,Securin,40301,-0.00350986217503873,0.00407587240867863,-0.0114985720960488,0.00447884774597138,0.389184203555587
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,42310,0.00497610182065087,0.00578099578259786,-0.00635464991324094,0.0163068535545427,0.389381029308045
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,42593,-0.00406377664165315,0.00472772830727529,-0.0133301241239127,0.00520257084060642,0.390045785998923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42675,0.0100103345425204,0.011655025985084,-0.0128335163882441,0.032854185473285,0.390418879570549
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_DRA,,42548,0.00313497881380947,0.00366085726123356,-0.0040403014182083,0.0103102590458272,0.391819019557312
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40181,0.006689915112094,0.00781607448204111,-0.00862959087270657,0.0220094210968946,0.3920620670817
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,40256,-0.0042192602434938,0.00495235911290358,-0.0139258841047848,0.00548736361779721,0.39424931560376
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,40448,-0.00637376404394151,0.00748789023649508,-0.0210500289074719,0.00830250081958885,0.394671042679729
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40448,-0.00365994750469851,0.00430529061679577,-0.0120983171136182,0.0047784221042212,0.395285000202829
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40079,-0.00533721209455778,0.00629319659474442,-0.0176718774202568,0.00699745323114129,0.39640517192588
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40282,-0.00307533302053584,0.00362874030470341,-0.0101876640177545,0.00403699797668285,0.396738524091229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42494,0.00306380578031155,0.00361689367421143,-0.00402530582114285,0.010152917381766,0.396964620339352
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40341,0.00363303649287511,0.0043043259505489,-0.00480344237020073,0.012069515355951,0.398663450893395
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,40538,0.00262508811428338,0.00311730007562634,-0.00348482003394426,0.00873499626251101,0.399747988523891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,40115,-0.00486150472968783,0.00578009425176785,-0.0161904894631528,0.00646748000377716,0.400323175637524
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40115,0.0044613052237833,0.0053082276805027,-0.005942821030002,0.0148654314775686,0.400673967947835
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40198,-0.00513613079637828,0.00611388683930532,-0.0171193490014167,0.00684708740866016,0.400883917612566
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,40115,0.00307328513191131,0.00366573706984716,-0.00411155952498912,0.0102581297888117,0.401834979825742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40282,-0.00714631849889235,0.00852956439730414,-0.0238642647176085,0.00957162771982376,0.402144670409418
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42345,0.00394055654608617,0.0047112391764665,-0.00529347223978818,0.0131745853319605,0.402936026025702
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,40181,-0.00396565920139881,0.00476329795746925,-0.0133017231980385,0.00537040479524091,0.405119567333116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40301,-0.00363412644091886,0.00436771194073368,-0.0121948418447569,0.00492658896291915,0.405402265276597
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42753,0.00294282779335161,0.00354200319348888,-0.0039994984658866,0.00988515405258981,0.406080269403733
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40115,-0.00574943217850259,0.00695206541961203,-0.0193754804009422,0.00787661604393699,0.40824909100071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,42562,0.0053259568832801,0.0064483838661933,-0.00731287549445876,0.017964789261019,0.408854741070906
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40198,0.00289769024343035,0.00350870977289255,-0.00397938091143905,0.00977476139829975,0.408903489016381
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,42778,-0.0029048155761282,0.0035197930976478,-0.0098036100475179,0.00399397889526149,0.409227018729565
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,40181,-0.0042741664357063,0.00518370798229164,-0.0144342340809979,0.00588590120958532,0.409651589512588
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,40181,-0.00425319268625825,0.00516968633371275,-0.0143857779003352,0.00587939252781874,0.410686376589959
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,40079,-0.00502328705554549,0.00610982843767848,-0.0169985507933953,0.00695197668230433,0.411001008214047
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40526,-0.00205933915923581,0.00250772911516933,-0.00697448822496769,0.00285580990649608,0.41155144644067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40510,0.0049411531126345,0.00602158073036095,-0.00686114511887295,0.016743451344142,0.41190619754122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40115,0.00391497337466889,0.00477617395005407,-0.00544632756743709,0.0132762743167749,0.412411773124541
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40115,0.00264366498496889,0.00322951815197507,-0.00368619059290225,0.00897352056284003,0.413035810650153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,40079,-0.00596313912759834,0.00728547012617306,-0.0202426605748975,0.00831638231970086,0.413091083438981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,40465,0.00531832175867401,0.00649862985707867,-0.00741899276120018,0.0180556362785482,0.41315990624607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,42345,-0.00421079926730874,0.00514688713404218,-0.0142986980500314,0.00587709951541393,0.413300390453017
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,40198,-0.00273222624328981,0.00333995201204829,-0.00927853218690445,0.00381407970032483,0.413350026024162
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,42356,0.00315720123757843,0.00386125215667644,-0.00441085298950738,0.0107252554646642,0.413564708245512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,40301,0.0048010547442925,0.00589080582997211,-0.00674492468245282,0.0163470341710378,0.415085121555245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40301,0.00654502346591561,0.00807291958612643,-0.00927789892289219,0.0223679458547234,0.417533461113633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,40135,0.00459510136763073,0.00566911758256161,-0.00651636909419003,0.0157065718294515,0.417641961718756
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,42369,0.00263008715457124,0.00325029590457889,-0.00374049281840339,0.00900066712754587,0.418423980038583
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40115,0.00218976901762892,0.00270871110498482,-0.00311930474814133,0.00749884278339917,0.418867984439143
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40079,-0.00253480063788625,0.00314401985008664,-0.00869707954405607,0.00362747826828356,0.420128312859424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,40427,0.00221622912298421,0.00275920378492712,-0.00319181029547294,0.00762426854144137,0.42186846587043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40222,0.00340634523096799,0.00424950017829872,-0.0049226751184975,0.0117353655804335,0.422809016867421
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,40115,0.0041507572544155,0.00518241298692781,-0.006006772199963,0.014308286708794,0.42318878857085
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40079,-0.00689465814406817,0.008628707617202,-0.0238069250737841,0.0100176087856477,0.424286291847143
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,40482,-0.00770235834736232,0.00964791179517065,-0.0266122654658968,0.0112075487711722,0.424687334334351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,40181,-0.00482042782194951,0.00605494527256745,-0.0166881205561817,0.00704726491228269,0.425982870362227
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,42680,-0.00545866069511528,0.00687153568107322,-0.0189268706300188,0.00800954923978822,0.426983972192555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,40135,0.00718432776560883,0.0090516334579576,-0.0105568738119881,0.0249255293432057,0.427384335408662
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40058,-0.00392793493544871,0.00495221669811077,-0.0136342796637458,0.0057784097928484,0.427697844193562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40481,0.00292314371267185,0.0036883108708565,-0.0043059455942069,0.0101522330195506,0.428060984439147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40198,-0.00653062100679499,0.00827691466985823,-0.0227533737597171,0.00969213174612714,0.430119449071224
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,42153,-0.00292035697764909,0.00370787779277864,-0.0101877974514952,0.00434708349619704,0.430940002445295
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,40450,-0.00547707259205762,0.00696371410677219,-0.0191259522413311,0.00817180705721588,0.431581804883765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40115,0.00468518363759657,0.00595702072414102,-0.00699057698171983,0.016360944256913,0.431592978459479
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,40115,-0.00310749109068683,0.00395896994769774,-0.0108670721881744,0.00465209000680074,0.432515072493099
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,40135,0.0029022312734924,0.00369968977739712,-0.00434916069020594,0.0101536232371908,0.432791566702503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,40181,0.00425546318534318,0.00542748119841925,-0.00638239996355856,0.0148933263342449,0.433022642408302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40301,0.00315787193072341,0.00403227991643041,-0.00474539670548019,0.011061140566927,0.433556907676983
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40510,-0.00543610766404513,0.00695000372011539,-0.0190581149554713,0.00818589962738104,0.434129072579648
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40188,-0.00272342556519847,0.00348704613014843,-0.0095580359802894,0.00411118484989246,0.434812136677805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40135,-0.00346227716380767,0.00443465231126977,-0.0121541956938964,0.00522964136628107,0.434976735527293
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42310,0.0051731349891941,0.00663155498099997,-0.00782471277356584,0.018170982751954,0.435358611796319
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRTN,Neurturin,42369,-0.00380472894891998,0.00488428543883805,-0.0133779284090426,0.00576847051120259,0.43600931293964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,42653,-0.00429996824062302,0.00553439462119483,-0.0151473816981649,0.00654744521691885,0.437199756640092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,42369,-0.00704793615169283,0.00909145708574463,-0.0248671920397523,0.0107713197363666,0.438219895116245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40526,0.00230691583405061,0.0029814938366316,-0.00353681208574733,0.00815064375384855,0.439097766549507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,42433,-0.00576641615848658,0.00746348471754928,-0.0203948462048832,0.00886201388791001,0.439762794931183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,40369,-0.00502207548383464,0.00650318494969887,-0.0177683179852444,0.00772416701757514,0.439983532029079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,40301,-0.00469919817447299,0.00610527689821907,-0.0166655408949824,0.00726714454603639,0.441497489775909
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42345,-0.00378823748047097,0.00492571875268133,-0.0134426462357264,0.00586617127478444,0.441863765247341
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,40198,-0.00167844637882763,0.00218835548504714,-0.00596762312952003,0.00261073037186477,0.443104023226882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,40222,-0.00231459747799471,0.00302008414365355,-0.00823396239955567,0.00360476744356625,0.443453754477408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,42345,-0.00565227181703188,0.00739292052743527,-0.020142396050805,0.00883785241674125,0.444552107942505
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42590,-0.00330938998352007,0.00434061562351229,-0.0118169966056042,0.00519821663856403,0.445820347793382
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,42369,0.00359387443438763,0.00471394438189657,-0.00564545655412965,0.0128332054229049,0.445839607840744
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40181,0.00285277066702224,0.00376871445730753,-0.00453390966930053,0.010239451003345,0.449089332249748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,40482,0.00777035704687391,0.0102777441804029,-0.0123740215467158,0.0279147356404636,0.449642662507728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,40079,-0.00561759196332329,0.00744507059091265,-0.0202099303215121,0.00897474639486551,0.450542294777088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,42508,0.0039640073965837,0.00525553594785385,-0.00633684306120983,0.0142648578543772,0.450710241988779
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40482,-0.00723222720878832,0.0096009945471343,-0.0260501765211716,0.0115857221035949,0.451298008310671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40301,-0.00429079361788784,0.00570121644934731,-0.0154651778586086,0.00688359062283288,0.451700139945506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,42369,-0.002386268957075,0.00318494283377578,-0.00862875691127554,0.00385621899712553,0.453729272964011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,42479,-0.00350761497342516,0.00468346414393633,-0.0126872046955404,0.00567197474869004,0.453909031380332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42745,0.00299068846058087,0.00400691731275736,-0.00486286947242356,0.0108442463935853,0.455450013984361
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40079,-0.00315506585328761,0.0042311670012999,-0.0114481531758354,0.00513802146926019,0.455881237283977
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40135,-0.0057788303447111,0.00777942574775109,-0.0210265048103032,0.00946884412088104,0.457597482912525
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40481,-0.00621297868470574,0.0084061350240716,-0.0226890033318861,0.0102630459624746,0.459861336672842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,40181,-0.00261133142981558,0.00353612092354077,-0.00954212843995548,0.00431946558032433,0.460242566832784
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALB1,Calbindin,42586,-0.00334025415837309,0.00452916937269348,-0.0122174261288523,0.00553691781210613,0.460832372229934
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,42369,0.00552928605879863,0.00750310704766019,-0.00917680375461536,0.0202353758722126,0.461176308376394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40079,-0.00286205174124438,0.0038857517015678,-0.0104781250763173,0.0047540215938285,0.461411716585904
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40079,0.00619605681334103,0.0084302472627462,-0.0103272278216415,0.0227193414483236,0.462367965255303
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,42663,0.00312081515056825,0.00426420609129889,-0.00523702878837758,0.0114786590895141,0.464264855066443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42369,-0.00478285192546658,0.00655073632511889,-0.0176222951226996,0.00805659127176645,0.46532717651955
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42720,0.00247540983696797,0.00339714713613593,-0.00418299854985845,0.00913381822379438,0.466214248446352
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42345,0.00296697047387432,0.00407520091140293,-0.00502042331247542,0.0109543642602241,0.466592870174022
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,40282,-0.00412851295501231,0.00567351750360902,-0.015248607262086,0.00699158135206136,0.466824025931662
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,40115,-0.00348510108155465,0.00480149706615467,-0.0128960353312178,0.0059258331681085,0.467954657011055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42310,0.00557090157279386,0.00768068311748261,-0.00948323733747206,0.0206250404830598,0.468272791993735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,40198,-0.00320359785245694,0.00442197406607308,-0.0118706670219602,0.00546347131704629,0.46879121175181
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42593,-0.00705488618321086,0.0097806820635687,-0.0262250230278055,0.0121152506613838,0.470732497841931
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40427,0.00493120418134593,0.00684435341240218,-0.00848372850696234,0.0183461368696542,0.471245901228722
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,40448,0.00245778260724115,0.00341617070110912,-0.00423791196693273,0.00915347718141502,0.471875285398446
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,42678,-0.00411549720248046,0.00572494375834502,-0.0153363869688367,0.00710539256387578,0.472232738456204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,40181,-0.0061581524027286,0.0085841028416962,-0.0229829939724531,0.0106666891669959,0.473148533567031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,42345,-0.00566994092771418,0.00790574851881051,-0.0211652080245828,0.00982532616915442,0.473268268197145
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40181,0.00226085369663399,0.00315377700163152,-0.00392054922656378,0.00844225661983176,0.473468461551475
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,42356,-0.00482670453818758,0.00673728149556573,-0.0180317762694964,0.00837836719312125,0.473746470725207
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,40198,0.00392866144777411,0.00549895941317849,-0.00684929900205572,0.0147066218976039,0.474971999019044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,40198,-0.00203061838483544,0.00284727310823109,-0.00761127367696837,0.00355003690729749,0.475749471721782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40181,0.00261012164942764,0.00366631831943269,-0.00457586225666043,0.00979610555551571,0.476530055419495
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BSG,Basigin,42745,0.00153425631208364,0.00215618450159611,-0.00269186531104473,0.005760377935212,0.476749053381633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEB,Nebulin,40115,0.00271663803575403,0.00381871601930024,-0.00476804536207444,0.0102013214335825,0.476851032009146
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40115,0.00256250317250028,0.00360536444293815,-0.00450401113565849,0.00962901748065906,0.477255998815232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,40079,-0.00544229934518378,0.00766395746951484,-0.0204636559854329,0.00957905729506531,0.477647375267356
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40222,0.00456233051827468,0.00642639436466106,-0.008033402436461,0.0171580634730104,0.477758660984732
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42675,0.00475358214800422,0.00672048820809138,-0.00841857473985488,0.0179257390358633,0.479375574001197
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40198,0.00383261513340682,0.00545020544936541,-0.00684978754734939,0.014515017814163,0.481942490999355
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,40115,-0.00418394438362786,0.00595987281737829,-0.0158652951056893,0.0074974063384336,0.482682230419838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,40198,0.00679513668400075,0.00972448738800224,-0.0122648585964836,0.0258551319644851,0.484713334785094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,40481,0.0110879688128407,0.0158919043260916,-0.0200601636662989,0.0422361012919803,0.485371833270405
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40280,0.00376771085224264,0.00541666500415569,-0.00684895255590251,0.0143843742603878,0.486707977540994
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42494,0.00424730109838358,0.00612658993790053,-0.00776081517990146,0.0162554173766686,0.488160415584378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,42610,0.0082343033640461,0.0118805766483291,-0.015051626866679,0.0315202335947712,0.488265361384671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40135,-0.0022281802264424,0.00322364431324915,-0.00854652308041073,0.00409016262752592,0.489455059487902
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCLN,Nicalin,42369,-0.00354489167225197,0.0051471227944419,-0.0136332523493581,0.00654346900485415,0.491015862883814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40222,0.0064452290568035,0.00937846159369301,-0.0119365556668348,0.0248270137804418,0.491947625444549
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42310,0.00311372660595072,0.0045338029786065,-0.00577252723211802,0.0119999804440195,0.492233322460061
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40170,-0.00266032952782812,0.00389715731911711,-0.0102987578732977,0.0049780988176414,0.494852966069405
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,40282,-0.00221964925056685,0.00325297580326909,-0.00859548182497426,0.00415618332384057,0.495035569158121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40301,0.00249244697425448,0.0036661265683634,-0.00469316109973778,0.00967805504824674,0.496608287840261
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,40482,-0.0066589244826425,0.0097946367663153,-0.0258564125446205,0.0125385635793355,0.496610755358949
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42610,0.00289426186618761,0.00426867516188112,-0.0054723414510994,0.0112608651834746,0.497768517383566
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,40482,-0.00547638580604822,0.00810656133645303,-0.0213652460254962,0.0104124744133997,0.499340367857053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,40515,0.00148600850290379,0.00220088566824162,-0.00282772740684978,0.00579974441265737,0.49957101081323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42753,0.00407424698773157,0.0060353446256321,-0.00775502847850735,0.0159035224539705,0.499646288683589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,40510,-0.0071290517347243,0.0105631162704405,-0.0278327596247877,0.0135746561553391,0.499752814623985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,42635,-0.00249667054888469,0.00369968271333584,-0.00974804866702295,0.00475470756925356,0.499793038681896
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40301,-0.00300173536113824,0.0044498420243425,-0.0117234257288495,0.00571995500657306,0.499962263372582
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40482,-0.00313371395032568,0.00465478410201473,-0.0122570907902746,0.0059896628896232,0.500818361796607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,40538,0.00172787583480324,0.00256882817988373,-0.00330702739776888,0.00676277906737536,0.501195188732578
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,42310,-0.00576746301898264,0.00857644227164259,-0.0225772898714021,0.0110423638334368,0.501291712471329
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42291,-0.00285872618842734,0.00426914411484656,-0.0112262486535266,0.00550879627667192,0.503108594011451
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40181,-0.00279772338249716,0.00417863579425611,-0.0109878495392391,0.00539240277424481,0.503171312169789
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42593,-0.00463621740394073,0.00694862612206484,-0.0182555246031878,0.00898308979530635,0.504647236236003
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40222,-0.00210292680450978,0.00315979513164865,-0.00829612526254114,0.00409027165352157,0.505727838121778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40181,0.00245315348773718,0.00369117899790495,-0.00478155734815652,0.00968786432363088,0.506321023487901
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGN,Cingulin,40181,-0.00272161903861415,0.00409947366055735,-0.0107565874133066,0.00531334933607826,0.506771607779347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40526,0.00389268755384175,0.00591729359144448,-0.00770520788538944,0.0154905829930729,0.510648322953216
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40301,-0.00354794077805558,0.00540185777534118,-0.0141355820177243,0.00703970046161312,0.511323061773823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,42586,0.00273004157781118,0.00415705195319622,-0.00541778025045341,0.0108778634060758,0.511368788347333
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,40450,0.00357138683190178,0.00547003648250214,-0.00714988467380241,0.014292658337606,0.513834081938102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42586,-0.00286384977203685,0.00439290781182636,-0.0114739490832165,0.00574624953914282,0.514460252953288
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42310,0.00181200489382902,0.00278922813050652,-0.00365488224196376,0.00727889202962179,0.515933679823605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42369,-0.00238229253005282,0.00368039431092871,-0.00959586537947309,0.00483128031936746,0.517453774877763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,40115,0.00320915946531001,0.00496741174489009,-0.00652696755467457,0.0129452864852946,0.518265359062968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40135,-0.00243206294029178,0.00377202808649285,-0.00982523798981777,0.00496111210923421,0.519094508055316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40481,-0.00722486857892629,0.0112078999542526,-0.0291923524892614,0.0147426153314088,0.519184714300873
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,40115,0.00290138016317045,0.0045095392708836,-0.00593731680776141,0.0117400771341023,0.519986350301884
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,42369,0.00416978876735865,0.00648865285378224,-0.00854797082605454,0.0168875483607718,0.520476816543365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42666,-0.00705130176423898,0.0109771790511825,-0.0285665727045568,0.0144639691760788,0.52065033487826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42793,-0.00173587864725771,0.00270729852677914,-0.00704218375974483,0.00357042646522941,0.521413433507618
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,40198,-0.00387057412090437,0.00606491277990286,-0.015757803169514,0.00801665492770523,0.523362488679646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42688,-0.0020000284635134,0.00314263481392108,-0.00815959269879872,0.00415953577177192,0.52451499299529
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40135,0.00359079529686025,0.00566295848143764,-0.00750860332675753,0.014690193920478,0.526038807335322
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40482,0.00654226999625359,0.010429635382905,-0.0138998153542403,0.0269843553467474,0.530490389632046
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42697,-0.00406858168400483,0.00649792754888382,-0.0168045196798171,0.00866735631180746,0.531236797115027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40135,0.003331014578589,0.00532837729069098,-0.00711260491116533,0.0137746340683433,0.531888175114684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,40079,-0.00278708276747525,0.00447092936897317,-0.0115501043306627,0.00597593879571215,0.533048660600208
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40198,-0.00248744023823023,0.00399842205266044,-0.0103243474614447,0.00534946698498424,0.533885406387305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40301,-0.00268561798875489,0.00432129712397122,-0.0111553603517385,0.0057841243742287,0.534293826264877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40115,-0.00276405571524763,0.00446133198703297,-0.0115082664098322,0.00598015497933698,0.535561485893106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40181,-0.0041560499223978,0.00671356587691934,-0.0173146390411597,0.00900253919636411,0.535894590887742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40064,0.00320694977925736,0.005189375394467,-0.00696422599389795,0.0133781255524127,0.536598983068768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,40222,-0.00714932293564595,0.0116005833943935,-0.0298864663886572,0.0155878205173653,0.53771589259254
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42520,0.0035369892463812,0.00574326641551076,-0.00771981292801988,0.0147937914207823,0.538004200274278
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEO1,Neogenin,40481,0.00135865959851949,0.00220770207500228,-0.00296843646848497,0.00568575566552395,0.538291114353082
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPL,Periplakin,40198,0.00203084902946631,0.00330905054116609,-0.00445489003121923,0.00851658809015185,0.539409354770559
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,42589,-0.00525783059226936,0.00859731700426127,-0.0221085719206214,0.0115929107360827,0.540835023660102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,42447,-0.00409052022135142,0.00669420901236729,-0.0172111698855913,0.00903012944288846,0.541174605293291
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F2,Prothrombin,40538,0.000900037777184971,0.0014754676975693,-0.00199187891005086,0.0037919544644208,0.541872912056606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42310,0.00516688308112248,0.00850313756263473,-0.0114992665416416,0.0218330327038866,0.543433932129453
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42606,0.00574686026720305,0.00946249497894531,-0.0127996298915297,0.0242933504259359,0.543641990919827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42458,-0.00179273945734933,0.00295503425126735,-0.00758460658983333,0.00399912767513468,0.544078335478835
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42678,0.00197844602401291,0.00326918230688058,-0.00442915129747303,0.00838604334549884,0.545069125264442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42710,0.00139933804546499,0.00231228007320103,-0.00313273089800904,0.00593140698893901,0.545071749827728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42675,-0.00150145281081121,0.00249252248587008,-0.00638679688311656,0.00338389126149414,0.546929451679093
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,42562,0.00216975192244667,0.00361128791820247,-0.00490837239723018,0.00924787624212352,0.547966763490322
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40222,0.00504202711802809,0.00841982166220311,-0.01146082333989,0.0215448775759462,0.549299717934452
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42171,-0.0039460480547859,0.0066089205717789,-0.0168995323754725,0.00900743626590074,0.550465017414696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42675,0.0039929730185436,0.00669519376269853,-0.00912960675634551,0.0171155527934327,0.550922098763362
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40115,-0.00495365634780074,0.00831063956988349,-0.0212425099047724,0.0113351972091709,0.5511461696921
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,42369,-0.00553417001493558,0.00929888710696311,-0.0237599887445833,0.0126916487147121,0.551757933389484
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NENF,Neudesin,40450,-0.00646189158419845,0.0109488476780726,-0.0279216330332208,0.0149978498648239,0.555075663855501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40198,0.00171882012667129,0.00291402428994291,-0.00399266748161681,0.0074303077349594,0.555307263453335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40135,0.00342544876642166,0.00581402014855617,-0.00797003072474844,0.0148209282575918,0.555759113729205
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40301,-0.00392305976402717,0.00667061021990737,-0.0169974557950456,0.00915133626699128,0.556469695543519
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,40079,-0.00361867927587438,0.00615902261491928,-0.0156903636011162,0.00845300504936741,0.556852504526417
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42635,-0.00481074675570908,0.00821172578764069,-0.0209057292994848,0.0112842357880667,0.557993751185951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,42310,-0.00401536084438653,0.00686812199277846,-0.0174768799502323,0.00944615826145926,0.558801624153176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,40301,-0.00258687584438395,0.00442940529300747,-0.0112685102186786,0.0060947585299107,0.55921650432145
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42594,-0.0018743620268355,0.00321416719507687,-0.00817412972918616,0.00442540567551517,0.559797862852182
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,40181,-0.00439675890220385,0.00754571522791382,-0.0191863607489149,0.0103928429445072,0.560118773906381
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,40526,-0.00536713590312628,0.0092212363518338,-0.0234407591527205,0.012706487346468,0.560550769315133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40135,0.00235079695253999,0.00403956273872238,-0.00556674601535587,0.0102683399204359,0.560616783212304
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,40481,0.00182216395686871,0.00313149732588365,-0.00431557080186324,0.00795989871560067,0.560657350284631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,40198,0.00153283364323964,0.00264340575123589,-0.00364824162918272,0.00671390891566199,0.562013662375198
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40481,-0.00217844007519859,0.00377362288122157,-0.00957474092239287,0.00521786077199569,0.563761288753543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,42593,-0.00290468951322913,0.00503470825090964,-0.012772717685012,0.00696333865855377,0.563994385527633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40301,0.00213068162403913,0.00369867286545872,-0.00511871719225995,0.00938008044033822,0.564581888931401
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40198,0.00242546385038362,0.00422131287144274,-0.00584830937764415,0.0106992370784114,0.565590027583272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40450,0.00436133632261263,0.00762303995333412,-0.0105798219859222,0.0193024946311475,0.567248311182793
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40135,-0.0048649297715569,0.00851112777844048,-0.0215467402173002,0.0118168806741864,0.567607194878412
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40198,0.00236643543647608,0.00414544914966479,-0.00575864489686692,0.0104915157698191,0.568112036668917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40481,-0.0018426545708826,0.00322793733886793,-0.00816941175506375,0.00448410261329854,0.568115517643368
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,40450,-0.00464977071415841,0.00815436095502247,-0.0206323181860025,0.0113327767576856,0.568540621651032
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42617,0.00295614716418811,0.00518603225101848,-0.00720847604780811,0.0131207703761843,0.568673011427271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,42635,0.0014019719544447,0.0024622002636009,-0.00342394056221307,0.00622788447110247,0.569095575506767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,42436,0.00192996334301254,0.00339059894838957,-0.00471561059583101,0.0085755372818561,0.569223186338864
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,40079,0.00241749287288026,0.0042508111518756,-0.00591409698479592,0.0107490827305564,0.569562447845473
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,42635,-0.00376969578273077,0.00663384945810144,-0.0167720407206096,0.00923264915514806,0.56987360940007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,40482,-0.0012750115962006,0.00224555720491717,-0.00567630371783826,0.00312628052543706,0.570186846202646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42610,0.00172666170160443,0.00305425175651545,-0.00425967174116585,0.00771299514437472,0.571858434163323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,42593,-0.00200948168464857,0.00355802662726753,-0.00898321387409294,0.00496425050479579,0.572236804256377
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42544,0.00158711880030977,0.00281211738401346,-0.00392463127235661,0.00709886887297614,0.572501159723178
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,40531,0.00293406962187638,0.00520622794408394,-0.00727013714852814,0.0131382763922809,0.573058512061987
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40115,0.00271456431391595,0.00483566648537738,-0.00676334199742371,0.0121924706252556,0.574561610646445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40079,-0.00321644037775605,0.00574802487421811,-0.0144825691312235,0.00804968837571144,0.575782137818629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42589,0.00130781717208423,0.00233739037782536,-0.00327346796845348,0.00588910231262194,0.575816092590442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42369,0.00215454209342471,0.00385701092227876,-0.00540519931424166,0.00971428350109108,0.576441438350452
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,40079,0.0038376746174672,0.00687987970768047,-0.00964688960958653,0.0173222388445209,0.57698471969565
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40301,0.00290384085636962,0.00523084333518108,-0.0073486120805853,0.0131562937933245,0.578811328158576
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,40198,0.00147566039988326,0.00266151910206168,-0.00374091704015765,0.00669223783992416,0.579287033191653
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,40301,0.00390636436797105,0.00704941322805874,-0.00991048555902408,0.0177232142949662,0.579493948358493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCIN,Adseverin,40135,0.00401769518834485,0.00725054475962561,-0.0101933725405213,0.018228762917211,0.579505846934638
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40481,-0.00363493593412369,0.00656569097606549,-0.0165036902472121,0.00923381837896468,0.579845930257339
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,42310,0.00251266286428069,0.00455216070727331,-0.006409572121975,0.0114348978505364,0.580977300616081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,42542,0.00179110971445103,0.00325115431245209,-0.00458115273795507,0.00816337216685712,0.581701157047079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,42586,-0.0044445266527976,0.00807116684122985,-0.0202640136616081,0.0113749603560129,0.581871034954799
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,40481,0.0019821342228692,0.0036118959585607,-0.00509718185590976,0.00906145030164816,0.583167680014963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,40115,0.00202602032859705,0.00369402790980168,-0.00521427437461425,0.00926631503180835,0.583388454442481
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,42369,0.0030719941053724,0.00560118577872609,-0.00790633002093074,0.0140503182316755,0.58338933282004
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,40198,0.00305092976153495,0.00556344781526447,-0.0078534279563834,0.0139552874794533,0.583436424425212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,42610,-0.00252587751258735,0.00460704295191973,-0.01155568169835,0.00650392667317531,0.583519509432727
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTN,Titin,40115,0.00357486235578626,0.00652688069531527,-0.00921782380703167,0.0163675485186042,0.583899657004905
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40135,0.00293756849053751,0.00537117744653308,-0.00758993930466732,0.0134650762857423,0.58444943807015
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40181,-0.00267922568053298,0.00490068855604513,-0.0122845752503814,0.00692612388931548,0.584593257946044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40482,-0.00254984702986716,0.00467230361817709,-0.0117075621214943,0.00660786806175993,0.585257802572717
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,42332,-0.00273063074731576,0.00500458282756135,-0.012539613089336,0.00707835159470449,0.58533227916336
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40222,0.00127460439408953,0.002342276174665,-0.00331625690825386,0.00586546569643292,0.586333154944881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,42369,-0.00314489647486464,0.00578780842298853,-0.0144890009839222,0.00819920803419287,0.586887241842772
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40301,0.00339642469855054,0.00626240936964637,-0.00887789766595635,0.0156707470630574,0.587587530806803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40301,-0.00281913728178816,0.00520808416089389,-0.0130269822371402,0.00738870767356387,0.588311501605543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40450,-0.00284856108542428,0.00527001166793538,-0.0131777839545776,0.00748066178372906,0.588847285953837
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40301,-0.00379143689010538,0.00703524654330578,-0.0175805201149847,0.00999764633477395,0.589952678756445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40135,0.00300609735805504,0.0055872279840895,-0.00794486949076038,0.0139570642068705,0.590567147245523
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40481,0.00398930120084681,0.00744269688003026,-0.0105983846840125,0.0185769870857061,0.59196765727163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40079,-0.00414990576192558,0.00774625048061716,-0.0193325567039352,0.0110327451800841,0.592155488762144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42345,0.00239221930640528,0.00446791251834641,-0.00636488922955368,0.0111493278423642,0.592367033872154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,40181,-0.00323113619826383,0.0060359275209808,-0.0150615541393862,0.00859928174285854,0.592441325882246
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40482,-0.00211761870664079,0.00396344985574189,-0.00988598042389489,0.00565074301061331,0.593153686278127
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MB,Myoglobin,42793,0.00280823399201518,0.00526525087246757,-0.00751165771802127,0.0131281257020516,0.593798403366494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIT,Vitrin,40510,0.00203537374513228,0.00382547268803327,-0.00546255272341293,0.0095333002136775,0.594696198739828
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,40428,0.00280021315773478,0.00531013148939564,-0.00760764456148067,0.0132080708769502,0.597972044494296
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40450,0.00473920536137644,0.00901203294263159,-0.0129243792061815,0.0224027899289344,0.598985224285679
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40115,0.00187702920676347,0.00357063610621707,-0.00512141756142199,0.00887547597494893,0.599117884313127
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40181,0.00286924289255217,0.00547361685709226,-0.00785904614734866,0.013597531932453,0.600153453944094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,42720,-0.00112877125729936,0.00215350234611227,-0.00534963585567942,0.00309209334108069,0.600178603807299
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40058,0.00138322475921113,0.00263910501103864,-0.0037894210624246,0.00655587058084686,0.600201280438639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,40510,-0.00368778930098546,0.00706975532258294,-0.017544509733248,0.0101689311312771,0.601938886281681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42345,-0.0020433421275844,0.00391904511275328,-0.00972467054858083,0.00563798629341202,0.602105460562043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40079,0.00288691178542453,0.00553726239312384,-0.0079661225050982,0.0137399460759472,0.602126030973743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,42720,-0.00167731557352333,0.00322766967003192,-0.0080035481267859,0.00464891697973923,0.603303728661151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40115,-0.00517266306561223,0.00998263917747845,-0.02473863585347,0.0143933097222455,0.6043530317802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRL,Prolactin,42710,0.00382840313996969,0.00743018518146386,-0.0107347598156995,0.0183915660956389,0.60638673896791
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,42346,0.00220692222949358,0.00428564269215229,-0.00619293744712491,0.0106067819061121,0.606591636758463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40301,0.0033320855099728,0.0064783338040189,-0.00936544874590424,0.0160296197658498,0.607022451038142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42356,0.00305688420807678,0.00594692614619612,-0.00859909103846762,0.0147128594546212,0.607241319829123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,40135,-0.00382674997806661,0.0074512626248952,-0.0184312247228612,0.010777724766728,0.607562556987503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42586,0.00171173182386884,0.00333707385671959,-0.00482893293530155,0.00825239658303923,0.607998994019477
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,40481,-0.00231772194948954,0.00453184776953543,-0.011200143577779,0.0065646996787999,0.60906014459754
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,42345,-0.00244244895281075,0.00477824783435013,-0.011807814708137,0.0069229168025155,0.609247637177345
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42310,0.00255301998609001,0.00501868979160534,-0.00728361200545646,0.0123896519776365,0.61096933428673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40115,-0.00196949402192999,0.00388211219451055,-0.00957843392317068,0.00563944587931069,0.611936781619986
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42369,-0.00573844996306041,0.0113128769828357,-0.0279116888494185,0.0164347889232977,0.611988333527614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,40222,0.00431638307030676,0.00851285498009189,-0.0123688126906733,0.0210015788312869,0.61213482373555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,40249,-0.00429136219515582,0.00849704469657836,-0.0209455698004494,0.0123628454101378,0.61353959071572
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,40181,0.00456600527466883,0.00904816360492682,-0.0131683953909877,0.0223004059403254,0.61382648919272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,42720,-0.00542589222144995,0.0107834741890954,-0.026561501632077,0.0157097171891771,0.614854805342038
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,40115,-0.00192604792487162,0.00383094970607703,-0.0094347093487826,0.00558261349903936,0.615143221825632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40079,-0.00154064330907838,0.00306481174261659,-0.0075476743246069,0.00446638770645014,0.615193995856104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42635,-0.00144569692011218,0.00288674399058014,-0.00710371514164926,0.0042123213014249,0.616516299695295
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42356,0.00241417018444255,0.00482150610732216,-0.00703598178590889,0.011864322154794,0.616584502084608
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40198,-0.00316897269506096,0.0063453166325169,-0.0156057932947941,0.00926784790467217,0.617494109628358
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40181,0.00415609208723411,0.0083604208883,-0.0122303328538339,0.0205425170283021,0.619117781674277
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C3,Complement C3,39988,0.00230879180544249,0.00467255673544076,-0.00684941939602141,0.0114670030069064,0.621233291739761
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,42678,0.00277067717333205,0.00560806539960464,-0.00822113100989305,0.0137624853565571,0.6212773466427
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,40526,0.00212199635309046,0.00429951073764599,-0.00630504469269567,0.0105490373988766,0.621638048816071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40481,-0.00231883100843515,0.00469955599915348,-0.011529960766776,0.00689229874990568,0.621729048166471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,40448,-0.00173394824297557,0.00353364132515406,-0.00865988524027753,0.00519198875432639,0.623650126667527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40135,-0.00478858101938561,0.00979823770782127,-0.0239931269267153,0.0144159648879441,0.625050728882991
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,40115,-0.00186664087491317,0.00382081567317439,-0.00935543959433498,0.00562215784450864,0.625173579760237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40301,-0.0042129072512391,0.00863953559610688,-0.0211463970196086,0.0127205825171304,0.625820704897287
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,42369,0.00211688644170056,0.00434878966634676,-0.0064067413043391,0.0106405141877402,0.626425177043353
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,42720,-0.00106090595920661,0.00218021447282698,-0.00533412632594749,0.00321231440753427,0.626545287444116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40181,-0.00519830900749778,0.010684860671698,-0.026140635924026,0.0157440179090304,0.626614163946666
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,42356,0.00293528190347678,0.00606119309689954,-0.00894465656644631,0.0148152203733999,0.628199052735822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGMN,Legumain,42675,0.00171160846726883,0.00353483205261324,-0.00521666235585311,0.00863987929039078,0.628243213240536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40450,-0.00223289353589847,0.0046459707432733,-0.0113389961927141,0.00687320912091719,0.630804036384685
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',40115,0.00206618678878447,0.00430517045717526,-0.00637194730727905,0.010504320884848,0.631285734321286
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42296,0.00268301266246119,0.0055937560302355,-0.00828074915680039,0.0136467744817228,0.63148841441939
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40510,0.00341214227426013,0.00711912690211207,-0.0105413464538795,0.0173656310023998,0.631740004444738
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42610,0.00172049107401548,0.00361200915366017,-0.00535904686715845,0.00880002901518941,0.633850453858362
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40135,-0.00259958860511938,0.00545786737428306,-0.0132970086587142,0.00809783144847542,0.633869344531046
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,40115,0.00159569446357657,0.00335241110987723,-0.00497503131178281,0.00816642023893595,0.634095210109735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40181,-0.00245173248854711,0.00515236403586366,-0.0125503659988399,0.00764690102174566,0.634193463620887
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40079,-0.00438144458648897,0.00920984297800534,-0.0224327368233794,0.0136698476504015,0.634272734596161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40198,-0.00407037920609393,0.00871268375720652,-0.0211472393702187,0.0130064809580308,0.640381369166146
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40450,0.00186405475581782,0.00399245640204586,-0.00596115979219206,0.00968926930382771,0.640584608756364
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,40115,-0.00307676034918672,0.00659935781063209,-0.0160115016580256,0.00985798095965218,0.641066493121586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40448,0.00445584761115286,0.00961669163553266,-0.0143928679944912,0.0233045632167969,0.643125934252378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,42310,0.00243264521496377,0.00529268698342672,-0.0079410212725526,0.0128063117024801,0.645793848625586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,40181,0.00310707282742723,0.00679800414610217,-0.010217015298933,0.0164311609537875,0.647639382576191
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,40135,-0.0028094877176109,0.00615425863807541,-0.0148718346482387,0.00925285921301691,0.648031513370309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,40526,0.00124901943891173,0.00276014258208521,-0.00416086002197527,0.00665889889979874,0.650903152695467
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,42610,0.00330707705382302,0.00732296720865048,-0.0110459386751319,0.017660092782778,0.651562004156202
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40510,-0.00132477652767962,0.00293798281644978,-0.0070832228479212,0.00443366979256195,0.652060431806377
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42345,-0.00206907688739458,0.00461468228491581,-0.0111138541658296,0.00697570039104041,0.653894859407457
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,42474,0.00204742065481394,0.00462101323414616,-0.00700976528411252,0.0111046065937404,0.657724148801248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,42593,-0.00290940067253205,0.00657959063983976,-0.015805398326618,0.00998659698155389,0.658361994233198
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42345,-0.00322269313086824,0.0072983494241547,-0.0175274580022114,0.011082071740475,0.65881152684763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,42593,0.00257832180049193,0.00585196125320102,-0.00889152225578207,0.0140481658567659,0.659516185278004
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40135,0.00252598102049314,0.00577046445710774,-0.00878412931543803,0.0138360913564243,0.661581160664389
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,40450,-0.00162203528327606,0.00371561040385038,-0.00890463167482281,0.00566056110827069,0.662448922500881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40285,0.00444257289033907,0.0101874657115705,-0.0155248599043392,0.0244100056850173,0.662785548233212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,40198,-0.00375381465980452,0.00863071568897982,-0.020670017410205,0.0131623880905959,0.663616932740418
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,40198,-0.00527592232172433,0.0122203845625578,-0.0292278760643376,0.018676031420889,0.665945185646042
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,40035,-0.00149850320024452,0.00348524300616317,-0.00832957949232434,0.0053325730918353,0.66723576453102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42369,0.00163159265537262,0.00382242048889367,-0.00586035150285897,0.00912353681360421,0.669496995307577
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40115,-0.00143762976880863,0.00337519167263522,-0.00805300544717367,0.00517774590955641,0.670159825487084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,40222,0.000957263061355975,0.00224785797143891,-0.00344853856266429,0.00536306468537624,0.670221329809308
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40510,-0.0037918618269381,0.00892633797277854,-0.021287484253584,0.0137037605997078,0.670994355612033
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42345,0.00151002238209407,0.00357701307679435,-0.00550092324842285,0.008520968012611,0.672925228207711
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42291,0.00201860561608628,0.00480235345830305,-0.00739400716218771,0.0114312183943603,0.674246367036156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40079,0.00128224221033053,0.00305267820577239,-0.00470100707298335,0.00726549149364441,0.674465658670976
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40115,-0.00250212875841494,0.0059988855789674,-0.014259944493191,0.00925568697636116,0.676614245707602
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,42310,0.00196018124884027,0.00471662453558874,-0.00728440284091366,0.0112047653385942,0.677716959227589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,42356,0.00136635124343437,0.00329525579509668,-0.00509235011495511,0.00782505260182385,0.678410801442112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42356,0.00378331886284119,0.00913410523499287,-0.0141195273977448,0.0216861651234272,0.678736598067632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40135,0.00182754956106763,0.0044157023610966,-0.00682722706668169,0.010482326188817,0.67897364236567
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,42310,-0.00211345669158329,0.00511096413112408,-0.0121309463885865,0.00790403300541992,0.679236617342024
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40115,0.00277567837843802,0.00672193425070803,-0.0103993127529497,0.0159506695098258,0.679667089651459
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,40482,-0.00378036616991969,0.00915886238138592,-0.0217317364374361,0.0141710040975967,0.679793969183722
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESPL1,Separin,40079,0.00236513420558678,0.005733618460812,-0.00887275797760475,0.0136030263887783,0.679978984247034
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,40460,0.000980536565773876,0.00237776894706063,-0.00367989057046496,0.00564096370201271,0.680071168298605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42635,0.00237503462368969,0.00578491838370445,-0.00896340540837102,0.0137134746557504,0.681404465224175
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42345,0.00196338108960016,0.0047866196731542,-0.00741839346978207,0.0113451556489824,0.681679760390239
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40450,-0.00382230863349241,0.00932182786327026,-0.0220930912455021,0.0144484739785173,0.681785484109106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40481,0.0014674971970539,0.00359071306741565,-0.00557030041508077,0.00850529480918856,0.682773154052803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,40450,0.00186735553507317,0.00456997422570579,-0.00708979394731018,0.0108245050174565,0.682830714283161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40181,0.00147088647184719,0.00360124742346329,-0.00558755847814086,0.00852933142183524,0.68296006373878
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,42356,0.00191557111417153,0.00472370360452251,-0.00734288795069259,0.0111740301790357,0.685099604729122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,40115,-0.00161273398900734,0.0039824491625844,-0.00941833434767276,0.00619286636965808,0.685514591222414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,42675,-0.00258068997019071,0.0063746121008903,-0.0150749296879357,0.00991354974755427,0.685602469302089
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40282,-0.00473673485838969,0.0117158492776201,-0.027699799442525,0.0182263297257456,0.685998856875815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42345,-0.00119729162131828,0.00296709989698647,-0.00701280741941175,0.00461822417677519,0.686570433354843
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40198,-0.00082638438567132,0.00205840711203919,-0.00486086232526813,0.00320809355392549,0.688083461265506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42610,0.00174485304418189,0.00436257322827713,-0.00680579048324129,0.0102954965716051,0.689192640737977
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40115,0.0019307789055727,0.00483662619097607,-0.00754900842874039,0.0114105662398858,0.689753994773347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,42494,0.00221647358859284,0.00557438691090081,-0.00870932475677274,0.0131422719339584,0.690918566308335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42780,0.002340549671483,0.00589135004961744,-0.00920649642576718,0.0138875957687332,0.691162964399428
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,40115,0.0017135777788662,0.00431984173895752,-0.00675331202949054,0.0101804675872229,0.691614110754068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,40198,0.0011454043597381,0.00289288096487635,-0.00452464233141954,0.00681545105089574,0.692157715026859
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42777,0.0009319069944087,0.00236608328554617,-0.0037056162452618,0.0055694302340792,0.693690139453766
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40079,0.00222480420647285,0.00572201457655048,-0.0089903443635661,0.0134399527765118,0.697420724127878
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40301,-0.00147227229697266,0.00379209586411524,-0.00890478019063853,0.0059602355966932,0.697840216861505
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42291,0.00180183688344006,0.00465581276999474,-0.00732355614574963,0.0109272299126297,0.698756558331874
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,40079,-0.00162993307009027,0.00424332191683348,-0.00994684402708389,0.00668697788690336,0.700899063039961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,40282,-0.00132518658542975,0.00346420027312802,-0.00811501912076067,0.00546464594990117,0.702070035491232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40301,0.00268139883366244,0.0070160953939753,-0.0110701481385292,0.016432945805854,0.702336489412404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40198,-0.00162468058018336,0.00430558777404073,-0.0100636326173032,0.00681427145693647,0.705926485508439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,42676,-0.00156203241451285,0.00415552611186008,-0.0097068635937586,0.00658279876473291,0.707002495381107
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,42356,-0.00102933282138604,0.00274046185770467,-0.00640063806248719,0.0043419724197151,0.707216179588627
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,40135,0.00187133133762508,0.00500380776358578,-0.00793613187900304,0.0116787945542532,0.708425355940074
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,42460,0.00215920109314743,0.00580802014380301,-0.00922451838870646,0.0135429205750013,0.710076007991511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,40418,-0.00167793984667496,0.00452610669348051,-0.0105491089658968,0.00719322927254685,0.710849538027225
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40198,-0.00116197157645651,0.00314902529969111,-0.00733406116385109,0.00501011801093808,0.712139264350091
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42593,0.00435247110814798,0.0118151685476439,-0.018805259245234,0.02751020146153,0.712595770896479
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",42310,0.00198553212073274,0.00539292220305933,-0.00858459539726355,0.012555659638729,0.712749661114917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40079,-0.00523077804089574,0.0142839627729163,-0.0332273450758117,0.0227657889940202,0.714223435907372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40526,0.00148388548373205,0.00407075384918955,-0.00649479206067947,0.00946256302814357,0.715473922594535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42345,0.00171446428694264,0.00470399748385504,-0.00750537078141324,0.0109342993552985,0.715513198064245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40109,0.00124314974369155,0.00341529760421038,-0.00545083356056079,0.00793713304794389,0.715869123092087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40079,0.00348974828537381,0.00959647289500663,-0.0153193385888392,0.0222988351595868,0.716127153981223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40450,0.00172619605694466,0.00483787405458044,-0.00775603709003301,0.0112084292039223,0.721241633091884
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,40115,-0.00253787521916852,0.00711502879462845,-0.0164833316566403,0.0114075812183032,0.72132914233418
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,40198,-0.00208525167054373,0.0058764885621079,-0.0136031692522752,0.00943266591118775,0.72271135592031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,40268,-0.00131465947574255,0.00370705824212739,-0.00858049363031223,0.00595117467882714,0.722868415204312
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42310,-0.00186430080107115,0.00526023420388338,-0.0121743598406826,0.00844575823854028,0.723034319580659
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,40079,-0.00149134892952591,0.00421395763403267,-0.00975070589222994,0.00676800803317812,0.723415466655182
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40181,-0.0019613314455751,0.00556576144262903,-0.012870223873128,0.0089475609819778,0.724550839082286
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40115,0.00170333191123295,0.00483659810193541,-0.00777640036856045,0.0111830641910264,0.724713358758449
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,42310,-0.0021306559293753,0.00605378670415249,-0.0139960778695142,0.00973476601076357,0.724878231131156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40538,-0.000651454275885204,0.00186077807594349,-0.00429857930473445,0.00299567075296405,0.726271815655169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,40282,-0.00399320640476988,0.0114098686540396,-0.0263565489666875,0.0183701361571478,0.726361632422555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40282,0.00430711982416073,0.0123160176985313,-0.0198322748649607,0.0284465145132822,0.726557793191145
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,40448,-0.00107546707974062,0.00307560449993424,-0.00710365189961174,0.0049527177401305,0.726587922022863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42688,0.00235967123151689,0.00679280648984737,-0.0109542294885839,0.0156735719516177,0.728312809938412
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,40482,-0.00158846436118595,0.00459752646826047,-0.0105996162389765,0.00742268751660458,0.729721847629336
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42310,-0.00165323274330191,0.00480932367558954,-0.0110795071474574,0.00777304166085358,0.731035479087394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,40222,0.0024834283041837,0.00728379620568355,-0.0117928122589561,0.0167596688673235,0.733145858943817
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42369,-0.00223605805114151,0.00657157137103135,-0.0151163379383629,0.0106442218360799,0.73366442295985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40115,-0.00127352971253132,0.00376820637969633,-0.00865921421673612,0.00611215479167348,0.735394490965791
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40115,-0.0013366464895057,0.0039756135954547,-0.00912884913659692,0.00645555615758553,0.736717939570674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,40301,0.00204413011063122,0.00612988045645003,-0.00997043558401083,0.0140586958052733,0.738785964610594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40482,0.00179637742373149,0.00539695824197139,-0.00878166073053242,0.0123744155779954,0.739253712612146
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40450,-0.00217882984464286,0.00655613160846148,-0.0150288477972274,0.0106711881079416,0.739642750570235
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",40450,-0.00140436536735122,0.00425035150021244,-0.00973505430776761,0.00692632357306517,0.741095140080614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,40198,-0.00208666011917099,0.00637964502897437,-0.0145907643759608,0.0104174441376188,0.74361290936305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40115,0.00109465100326353,0.00334693484785787,-0.0054653412985379,0.00765464330506495,0.743628210034032
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,42710,-0.0020793133974411,0.00638171751237654,-0.0145874797216991,0.0104288529268169,0.744562958118934
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40301,0.0020450881948711,0.00633340327212799,-0.0103683822184998,0.0144585586082419,0.746773194795632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,40538,-0.000592076204766313,0.00183401577161541,-0.00418674711713251,0.00300259470759989,0.746829572752985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,40013,-0.00257708824809834,0.0080230399815306,-0.0183022466118983,0.0131480701157016,0.748056743616769
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,40135,-0.00269770695367825,0.00844475945220701,-0.019249435480004,0.0138540215726475,0.749388836916914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,40079,0.00168104533427631,0.00528813377493982,-0.00868369686460573,0.0120457875331584,0.750574406231015
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40115,0.00125858838052507,0.00396145643702452,-0.00650586623604299,0.00902304299709313,0.75071213749444
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,40482,0.000823636459929844,0.00259260354466085,-0.00425786648760542,0.00590513940746511,0.75072824433817
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSC1,Hamartin,40198,0.00231316333991459,0.00729728069877364,-0.0119895068296817,0.0166158335095109,0.751257377227136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,40282,-0.00294773846178601,0.00931017093015445,-0.0211956734848887,0.0153001965613167,0.751541819519669
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,40282,-0.00335692625341603,0.0106094915876522,-0.0241515297652142,0.0174376772583822,0.751698927656757
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,-0.00171046956367329,0.00542275153449621,-0.0123390625712859,0.00891812344393928,0.752445550333812
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42736,0.000971789541371118,0.0030924047671819,-0.00508932380230541,0.00703290288504765,0.753335681154502
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,40135,-0.00149929274329248,0.00478567396206856,-0.0108792137089469,0.0078806282223619,0.754068073145424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40481,0.00387813806966908,0.0124356017398096,-0.0204956413403578,0.028251917479696,0.755154436441795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40198,-0.00199381120424395,0.00640194560387906,-0.0145416245878469,0.010554002179359,0.755473323566484
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40079,-0.00198176583330642,0.00638048785646107,-0.0144875220319701,0.0105239903653573,0.756112306039138
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40222,0.00151976784141533,0.00491126875303846,-0.00810631891454004,0.0111458545973707,0.756988846521184
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,40181,0.000712431169883789,0.00230479032965879,-0.00380495787624744,0.00522982021601502,0.757244561639838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,40079,-0.00142047447756176,0.00460414339025842,-0.0104445955224683,0.00760364656734475,0.75769190100538
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40510,-0.000970729981546738,0.00315473834288007,-0.00715401713359168,0.0052125571704982,0.758312183515717
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,40198,0.00124454377152726,0.00404896956520193,-0.00669143657626851,0.00918052411932304,0.758565322059208
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,40198,0.000902623103140549,0.00293875816696743,-0.00485734290411562,0.00666258911039671,0.758739278505247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFB,Complement factor B,40343,-0.000985167418096218,0.00320965490956056,-0.00727609104083491,0.00530575620464247,0.758895737213463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40079,0.000771383824922468,0.00251350754329374,-0.00415509095993327,0.0056978586097782,0.758928884621594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,40079,-0.00125265693915617,0.00411220061952272,-0.0093125701534207,0.00680725627510835,0.760661708244716
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40181,0.00253237940338754,0.00836195811641754,-0.0138570585047908,0.0189218173115659,0.762013520780079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42310,-0.0044905070616053,0.0148378781976113,-0.0335727483289235,0.0245917342057129,0.762170485327584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,40301,0.0012364415188175,0.00408719669922435,-0.00677446401166223,0.00924734704929723,0.762264566753867
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40450,0.0013284715783086,0.00441303431917399,-0.00732107568727243,0.00997801884388962,0.763394438569534
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,40064,-0.00240601309177017,0.00805038304242474,-0.0181847638549227,0.0133727376713823,0.765045414623539
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40079,0.00259179447502859,0.00877832339306941,-0.0146137193753875,0.0197973083254446,0.767809019397877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42745,0.00153675327042739,0.00520610180573952,-0.00866720626882206,0.0117407128096768,0.767858533574805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40222,-0.00115997817067174,0.00393049132642774,-0.0088637411704701,0.00654378482912662,0.76790551897967
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40198,0.000909169342197228,0.00308726334843363,-0.0051418668207327,0.00696020550512715,0.768388771890357
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,40181,-0.000840153942482478,0.00289763441254156,-0.00651951739106394,0.00483920950609899,0.771863962287663
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,40301,-0.00100982976298391,0.00350408469723361,-0.00787783576956178,0.00585817624359396,0.773209390335547
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42356,-0.00143501193633787,0.00503479757043179,-0.0113032151743842,0.00843319130170843,0.775634227028735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,42369,-0.000806300252490182,0.00284422903887145,-0.00638098916867822,0.00476838866369786,0.776808459359771
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42593,0.00158218974704056,0.00563069432900306,-0.00945397113780543,0.0126183506318866,0.778719555088662
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,40181,-0.0018077047440303,0.00644425822601633,-0.0144384508670223,0.0108230413789617,0.77908845658375
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,40374,0.00273451367019367,0.00976108296742129,-0.0163972089459521,0.0218662362863394,0.779371830889055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42356,0.000768492874995255,0.00275231585989157,-0.00462604621039223,0.00616303196038274,0.780082825248113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42369,-0.00166907496846492,0.00601310489277782,-0.0134547605583095,0.0101166106213796,0.781344592091951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42345,-0.00154391958008851,0.00560709668179384,-0.0125338290764044,0.00944598991622742,0.783050925203996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40450,-0.000913697541862277,0.00332910195752712,-0.00743873737861542,0.00561134229489087,0.783737971893468
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40198,0.00198954813711709,0.00731875644162139,-0.0123552144884608,0.016334310762695,0.785748320574973
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42586,0.0012285970242193,0.0045199273756317,-0.00763046063201883,0.0100876546804574,0.785766255479345
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,40282,0.00295346003962501,0.0109851126653593,-0.0185773607844791,0.0244842808637291,0.788042235948672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,40079,-0.00194031406420311,0.00723860372067051,-0.0161279773567173,0.0122473492283111,0.788665237388327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,42720,-0.000794815886515074,0.00296722640853691,-0.00661057964724741,0.00502094787421726,0.788807375775047
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,40450,-0.00141055540112235,0.00527689027963017,-0.0117532603491975,0.00893214954695279,0.789236864606516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40448,0.00116379080748106,0.00436188637769189,-0.00738550649279505,0.00971308810775717,0.789621066119862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42474,0.001069889521798,0.00402102944753454,-0.00681132819536969,0.00895110723896569,0.790186706706761
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,40481,-0.00125431387947654,0.00471594606915746,-0.0104975681750252,0.00798894041607208,0.790264933727309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,40198,-0.000988211731056454,0.00372217776733361,-0.00828368015503033,0.00630725669291742,0.79063476005529
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,40165,0.00117571049512853,0.0044380411815094,-0.0075228502206299,0.00987427121088696,0.791078736518734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,40448,-0.00154999242554362,0.00595590150114254,-0.013223559367783,0.0101235745166958,0.794679706133141
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40115,0.00124592388361226,0.00479551575409498,-0.0081532869944139,0.0106451347616384,0.795015083960233
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40450,0.00163412422275986,0.0063392168368893,-0.0107907407775432,0.0140589892230629,0.796581302780629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40450,0.00124952163705023,0.00497172525667634,-0.00849505986603541,0.0109941031401359,0.801567002644822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,40115,0.00128896689513064,0.00513183605536562,-0.00876943177338598,0.0113473655636473,0.801686855971275
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,42650,0.000863025293554766,0.00348996293578181,-0.00597730206057758,0.00770335264768711,0.804689264393698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40198,0.00119906088471831,0.00486822378237907,-0.00834265772874467,0.0107407794981813,0.805451842674529
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,40301,0.000749516457962035,0.00304359002361015,-0.00521591998831385,0.00671495290423792,0.805485019379456
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40198,-0.00216296651367684,0.00881101129704123,-0.0194325486558776,0.015106615628524,0.806085902892703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,40198,0.000782341445696724,0.0031908166593775,-0.00547165920668318,0.00703634209807663,0.806317504417524
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,40115,0.00121244631070703,0.00494547639440827,-0.00848068742233317,0.0109055800437472,0.806335068158689
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,42310,0.000711258427238366,0.00290264864503938,-0.00497793291703883,0.00640044977151556,0.80643105292522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40079,-0.00141764962449917,0.00578698268084799,-0.0127601356789612,0.00992483642996288,0.806482608688419
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,40181,0.000669232614353577,0.00275465461561377,-0.0047298904322494,0.00606835566095656,0.808051682469227
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,42356,0.00117192259874164,0.0048327936195419,-0.00830035289556048,0.0106441980930438,0.808401321219351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,40526,-0.00233348132357256,0.0097106141611256,-0.0213662850793787,0.0166993224322336,0.810100386113009
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,40064,-0.000983794645035818,0.00410881678661851,-0.00903707554680811,0.00706948625673647,0.810772788952954
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40079,-0.00140449715253618,0.0058881218771937,-0.0129452160318358,0.0101362217267635,0.811474087089787
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,42276,0.00175988935323479,0.00738961484066499,-0.0127237557344686,0.0162435344409382,0.811762967281587
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40198,-0.000672159547939058,0.00282700384013481,-0.00621308707460329,0.00486876797872517,0.812068621509946
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40531,-0.000666034175106283,0.00283527718384776,-0.0062231774554479,0.00489110910523533,0.814283046121799
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40115,-0.00137713353589232,0.00588737313858341,-0.0129163848875158,0.0101621178157312,0.815056849355689
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40198,-0.000912878061796538,0.00398957137153017,-0.00873243794999567,0.00690668182640259,0.819016124364011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAYN,Layilin,42475,-0.000849762961254965,0.00375096539997632,-0.00820165514520855,0.00650212922269862,0.820780945761983
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40450,0.00217719301639611,0.00961255890310881,-0.0166634224336972,0.0210178084664894,0.820820844565741
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40450,-0.000771481810346523,0.00341284199223582,-0.00746065211512872,0.00591768849443568,0.821164613406026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40448,0.00116211480086623,0.00521213033788322,-0.00905366066138488,0.0113778902631173,0.823567963934201
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,42356,-0.00171365751882121,0.00770256760099226,-0.016810690016766,0.0133833749791236,0.823944675234803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,42569,-0.00145574469429072,0.00658462968192943,-0.0143616188708724,0.011450129482291,0.825031771612555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,42291,-0.00192739177395224,0.00881264110716394,-0.0192001683439936,0.0153453847960891,0.826881219561342
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,40079,0.00103950910138161,0.00476542889756391,-0.00830073153784365,0.0103797497406069,0.827327646066992
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40181,0.00119952428958532,0.00551156274035401,-0.00960313868150854,0.0120021872606792,0.827715385837896
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,42369,-0.000836184097002829,0.00384759422842417,-0.00837746878471421,0.00670510059070855,0.82795729011476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40115,-0.00084936811678311,0.00392033563249116,-0.00853322595646578,0.00683448972289956,0.828479715866066
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40079,0.00105105411694173,0.00488006795150544,-0.00851387906800894,0.0106159873018924,0.829477480221526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,42369,0.000698920440091947,0.00327965006106086,-0.00572919367958734,0.00712703455977123,0.831245837843841
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40181,0.000879018623998495,0.00418025884623058,-0.00731428871461345,0.00907232596261043,0.833454201921673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,42356,0.0029305668008833,0.0140495581454106,-0.0246065671641214,0.030467700765888,0.83477324205067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42720,-0.000717942592902332,0.00345770202616579,-0.00749503856418727,0.00605915337838261,0.835516505206643
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40482,-0.000560002017296796,0.00270967583424274,-0.00587096665241256,0.00475096261781897,0.836273243147017
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,40079,0.000777546150424282,0.00378934297881045,-0.0066495660880442,0.00820465838889276,0.837425278944316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40222,-0.00130367149883967,0.00638193478448587,-0.013812263676432,0.0112049206787526,0.8381421578886
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40176,0.000767393093336776,0.0037798733449671,-0.00664115866279874,0.00817594484947229,0.839122498062235
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40482,0.000520062731115645,0.00259389962916559,-0.00456398054204891,0.0056041060042802,0.841097434282475
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42369,-0.00130233957523178,0.00651975958278057,-0.0140810683574817,0.0114763892070181,0.841677078993745
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42593,-0.00160203327000497,0.00804714835327429,-0.0173744440424226,0.0141703775024126,0.842202508381246
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40450,-0.00123460359836008,0.00622465432037998,-0.0134349260663049,0.0109657188695847,0.842781928311133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40198,-0.000570844195246276,0.00289190164346512,-0.00623897141643791,0.00509728302594535,0.843522826506621
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40222,0.00527946136129789,0.0269027940122729,-0.0474500149027571,0.0580089376253529,0.844424276986779
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,40198,0.000808628637766031,0.00412346815064772,-0.00727336893750351,0.00889062621303557,0.844532379161297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,40198,0.000817384802276762,0.00419996631354212,-0.0074145491722658,0.00904931877681932,0.845696393981691
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,42369,-0.00161068316618568,0.00843189909210688,-0.0181372053867152,0.0149158390543438,0.84851084162537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40222,-0.000916076192519504,0.00481977260775608,-0.0103628305037214,0.00853067811868241,0.849260700655204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42369,-0.000844547281805037,0.00446355537185791,-0.00959311581064654,0.00790402124703646,0.849931501358978
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42369,-0.000681041808531493,0.00363584787182125,-0.00780730363730115,0.00644522002023816,0.851418064308601
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,42302,-0.00199962012772051,0.0106965161716542,-0.0229647918241627,0.0189655515687217,0.851709587856391
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40448,0.00105710725794464,0.00567755240190779,-0.0100708954497946,0.0121851099656839,0.852298599943383
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42345,-0.00146901928258401,0.00797648110350939,-0.0171029222454624,0.0141648836802944,0.853883841960914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40135,0.00108197943995424,0.0060049597944975,-0.0106877417572609,0.0128517006371693,0.857013839951504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,40101,-0.000971009716711899,0.0053956852985661,-0.0115465529019015,0.00960453346847766,0.857186995283014
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,42345,-0.000566698865362845,0.00315270837135622,-0.00674600727322103,0.00561260954249534,0.857351723359312
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40448,0.00309816042958097,0.0173933019044087,-0.0309927113030601,0.037189032162222,0.85862898433068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40079,-0.000894953229157026,0.00503904384189031,-0.010771479159262,0.00898157270094799,0.859037461207292
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40510,-0.00131310133249886,0.00739747705045031,-0.0158121563513815,0.0131859536863837,0.859113623257675
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40198,0.00179221341777364,0.010100379622536,-0.018004530642397,0.0215889574779443,0.859165896214589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40481,0.000477040586725115,0.0027006021561461,-0.00481613963932124,0.00577022081277147,0.859792532133574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40482,0.000855029063496917,0.00484506915939711,-0.00864130648892142,0.0103513646159153,0.859924685702405
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,42356,-0.00146158001262463,0.00831149215668604,-0.0177521046397293,0.01482894461448,0.860414103434636
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42675,-0.00186880968688624,0.0108324282286276,-0.0231003690149964,0.0193627496412239,0.863031389479798
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,40008,0.00066625102608787,0.00388660456029369,-0.00695149391208777,0.00828399596426351,0.863894861435888
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40198,-0.00146884103481462,0.00871256437939675,-0.0185454672184322,0.015607785148803,0.866123165694201
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42635,0.00140157565932605,0.00848672869682447,-0.0152324125864499,0.018035563905102,0.868829106036706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42759,-0.000745476523973563,0.00454101691496665,-0.0096458696773082,0.00815491662936107,0.869603615503247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPHS2,Podocin,40198,0.00170201483152158,0.0104428574845191,-0.0187659858381359,0.022170015501179,0.870534315711522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,40510,-0.000461601261531298,0.00283239793416851,-0.00601310121250157,0.00508989868943897,0.870543472684663
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42710,0.00107358707565508,0.00661397339603602,-0.0118898007805755,0.0140369749318857,0.871055469121207
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40301,-0.00128323169042825,0.00795115798608363,-0.0168675013431522,0.0143010379622957,0.871789741934527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42345,0.000518403697162099,0.00321858079308983,-0.00579001465729396,0.00682682205161816,0.872043950658271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,42310,0.000878519808208806,0.00550167535198988,-0.00990476388169136,0.011661803498109,0.873133855749783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42710,0.00200660124646722,0.0126501083523006,-0.0227876111240419,0.0268008136169763,0.873968083043117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40198,-0.000472476127572049,0.00299389297643449,-0.00634050636138365,0.00539555410623955,0.874606814499937
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,42494,0.000552458031027376,0.00354231532865447,-0.00639048001313538,0.00749539607519013,0.876067244251473
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40450,0.00083669849247087,0.00547259599989394,-0.00988958966732124,0.011562986652263,0.878488729431267
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40181,-0.000456422135611058,0.00299177728178943,-0.00632030560791834,0.00540746133669622,0.878748970383101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40115,-0.000595119128400647,0.00400391359876195,-0.00844278978197407,0.00725255152517278,0.881844904398458
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,40481,0.00110800032421083,0.00755423146619231,-0.0136982933495261,0.0159142939979478,0.883392903817115
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42610,0.000350235040307882,0.00240069575083991,-0.00435512863133834,0.0050555987119541,0.884011227619952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42356,0.00111768886908599,0.00772077004584264,-0.0140150204207656,0.0162503981589376,0.884899493242651
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42675,0.00123618058401279,0.00856503007725876,-0.0155512783674144,0.01802363953544,0.885242988167027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,40198,0.000474357685417071,0.00330905843079351,-0.00601139683893822,0.00696011220977236,0.886015401412488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,42675,0.00110071983168009,0.00768018480056799,-0.0139524423774332,0.0161538820407934,0.886040040637526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40198,-0.000584623888036919,0.00408451514512464,-0.00859027357248121,0.00742102579640738,0.886188734029237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,40448,-0.000506457299652388,0.00359775403283853,-0.0075580552040159,0.00654514060471113,0.888053841392734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PI3,Elafin,42445,-0.000790045133686686,0.00564821081918313,-0.0118605383392856,0.0102804480719123,0.8887606498823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40531,0.000515541037977894,0.00375123328375904,-0.00683687619818983,0.00786795827414562,0.89069145364204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,42617,0.000380954456395675,0.00277652848435245,-0.00506104137293512,0.00582295028572647,0.890870570246121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40115,-0.000813669643830138,0.00596321557545076,-0.0125015721717136,0.0108742328840534,0.891469538314009
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,42310,-0.000782722895148617,0.00579037963550341,-0.0121318669807353,0.0105664211904381,0.892474449957646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,42720,0.000808562790648722,0.00601605308558524,-0.0109829012570983,0.0126000268383958,0.893087590510574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40181,0.00136566899134237,0.0102342170793608,-0.0186933964842048,0.0214247344668895,0.893846692700171
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,40450,0.000502122888409712,0.00380354000062221,-0.00695281551280983,0.00795706128962925,0.894975087320474
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42189,-0.00157101474336921,0.0119563512669304,-0.0250054632265528,0.0218634337398144,0.895464218345189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40115,0.000619025655309482,0.00473184816022504,-0.0086553967387316,0.00989344804935056,0.895919228286188
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,40285,0.00128799017355021,0.00992013121723451,-0.0181554670122294,0.0207314473593299,0.89669853325123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40301,-0.00081388657100875,0.00630691134328304,-0.0131754328038435,0.011547659661826,0.897322973475434
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDK,Midkine,42637,-0.000645150746571046,0.00505764083829792,-0.010558126789635,0.00926782529649288,0.898499396040012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,42586,-0.000243973295380279,0.0019217182348129,-0.00401054103561356,0.00352259444485301,0.898977279868199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40450,-0.000507632058520538,0.00407686614015622,-0.00849828969322673,0.00748302557618566,0.900909539974517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40510,-0.00064440623483733,0.00520838993584868,-0.0108528505091008,0.00956403803942609,0.901535489183229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,42593,0.000756387295500265,0.00627435489847169,-0.0115413483055042,0.0130541228965048,0.904047537907948
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,42494,0.000140919302304905,0.00119082385481982,-0.00219309545314193,0.00247493405775174,0.905801909839465
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,40115,0.000991554196830788,0.00842075758614429,-0.015513130672012,0.0174962390656736,0.906266973360261
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40079,-0.000404215408005885,0.00344771412109951,-0.00716173508536092,0.00635330426934916,0.906670790978211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40135,-0.000600233273184078,0.00512919356200612,-0.0106534526547161,0.00945298610834792,0.906844028584081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40481,0.000865842436683578,0.0074987386206207,-0.013831685259733,0.0155633701331001,0.908078553361392
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42586,0.00100750128467574,0.00873016067268821,-0.0161036136337932,0.0181186162031446,0.908126110250354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40448,-0.000291788806213564,0.00254759566401992,-0.0052850763076926,0.00470149869526547,0.908815765841535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,42537,-0.000635322821540981,0.00582142503064952,-0.012045315881614,0.0107746702385321,0.913096837714676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42310,0.000326025901840353,0.00299006599431973,-0.00553450344702632,0.00618655525070703,0.913175321886365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,40181,0.000699048338684313,0.00641739014283631,-0.0118790363412749,0.0132771330186435,0.913259749966893
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40448,-0.000285648125206303,0.00271291356113744,-0.00560295870503568,0.00503166245462308,0.9161459783199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40448,-0.000909879383950248,0.00878376668700115,-0.0181260620904725,0.016306303322572,0.91749937107931
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40481,0.000397901914392103,0.0038805714655062,-0.00720801815800004,0.00800382198678425,0.918332316871544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,40198,-0.000563814984875851,0.0055108763685147,-0.0113651326671647,0.010237502697413,0.918512882174125
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40198,-0.000479467360272576,0.00469210415904765,-0.00967599151200597,0.00871705679146081,0.918610901088097
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,42356,-0.000718314293912957,0.00710102410594517,-0.0146363215415655,0.0131996929537396,0.919427818724085
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,40181,0.000347071022248769,0.00343888824441827,-0.00639314993681103,0.00708729198130857,0.919611555809426
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40115,-0.000371538366742784,0.00375265812967175,-0.00772674830089941,0.00698367156741384,0.921134752920695
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40135,-0.00117825029666048,0.0120010956333515,-0.0247003977380294,0.0223438971447084,0.921792304741454
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,40482,-0.000269097196653727,0.00284410503616173,-0.00584354306753071,0.00530534867422325,0.924621700332183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40222,0.000567089092595401,0.00602688456014473,-0.0112456046452883,0.0123797828304791,0.925036800017196
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,40510,0.000455999086721607,0.00485158300138475,-0.00905310359599249,0.00996510176943571,0.925118960867388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40328,-0.000507003672441122,0.00553491608597776,-0.0113554392009575,0.0103414318560753,0.927016730065095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,40181,-0.000300399720805166,0.00332955037596799,-0.00682631845770243,0.0062255190160921,0.928112201702764
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,42603,-0.000817349972059753,0.0090675390885321,-0.0185897265855827,0.0169550266414632,0.928177134345694
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40301,-0.000809947036925654,0.00902117641425257,-0.0184914528088607,0.0168715587350094,0.928461386193707
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,40181,0.00054356586969467,0.00605672926766026,-0.0113276234949194,0.0124147552343088,0.928490874349483
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42356,-0.000283007851745601,0.00330282909175128,-0.00675655287157811,0.00619053716808691,0.931716940592071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,42124,-0.000285502217455101,0.00334887475845168,-0.00684929674402039,0.00627829230911019,0.932061434062638
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42310,-0.00070832688468762,0.00837652803941956,-0.01712632184195,0.0157096680725747,0.932611762753403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40079,0.00051945025056595,0.00631216200961662,-0.0118523872882826,0.0128912877894145,0.93441479264101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,40301,0.000362374499171567,0.00443801130953062,-0.00833612766750844,0.00906087666585158,0.934924562213684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40448,0.00119271225071999,0.0147536529428201,-0.0277244475172074,0.0301098720186474,0.935569181731016
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40301,0.000375559376966946,0.00471134474930088,-0.00885867633166278,0.00960979508559667,0.936466288620806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40481,-0.00026925245906265,0.00340380150551386,-0.00694070340986981,0.00640219849174451,0.936951737776384
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40135,0.000470646978451461,0.00622451914392839,-0.0117294105436482,0.0126707045005511,0.939729345827613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,40515,-0.000109093123862423,0.00145997524390322,-0.00297064460191273,0.00275245835418788,0.940436758116617
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42793,0.000519132378868663,0.00696993443771052,-0.013141939119044,0.0141802038767813,0.940628218852783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,42352,-0.000652789077828752,0.00881718878562255,-0.017934479097649,0.0166289009419914,0.940982893484392
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,40079,0.000192048685071403,0.00260879317420029,-0.00492118593636117,0.00530528330650398,0.941317363327855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,42345,0.000756432142748286,0.0104738641910096,-0.0197723416716305,0.021285205957127,0.942427192503277
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,42586,0.0013292219402479,0.0190607006786695,-0.0360297513899443,0.0386881952704401,0.944404623519571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,42369,-0.000202860309150931,0.00292508670552867,-0.00593603025198712,0.00553030963368526,0.944710570564857
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40448,0.000678629561501243,0.0103414750432228,-0.0195906615232154,0.0209479206462179,0.947679839973624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40482,0.000247144031759396,0.00377144494137925,-0.00714488805334394,0.00763917611686273,0.947752918799187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42593,0.000746610228996231,0.0118366223463703,-0.0224531695698896,0.023946390027882,0.949706695051342
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42720,0.000241212601874525,0.00393686684421168,-0.00747504641278036,0.00795747161652941,0.951144931850918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42345,0.000316234598135024,0.00524205333452021,-0.00995818993752458,0.0105906591337946,0.951896533206408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAX,Protein max,42310,0.000601574239584289,0.010373040413096,-0.0197295849700838,0.0209327334492524,0.953754280968683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,42602,0.000220491427511202,0.00400306491992309,-0.00762551581553806,0.00806649867056046,0.956075030534364
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40198,0.000153355422371823,0.0029398993188923,-0.00560884724265708,0.00591555808740073,0.958399367215919
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,42310,-0.000225413286917883,0.00452987858108687,-0.00910397530584815,0.00865314873201238,0.960313251724601
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40450,-0.000258055004683506,0.00547764149078353,-0.0109942323266192,0.0104781223172522,0.962425910921937
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,40115,-0.00042689266778504,0.00917959943387504,-0.0184189075581801,0.01756512222261,0.962908999018538
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40301,0.000371054423910318,0.00801835838071167,-0.0153449280022846,0.0160870368501052,0.963091410958569
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,40115,0.000213895876548092,0.00470651404044374,-0.00901087164272164,0.00943866339581782,0.963752030717459
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42369,-0.000133020966254189,0.00295366863072449,-0.00592221148247419,0.00565616954996581,0.9640794193052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,40079,0.000277455446275509,0.00664483055383925,-0.0127464124392494,0.0133013233318004,0.966694708768308
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,42590,-9.88709972078636e-05,0.00246602174526399,-0.00493227361792528,0.00473453162350956,0.9680193254328
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,42710,-0.000147465592031647,0.00372234104209449,-0.00744325403453684,0.00714832285047355,0.968399571700234
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40481,-0.000449597530249408,0.0114529272715573,-0.0228973349825016,0.0219981399220028,0.968686882093228
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42369,0.000209270871765229,0.00564060127441348,-0.0108463076260852,0.0112648493696157,0.970405188902011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42586,-0.00016781539421415,0.00452390430925895,-0.00903466784036169,0.00869903705193339,0.970409606479267
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,40301,0.000127982488590074,0.00350259396880478,-0.00673710169026728,0.00699306666744743,0.970852963700964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,40079,0.000113565381345136,0.00311480689581846,-0.00599145613445904,0.00621858689714932,0.970916363820283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40079,0.000172758246493917,0.00475122509740895,-0.00913964294442762,0.00948515943741545,0.970995353938684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40115,0.000204335683560464,0.00569893713992993,-0.0109655811107022,0.0113742524778231,0.971398591963186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,40222,0.000213840135229216,0.00622226183555115,-0.011981793062451,0.0124094733329095,0.97258516330598
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,42710,-0.000104812906824556,0.0031803949942543,-0.00633838709556297,0.00612876128191386,0.973710209898759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,40198,0.000148859557350785,0.00458459983389091,-0.0088369561170754,0.00913467523177697,0.974098246159922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,40079,0.000186548737615003,0.00589758668437445,-0.0113727211637589,0.0117458186389889,0.974766607400833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42172,0.000269776997561689,0.00853076398630937,-0.0164505204156047,0.0169900744107281,0.974772379063062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40181,0.000111473837132439,0.00360863600431461,-0.00696145273132419,0.00718440040558907,0.975357147375347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,40115,9.28434735568401e-05,0.00332280617986344,-0.0064198566389755,0.00660554358608918,0.977709491375577
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,42345,0.000375328002285368,0.0138358067541329,-0.0267428532358152,0.0274935092403859,0.978358616638287
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,40181,0.000163046672865605,0.00609580493136342,-0.0117847309926067,0.0121108243383379,0.978661726692602
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40135,-0.000107570065302137,0.00429959819609935,-0.00853478252965685,0.00831964239905258,0.980040558285081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40115,9.56145206971721e-05,0.00401547562489937,-0.00777471770410559,0.00796594674549994,0.981003397470914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40301,-0.000113458698225094,0.00542608337743921,-0.010748582118006,0.0105216647215558,0.983317928795477
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,40198,5.65355082527179e-05,0.00280280823465802,-0.00543696863167701,0.00555003964818244,0.983907309507684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,40181,0.000141288424567403,0.00709399718091141,-0.013762946050019,0.0140455228991538,0.984110251014835
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40481,-9.40096704210935e-05,0.00491124709998314,-0.00972005398638805,0.00953203464554587,0.984728395653946
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40181,-7.85517855203513e-05,0.00425845042510703,-0.00842511461873014,0.00826801104768943,0.985283314311946
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOST,Sclerostin,42612,7.03743444811313e-05,0.00386136063947516,-0.00749789250889018,0.00763864119785244,0.985459413536161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40079,-7.29655372381441e-05,0.00415417109655171,-0.0082151408864795,0.00806920981200321,0.985986676125993
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,42369,7.3763532200115e-05,0.00475364328779511,-0.0092433773118783,0.00939090437627853,0.987619747379784
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40135,-7.44644341402427e-05,0.00697703091474632,-0.013749445027043,0.0136005161587625,0.991484696362794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40510,-2.58989683001364e-05,0.0028172618565271,-0.00554773220709325,0.00549593427049298,0.992665346567204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42586,-8.1956667140065e-05,0.00920999689906533,-0.0181335505893081,0.017969637255028,0.992900119695571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,40198,-4.4110064732668e-05,0.00705919715793724,-0.0138801364942897,0.0137919163648243,0.995014488161398
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,40135,-3.62833989952648e-05,0.00724098885250587,-0.0142286215499068,0.0141560547519162,0.996002040355097
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42602,2.64432860765663e-05,0.0107726167236947,-0.021087885492365,0.0211407720645181,0.998041490228837
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40510,-1.55630427443011e-05,0.00962078550386559,-0.0188723026303209,0.0188411765448323,0.99870933285317
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,40198,4.57206507296906e-06,0.00307770506081938,-0.00602772985413301,0.00603687398427895,0.998814735057058
